[{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/oeoJiA3cbK","expanded_url":"http://bit.ly/1tLJzIV","display_url":"bit.ly/1tLJzIV"}],"hashtags":[{"start":79,"end":89,"tag":"Myroxylon"},{"start":123,"end":130,"tag":"herbal"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"517379740593033216","text":"Two weeks to answer our call for scientific data for use in assessment work on #Myroxylon balsamum: http://t.co/oeoJiA3cbK #herbal","id":"517379740593033216","lang":"en","created_at":"2014-10-01T18:25:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/LUFiVfMdNo","expanded_url":"http://bit.ly/1mUoCGB","display_url":"bit.ly/1mUoCGB"}],"hashtags":[{"start":25,"end":35,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"517379556358238208","text":"Comment on revising the  #guideline on medicines to prevent venous thromboembolic risk in non-surgical patients: http://t.co/LUFiVfMdNo","id":"517379556358238208","lang":"en","created_at":"2014-10-01T18:24:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/BRfJPZcp67","expanded_url":"http://bit.ly/1ucDP9s","display_url":"bit.ly/1ucDP9s"}],"hashtags":[{"start":83,"end":101,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"517379434098479105","text":"Two weeks left to comment on our draft procedural rules for public hearings at our #pharmacovigilance committee: http://t.co/BRfJPZcp67","id":"517379434098479105","lang":"en","created_at":"2014-10-01T18:24:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/LUFiVfMdNo","expanded_url":"http://bit.ly/1mUoCGB","display_url":"bit.ly/1mUoCGB"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"517238410713763841","text":"Comment on paper on revising #guideline on medicines to prevent venous thromboembolic risk in non-surgical patients: http://t.co/LUFiVfMdNo","id":"517238410713763841","lang":"en","created_at":"2014-10-01T09:03:41.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/BRfJPZcp67","expanded_url":"http://bit.ly/1ucDP9s","display_url":"bit.ly/1ucDP9s"}],"hashtags":[{"start":74,"end":92,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"517237342973988865","text":"Two weeks to comment on draft procedural rules for public hearings at our #pharmacovigilance committee: http://t.co/BRfJPZcp67","id":"517237342973988865","lang":"en","created_at":"2014-10-01T08:59:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/oeoJiA3cbK","expanded_url":"http://bit.ly/1tLJzIV","display_url":"bit.ly/1tLJzIV"}],"hashtags":[{"start":79,"end":89,"tag":"Myroxylon"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"517236873732059136","text":"Two weeks to answer our call for scientific data for use in assessment work on #Myroxylon balsamum: http://t.co/oeoJiA3cbK","id":"517236873732059136","lang":"en","created_at":"2014-10-01T08:57:35.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/nGco1FmG97","expanded_url":"http://bit.ly/1pDU218","display_url":"bit.ly/1pDU218"}],"hashtags":[{"start":70,"end":81,"tag":"paediatric"}],"mentions":[{"start":4,"end":18,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"517236355567734784","text":"The @EU_Commission has issued a revised guideline on applications for #paediatric investigation plans: http://t.co/nGco1FmG97","id":"517236355567734784","lang":"en","created_at":"2014-10-01T08:55:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/wNKXzUrXbk","expanded_url":"http://bit.ly/1CEffkA","display_url":"bit.ly/1CEffkA"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":35,"tag":"orphan"},{"start":36,"end":46,"tag":"medicines"},{"start":58,"end":63,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"517236222058856448","text":"The #agenda for next week's #orphan #medicines committee (#COMP) is now available: http://t.co/wNKXzUrXbk","id":"517236222058856448","lang":"en","created_at":"2014-10-01T08:54:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/GPIkTqQppM","expanded_url":"http://1.usa.gov/1nFLMDI","display_url":"1.usa.gov/1nFLMDI"}],"hashtags":[{"start":134,"end":138,"tag":"fda"}],"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516992361407475712","text":"RT @FDAcdrhIndustry: Internet/Social Media W Character Limits: Presenting Risk/Benefit Info; Comments Reopened http://t.co/GPIkTqQppM #fda …","id":"516992361407475712","lang":"en","created_at":"2014-09-30T16:45:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516992216381026304"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/M3TjdQ1cK4","expanded_url":"http://1.usa.gov/1vs99PT","display_url":"1.usa.gov/1vs99PT"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516991820145123328","text":"RT @FDAcdrhIndustry: Internet/Social Media: Correcting 3rd-Party Misinfo re Rx Drugs &amp; Med Devs; Comments Reopened http://t.co/M3TjdQ1cK4 #…","id":"516991820145123328","lang":"en","created_at":"2014-09-30T16:43:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516991209613844480"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/wNKXzUrXbk","expanded_url":"http://bit.ly/1CEffkA","display_url":"bit.ly/1CEffkA"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":36,"end":43,"tag":"orphan"},{"start":44,"end":53,"tag":"medicine"},{"start":65,"end":70,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"516987141625479170","text":"We've published the #agenda for our #orphan #medicine committee (#COMP) next week: http://t.co/wNKXzUrXbk","id":"516987141625479170","lang":"en","created_at":"2014-09-30T16:25:14.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":35,"end":42,"tag":"Animal"},{"start":127,"end":132,"tag":"Dogs"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516985882914881536","text":"RT @FDAanimalhealth: #FDA's Target #Animal Safety Data Supports Drug Applications for Potassium Bromide to Control Seizures in #Dogs http:/…","id":"516985882914881536","lang":"en","created_at":"2014-09-30T16:20:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516982899191848962"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":13,"end":35,"url":"http://t.co/rX11yUA0qS","expanded_url":"http://EpilepsyDiagnosis.org","display_url":"EpilepsyDiagnosis.org"},{"start":108,"end":130,"url":"http://t.co/sWbrP6wBE4","expanded_url":"http://www.ilae.org/commission/class/diagnostic.cfm","display_url":"ilae.org/commission/cla…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516985757693931520","text":"RT @IlaeWeb: http://t.co/rX11yUA0qS is the new online Diagnostic Manual from ILAE for clinicians worldwide. http://t.co/sWbrP6wBE4","id":"516985757693931520","lang":"en","created_at":"2014-09-30T16:19:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516981112074412032"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":44,"end":52,"tag":"patient"},{"start":100,"end":109,"tag":"medicine"},{"start":110,"end":122,"tag":"development"},{"start":123,"end":131,"tag":"IMI2OID"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516984925112008704","text":"RT @IMI_JU: Another new topic will create a #patient knowledge repository to enable patient-focused #medicine #development #IMI2OID","id":"516984925112008704","lang":"en","created_at":"2014-09-30T16:16:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516956862756171776"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/MgmL72UVdj","expanded_url":"http://bit.ly/1ylQQBt","display_url":"bit.ly/1ylQQBt"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516952489577689088","text":"RT @EU_ECHA: New JRC report reviews methods available for assessing chemical safety. Read and pass it on http://t.co/MgmL72UVdj http://t.co…","id":"516952489577689088","lang":"en","created_at":"2014-09-30T14:07:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516952027327660032"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/ThJkk9AMaL","expanded_url":"http://goo.gl/59c2yo","display_url":"goo.gl/59c2yo"}],"hashtags":[{"start":27,"end":37,"tag":"hepatitis"},{"start":76,"end":81,"tag":"HEPC"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":48,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516952458007175168","text":"RT @WHO: Analysis of 7 new #hepatitis C meds patents http://t.co/ThJkk9AMaL #HEPC","id":"516952458007175168","lang":"en","created_at":"2014-09-30T14:07:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516951903704719360"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":29,"end":43,"tag":"antimicrobial"},{"start":59,"end":66,"tag":"Europe"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516952333578928128","text":"RT @ECDC_EU: Surveillance of #antimicrobial consumption in #Europe 2012 - download the report &amp; individual images, excel files http://t.co/…","id":"516952333578928128","lang":"en","created_at":"2014-09-30T14:06:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516951424203493378"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/nGco1FmG97","expanded_url":"http://bit.ly/1pDU218","display_url":"bit.ly/1pDU218"}],"hashtags":[{"start":73,"end":84,"tag":"paediatric"}],"mentions":[{"start":4,"end":18,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"516951880120147968","text":"The @EU_Commission has published a revised guideline on applications for #paediatric investigation plans: http://t.co/nGco1FmG97","id":"516951880120147968","lang":"en","created_at":"2014-09-30T14:05:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/kGntfgE56x","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"hashtags":[{"start":15,"end":26,"tag":"employment"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":76,"end":103,"probability":0.3969,"type":"Organization","normalized_text":"Scientific Programme Officer"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516950891786940417","text":"RT @edqm_news: #employment Last day to apply for the Secondment position of Scientific Programme Officer  http://t.co/kGntfgE56x","id":"516950891786940417","lang":"en","created_at":"2014-09-30T14:01:11.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516949203126583296"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/iob1KUUQmC","expanded_url":"http://buzz.mw/bchwt_f","display_url":"buzz.mw/bchwt_f"}],"hashtags":[{"start":63,"end":76,"tag":"Transparency"},{"start":126,"end":137,"tag":"rtkd2014eo"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516941841091264512","text":"RT @EUombudsman: [VIDEO] You can watch the video of the event: #Transparency &amp; public health here: http://t.co/iob1KUUQmC #rtkd2014eo #allt…","id":"516941841091264512","lang":"en","created_at":"2014-09-30T13:25:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516941788029128705"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":27,"end":29,"probability":0.8382,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516941441495752704","text":"RT @FDA_Drug_Info: What is FDA doing to encourage greater diversity in clinical trials? Join the FDASIA 907 Action Plan webinar on 10/7! ht…","id":"516941441495752704","lang":"en","created_at":"2014-09-30T13:23:38.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516938749411098624"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/28dQtwqYoW","expanded_url":"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61723-2/fulltext","display_url":"thelancet.com/journals/lance…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":62,"end":67,"probability":0.9964,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516907791802699776","text":"RT @GCessak: Funding for antimicrobial resistance research in Europe: http://t.co/28dQtwqYoW","id":"516907791802699776","lang":"en","created_at":"2014-09-30T11:09:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516893078020694016"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/HeDqRvpLTi","expanded_url":"http://wh.gov/ilTUL","display_url":"wh.gov/ilTUL"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":[{"start":21,"end":25,"probability":0.962,"type":"Person","normalized_text":"Obama"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516907699775475712","text":"RT @EU_ScienceChief: Obama Administration Takes Actions to Combat Antibiotic-Resistant Bacteria | The White House: http://t.co/HeDqRvpLTi @…","id":"516907699775475712","lang":"en","created_at":"2014-09-30T11:09:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516892269324935168"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":90,"end":95,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516907128993611776","text":"RT @edqm_news: Are you attending our 50th anniversary conference on 6-8 October 2014? The #EDQM has important information for you: http://t…","id":"516907128993611776","lang":"en","created_at":"2014-09-30T11:07:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516886729115332608"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/YbPYza4Utf","expanded_url":"http://bit.ly/OID2014","display_url":"bit.ly/OID2014"}],"hashtags":[{"start":41,"end":46,"tag":"IMI2"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516905999228489728","text":"RT @IMI_JU: Starting now: session on the #IMI2 rules &amp; procedures plus tips for applicants. Follow it online via http://t.co/YbPYza4Utf #IM…","id":"516905999228489728","lang":"en","created_at":"2014-09-30T11:02:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516875327466110976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":28,"tag":"EPhearings2014"},{"start":29,"end":42,"tag":"Andriukaitis"},{"start":71,"end":75,"tag":"AMR"},{"start":89,"end":103,"tag":"Antimicrobial"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516905788888334336","text":"RT @EPHA_EU: #EPhearings2014 #Andriukaitis » Antimicrobial Resistance (#AMR) huge issue. #Antimicrobial used in European hospital should ge…","id":"516905788888334336","lang":"en","created_at":"2014-09-30T11:01:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516875183756681216"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":34,"tag":"Andriukaitis"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"},{"start":123,"end":133,"username":"beuctweet","id":"3061421219"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516905778423545856","text":"RT @IlariaPassarani: #Andriukaitis :\"We must strictly control that antibiotics in livestock are used only for diseases\".MT:@beuctweet http:…","id":"516905778423545856","lang":"en","created_at":"2014-09-30T11:01:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516875126215020544"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"Andriukaitis"},{"start":96,"end":108,"tag":"antibiotics"},{"start":110,"end":114,"tag":"AMR"},{"start":115,"end":130,"tag":"EPhearings2014"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516875028198350848","text":"RT @EU_Health: #Andriukaitis We have very strict rules on prudent human &amp; veterinary use of #antibiotics  #AMR #EPhearings2014 #TeamJuncker…","id":"516875028198350848","lang":"en","created_at":"2014-09-30T08:59:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516874847704858624"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":17,"end":32,"tag":"EPhearings2014"},{"start":33,"end":46,"tag":"Andriukaitis"},{"start":136,"end":140,"tag":"AMR"}],"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516875009776967680","text":"RT @CPME_EUROPA: #EPhearings2014 #Andriukaitis Antibiotics must be used only to treat diseases not for feeding animals to prevent human #AMR","id":"516875009776967680","lang":"en","created_at":"2014-09-30T08:59:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516874738640355328"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":37,"end":59,"url":"http://t.co/efWMfRIYUE","expanded_url":"http://bit.ly/1rpyz2y","display_url":"bit.ly/1rpyz2y"}],"hashtags":[{"start":60,"end":67,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516873924668563456","text":"RT @LV_MPA: Internal medicine doctor http://t.co/efWMfRIYUE #newjob","id":"516873924668563456","lang":"ro","created_at":"2014-09-30T08:55:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":117,"end":127,"username":"TheLancet","id":"27013292"}],"annotations":[{"start":61,"end":66,"probability":0.9952,"type":"Place","normalized_text":"Europe"},{"start":82,"end":109,"probability":0.4762,"type":"Person","normalized_text":"Commissioner Máire Geoghegan"},{"start":111,"end":115,"probability":0.4734,"type":"Person","normalized_text":"Quinn"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516872653437927424","text":"RT @EFPIA: \"Funding for antimicrobial resistance research in Europe\" - words from Commissioner Máire Geoghegan-Quinn @TheLancet http://t.co…","id":"516872653437927424","lang":"en","created_at":"2014-09-30T08:50:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516863539227938816"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":12,"end":17,"tag":"IMI2"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516872539789099008","text":"RT @IMI_JU: #IMI2 is OPEN to involvement of other life sci industries - animal health, imaging, diagnostics, vaccines, ICT etc all welcome …","id":"516872539789099008","lang":"en","created_at":"2014-09-30T08:49:51.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516863373066391552"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/sCROexsbke","expanded_url":"http://imi.efpia.eu","display_url":"imi.efpia.eu"}],"hashtags":[{"start":98,"end":106,"tag":"IMI2OID"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":44,"end":50,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516872282275590144","text":"RT @IMI_JU: Got an idea for an IMI project? @EFPIA wants to hear from you! http://t.co/sCROexsbke #IMI2OID","id":"516872282275590144","lang":"en","created_at":"2014-09-30T08:48:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516860749462142976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":130,"end":138,"tag":"IMI2OID"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516872017325592576","text":"RT @IMI_JU: Priority areas for IMI 2: neurodegeneration, immune-mediated diseases, metabolic disorders, infection control, safety #IMI2OID","id":"516872017325592576","lang":"en","created_at":"2014-09-30T08:47:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516859072231264256"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":120,"end":128,"tag":"IMI2OID"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":64,"end":68,"username":"WHO","id":"14499829"}],"annotations":[{"start":97,"end":102,"probability":0.9669,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516871888774377472","text":"RT @IMI_JU: IMI's new Strategic Research Agenda is aligned with @WHO report on priority meds for Europe &amp; the world #IMI2OID http://t.co/Ed…","id":"516871888774377472","lang":"en","created_at":"2014-09-30T08:47:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516858251640836096"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":50,"end":58,"tag":"science"},{"start":118,"end":127,"tag":"OpenEFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516871783560278016","text":"RT @EFSA_EU: How to increase public engagement in #science? 2 weeks left to comment on the paper Transformation to an #OpenEFSA http://t.co…","id":"516871783560278016","lang":"en","created_at":"2014-09-30T08:46:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516857672579440640"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/BZhgkI4Rna","expanded_url":"https://twitter.com/IMI_JU/status/516857147058290688/photo/1","display_url":"pic.twitter.com/BZhgkI4Rna"}],"hashtags":[{"start":69,"end":77,"tag":"IMI2OID"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":48,"end":59,"username":"MagdaEfpia","id":"301066342"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516871669311606784","text":"RT @IMI_JU: How has IMI evolved over the years? @MagdaEfpia explains #IMI2OID http://t.co/BZhgkI4Rna","id":"516871669311606784","lang":"en","created_at":"2014-09-30T08:46:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516857147058290688"}],"attachments":{"media_keys":["3_516857145732898816"]}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516869881174949889","text":"RT @innovationunion: #ResearchHeadlines - Better insights into treating hepatitis C: With nearly 200 million infected people worldwide,… ht…","id":"516869881174949889","lang":"en","created_at":"2014-09-30T08:39:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516853770076966912"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/FYvOFDXESi","expanded_url":"http://ow.ly/C68fD","display_url":"ow.ly/C68fD"}],"hashtags":[{"start":83,"end":90,"tag":"ESMO14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":27,"end":41,"probability":0.7795,"type":"Other","normalized_text":"Cancer Medicine"}]},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516869662609784833","text":"RT @myESMO: Press release: Cancer Medicine becoming ever more precise, as shown by #ESMO14 practice-changing results http://t.co/FYvOFDXESi","id":"516869662609784833","lang":"en","created_at":"2014-09-30T08:38:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516852614311731200"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":16,"end":21,"tag":"IMI2"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516869598785073152","text":"RT @IMI_JU: Our #IMI2 info day is starting now. Wish you were here? Follow all sessions live online – find out how at http://t.co/YbPYza4Ut…","id":"516869598785073152","lang":"en","created_at":"2014-09-30T08:38:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516852588151832577"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/aWV7jTTGcV","expanded_url":"http://bit.ly/10cKV2p","display_url":"bit.ly/10cKV2p"}],"hashtags":[{"start":57,"end":67,"tag":"medicines"},{"start":68,"end":79,"tag":"innovation"},{"start":105,"end":109,"tag":"SME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648995352215552","text":"We support small and medium-sized enterprises in driving #medicines #innovation: http://t.co/aWV7jTTGcV  #SME","id":"516648995352215552","lang":"en","created_at":"2014-09-29T18:01:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/c38WWG2Fsp","expanded_url":"http://bit.ly/1wQvlUZ","display_url":"bit.ly/1wQvlUZ"}],"hashtags":[{"start":0,"end":7,"tag":"Agenda"},{"start":23,"end":30,"tag":"herbal"},{"start":31,"end":41,"tag":"medicines"},{"start":90,"end":95,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648722852478976","text":"#Agenda of this week's #herbal #medicines committee now available: http://t.co/c38WWG2Fsp #HMPC","id":"516648722852478976","lang":"en","created_at":"2014-09-29T18:00:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":22,"tag":"Europe"},{"start":60,"end":63,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":81,"end":89,"username":"borgton","id":"1605512862"},{"start":90,"end":100,"username":"EU_Health","id":"606325697"},{"start":101,"end":115,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648542262558721","text":"RT @EU_Health: #Europe staying true to values 'enshrined in #EU health strategy' @borgton @EU_Health @EU_Commission \nhttps://t.co/ITjEWafzJ…","id":"516648542262558721","lang":"en","created_at":"2014-09-29T17:59:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516562076551356416"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/CAD5oMu4CO","expanded_url":"http://bit.ly/1sgXZjM","display_url":"bit.ly/1sgXZjM"}],"hashtags":[{"start":13,"end":28,"tag":"EPhearings2014"},{"start":50,"end":55,"tag":"TTIP"},{"start":124,"end":129,"tag":"ISDS"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":29,"end":41,"username":"MalmstromEU","id":"460966881"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648355309813760","text":"RT @EPHA_EU: #EPhearings2014 @MalmstromEU  » Will #TTIP bring benefits to patients or big pharma?: http://t.co/CAD5oMu4CO   #ISDS","id":"516648355309813760","lang":"en","created_at":"2014-09-29T17:59:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516573139019792384"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/YbPYza4Utf","expanded_url":"http://bit.ly/OID2014","display_url":"bit.ly/OID2014"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648293024419840","text":"RT @IMI_JU: Can’t make it to our Info Day tomorrow? Follow it live online (details at http://t.co/YbPYza4Utf) or join the conversation via …","id":"516648293024419840","lang":"en","created_at":"2014-09-29T17:58:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516579895930286080"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":76,"end":92,"tag":"50thanniversary"},{"start":111,"end":116,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648241627406336","text":"RT @edqm_news: Key representatives from 38 countries will attend high-level #50thanniversary conference at the #EDQM. Programme: http://t.c…","id":"516648241627406336","lang":"en","created_at":"2014-09-29T17:58:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516586179844907010"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/EZB6tCn4Sx","expanded_url":"http://bit.ly/1uGb1nV","display_url":"bit.ly/1uGb1nV"}],"hashtags":[{"start":85,"end":97,"tag":"stakeholder"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":109,"end":116,"probability":0.9837,"type":"Place","normalized_text":"Brussels"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648176892526592","text":"RT @EFSA_EU: Threshold of Toxicological Concern: register by 20 Oct to attend EFSA’s #stakeholder meeting in Brussels http://t.co/EZB6tCn4Sx","id":"516648176892526592","lang":"en","created_at":"2014-09-29T17:58:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516594266324606976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":30,"end":33,"probability":0.3838,"type":"Organization","normalized_text":"ECHA"},{"start":114,"end":121,"probability":0.9187,"type":"Place","normalized_text":"Helsinki"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516648096747765760","text":"RT @EU_ECHA: Wish to work for ECHA? Apply by 20 October for our Administrative Assistant positions and join us in Helsinki http://t.co/BK9G…","id":"516648096747765760","lang":"en","created_at":"2014-09-29T17:57:59.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516597033759948800"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":20,"end":23,"tag":"EU"},{"start":62,"end":68,"tag":"Ebola"},{"start":104,"end":119,"tag":"HealthSecurity"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":78,"end":86,"username":"borgton","id":"1605512862"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516647717666566144","text":"RT @EU_Health: 'The #EU is fully engaged in the fight against #Ebola' - Cssr. @borgton speech at Global #HealthSecurity Agenda http://t.co/…","id":"516647717666566144","lang":"en","created_at":"2014-09-29T17:56:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516620706051010560"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/5z4SMyol4X","expanded_url":"http://ow.ly/C4HGE","display_url":"ow.ly/C4HGE"}],"hashtags":[{"start":24,"end":36,"tag":"OncologyPRO"},{"start":136,"end":143,"tag":"ESMO14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":79,"end":90,"probability":0.3809,"type":"Organization","normalized_text":"ESMO Members"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516647616185368576","text":"RT @myESMO: Do you know #OncologyPRO, our scientific &amp; educational website for ESMO Members? Get a peek here http://t.co/5z4SMyol4X #ESMO14","id":"516647616185368576","lang":"en","created_at":"2014-09-29T17:56:05.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516629337672777728"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/yiHYVBtuYz","expanded_url":"http://bit.ly/1mHa9A8","display_url":"bit.ly/1mHa9A8"}],"hashtags":[{"start":13,"end":25,"tag":"Enterovirus"},{"start":55,"end":58,"tag":"EU"},{"start":89,"end":95,"tag":"Evd68"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516647526204985346","text":"RT @ECDC_EU: #Enterovirus D68: no increase of cases in #EU so far http://t.co/yiHYVBtuYz #Evd68","id":"516647526204985346","lang":"en","created_at":"2014-09-29T17:55:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"516642515102216193"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/c38WWG2Fsp","expanded_url":"http://bit.ly/1wQvlUZ","display_url":"bit.ly/1wQvlUZ"}],"hashtags":[{"start":41,"end":48,"tag":"herbal"},{"start":49,"end":59,"tag":"medicines"},{"start":102,"end":107,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"516516201510744064","text":"We've published the agenda of this weeks #herbal #medicines committee meeting: http://t.co/c38WWG2Fsp #HMPC","id":"516516201510744064","lang":"en","created_at":"2014-09-29T09:13:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/dqydHodOPT","expanded_url":"http://bit.ly/1pfQLG2","display_url":"bit.ly/1pfQLG2"}],"hashtags":[{"start":52,"end":62,"tag":"medicines"},{"start":73,"end":78,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516515973927825408","text":"We've published the highlights of last week's human #medicines committee #CHMP: http://t.co/dqydHodOPT","id":"516515973927825408","lang":"en","created_at":"2014-09-29T09:12:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/AqrEoQEWzm","expanded_url":"http://bit.ly/1yuaaN1","display_url":"bit.ly/1yuaaN1"}],"hashtags":[{"start":29,"end":41,"tag":"Clopidogrel"},{"start":44,"end":60,"tag":"Acetylsalicylic"},{"start":89,"end":98,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516515550374416384","text":"We've published the EPAR for #Clopidogrel / #Acetylsalicylic acid Teva, a blood-thinning #medicine: http://t.co/AqrEoQEWzm","id":"516515550374416384","lang":"en","created_at":"2014-09-29T09:11:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/xuVZw8m04Q","expanded_url":"http://bit.ly/1t1Ppjr","display_url":"bit.ly/1t1Ppjr"}],"hashtags":[{"start":30,"end":38,"tag":"Harvoni"},{"start":40,"end":51,"tag":"ledipasvir"},{"start":54,"end":65,"tag":"sofosbuvir"},{"start":92,"end":103,"tag":"hepatitisC"},{"start":128,"end":137,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516515319729623040","text":"We've recommended approval of #Harvoni (#ledipasvir / #sofosbuvir) for treatment of chronic #hepatitisC: http://t.co/xuVZw8m04Q #medicine","id":"516515319729623040","lang":"en","created_at":"2014-09-29T09:10:23.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/yFbkcHQkB8","expanded_url":"http://bit.ly/1uLMIVa","display_url":"bit.ly/1uLMIVa"}],"hashtags":[{"start":34,"end":43,"tag":"medicine"},{"start":44,"end":57,"tag":"Ketoconazole"},{"start":66,"end":74,"tag":"Cushing"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516515075352723456","text":"We've recommended approval of the #medicine #Ketoconazole HRA for #Cushing's syndrome: http://t.co/yFbkcHQkB8","id":"516515075352723456","lang":"en","created_at":"2014-09-29T09:09:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/0detryUayj","expanded_url":"http://bit.ly/1uti0UB","display_url":"bit.ly/1uti0UB"}],"hashtags":[{"start":37,"end":47,"tag":"medicines"},{"start":52,"end":58,"tag":"Ebola"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516514663732113408","text":"We've started reviewing experimental #medicines for #Ebola to support treatment decisions: http://t.co/0detryUayj","id":"516514663732113408","lang":"en","created_at":"2014-09-29T09:07:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/ZadzS8WQxw","expanded_url":"http://bit.ly/1qBM9JV","display_url":"bit.ly/1qBM9JV"}],"hashtags":[{"start":49,"end":58,"tag":"Valdoxan"},{"start":61,"end":70,"tag":"Thymanax"},{"start":72,"end":84,"tag":"agomelatine"},{"start":110,"end":125,"tag":"antidepressant"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"516514308990468096","text":"We've confirmed positive benefit-risk balance of #Valdoxan / #Thymanax (#agomelatine): http://t.co/ZadzS8WQxw #antidepressant","id":"516514308990468096","lang":"en","created_at":"2014-09-29T09:06:22.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/aWV7jTTGcV","expanded_url":"http://bit.ly/10cKV2p","display_url":"bit.ly/10cKV2p"}],"hashtags":[{"start":63,"end":74,"tag":"innovation"},{"start":78,"end":88,"tag":"medicines"},{"start":113,"end":117,"tag":"SME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"516513107032952833","text":"We're supporting small and medium-sized enterprises in driving #innovation in #medicines: http://t.co/aWV7jTTGcV #SME","id":"516513107032952833","lang":"en","created_at":"2014-09-29T09:01:35.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/AqrEoQEWzm","expanded_url":"http://bit.ly/1yuaaN1","display_url":"bit.ly/1yuaaN1"}],"hashtags":[{"start":42,"end":54,"tag":"Clopidogrel"},{"start":57,"end":73,"tag":"Acetylsalicylic"},{"start":102,"end":111,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515540877985710080","text":"We've published the assessment report for #Clopidogrel / #Acetylsalicylic acid Teva, a blood-thinning #medicine: http://t.co/AqrEoQEWzm","id":"515540877985710080","lang":"en","created_at":"2014-09-26T16:38:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/43OWRJ15s2","expanded_url":"http://europa.eu/rapid/press-release_SPEECH-14-633_en.htm","display_url":"europa.eu/rapid/press-re…"}],"hashtags":[{"start":61,"end":67,"tag":"Ebola"},{"start":99,"end":109,"tag":"GHSAgenda"}],"mentions":[{"start":3,"end":13,"username":"EUintheUS","id":"217616314"}],"annotations":[{"start":20,"end":21,"probability":0.4928,"type":"Organization","normalized_text":"EU"},{"start":71,"end":90,"probability":0.3275,"type":"Organization","normalized_text":"EU Commissioner Borg"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515531133447340032","text":"RT @EUintheUS: \"The EU is fully engaged in the fight against #Ebola\" - EU Commissioner Borg at the #GHSAgenda : http://t.co/43OWRJ15s2","id":"515531133447340032","lang":"en","created_at":"2014-09-26T15:59:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515530930996658177"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515531006326349824","text":"RT @MHRAgovuk: September's Drug Safety Update is out and includes: ferumoxytol, denosumab and reporting ADRs in children http://t.co/8NTJuF…","id":"515531006326349824","lang":"en","created_at":"2014-09-26T15:59:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515530381857406976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"},{"start":25,"end":29,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515528122582958080","text":"RT @ECDC_Outbreaks: From @WHO Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients ht…","id":"515528122582958080","lang":"en","created_at":"2014-09-26T15:47:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515528051820879872"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/yuODNiotrX","expanded_url":"http://bit.ly/1sy0COl","display_url":"bit.ly/1sy0COl"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":[{"start":71,"end":75,"probability":0.4397,"type":"Other","normalized_text":"Ebola"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515525081469317121","text":"RT @Berlaymont: Speech - “The EU is fully engaged in the fight against Ebola” http://t.co/yuODNiotrX","id":"515525081469317121","lang":"en","created_at":"2014-09-26T15:35:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515522733929541632"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/9nKJ6sNHM6","expanded_url":"http://ow.ly/BYBXB","display_url":"ow.ly/BYBXB"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":46,"end":76,"probability":0.3272,"type":"Organization","normalized_text":"Multikinase Inhibitor Therapies"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515500303194783744","text":"RT @myESMO: NEW: Mgmt of Skin Toxicities from Multikinase Inhibitor Therapies: for HCPs &amp; patients http://t.co/9nKJ6sNHM6 http://t.co/LYbxL…","id":"515500303194783744","lang":"en","created_at":"2014-09-26T13:57:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515499568918958080"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/mi8D2WrxXM","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/jobs/2014/09/job_detail_000105.jsp&mid=WC0b01ac058082af97","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":118,"end":121,"tag":"EU"},{"start":122,"end":127,"tag":"Jobs"},{"start":128,"end":131,"tag":"IT"}],"mentions":[{"start":3,"end":17,"username":"karlosponders","id":"17485749"}],"annotations":[{"start":23,"end":47,"probability":0.5638,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515498397781209089","text":"RT @karlosponders: The European Medicines Agency is looking to hire an IT Enterprise Architect http://t.co/mi8D2WrxXM #EU #Jobs #IT","id":"515498397781209089","lang":"en","created_at":"2014-09-26T13:49:30.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515498264284893185"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/qk6th5dRgw","expanded_url":"http://ec.europa.eu/research/researchersnight/events_en.htm","display_url":"ec.europa.eu/research/resea…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"},{"start":119,"end":133,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515487711294402560","text":"RT @EU_ScienceChief: Tonight's the night! European Researchers coming to a place near you - see http://t.co/qk6th5dRgw @EU_Commission #expl…","id":"515487711294402560","lang":"en","created_at":"2014-09-26T13:07:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515486654300422146"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":33,"end":45,"tag":"OpenScience"},{"start":113,"end":122,"tag":"OpenEFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515486565758291969","text":"RT @EFSA_EU: Public consultation #OpenScience at EFSA: how can we meet society's expectations and transform into #OpenEFSA? http://t.co/txH…","id":"515486565758291969","lang":"en","created_at":"2014-09-26T13:02:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515481892003774464"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/DIlP0TKDwd","expanded_url":"http://bit.ly/1sxgUHg","display_url":"bit.ly/1sxgUHg"},{"start":82,"end":104,"url":"http://t.co/1wbpkUwk6a","expanded_url":"https://twitter.com/EFPIA/status/515477363862568960/photo/1","display_url":"pic.twitter.com/1wbpkUwk6a"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":11,"end":16,"probability":0.9849,"type":"Place","normalized_text":"Europe"},{"start":48,"end":52,"probability":0.9225,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515477499787354115","text":"RT @EFPIA: Europe's pharma chiefs seek stronger China ties http://t.co/DIlP0TKDwd http://t.co/1wbpkUwk6a","id":"515477499787354115","lang":"en","created_at":"2014-09-26T12:26:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515477363862568960"}],"attachments":{"media_keys":["3_515477362889457664"]}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/yFbkcHQkB8","expanded_url":"http://bit.ly/1uLMIVa","display_url":"bit.ly/1uLMIVa"}],"hashtags":[{"start":22,"end":31,"tag":"medicine"},{"start":32,"end":45,"tag":"Ketoconazole"},{"start":66,"end":74,"tag":"Cushing"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515462281099214848","text":"We've recommended the #medicine #Ketoconazole HRA for approval in #Cushing's syndrome: http://t.co/yFbkcHQkB8","id":"515462281099214848","lang":"en","created_at":"2014-09-26T11:25:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/xuVZw8m04Q","expanded_url":"http://bit.ly/1t1Ppjr","display_url":"bit.ly/1t1Ppjr"}],"hashtags":[{"start":22,"end":31,"tag":"medicine"},{"start":32,"end":40,"tag":"Harvoni"},{"start":42,"end":53,"tag":"ledipasvir"},{"start":56,"end":67,"tag":"sofosbuvir"},{"start":98,"end":109,"tag":"hepatitisC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515461630302617600","text":"We've recommended the #medicine #Harvoni (#ledipasvir / #sofosbuvir) for the treatment of chronic #hepatitisC: http://t.co/xuVZw8m04Q","id":"515461630302617600","lang":"en","created_at":"2014-09-26T11:23:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/0detryUayj","expanded_url":"http://bit.ly/1uti0UB","display_url":"bit.ly/1uti0UB"}],"hashtags":[{"start":38,"end":48,"tag":"medicines"},{"start":53,"end":59,"tag":"Ebola"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":1,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515461018026532864","text":"We're starting to review experimental #medicines for #Ebola to support treatment decisions: http://t.co/0detryUayj","id":"515461018026532864","lang":"en","created_at":"2014-09-26T11:20:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/ZadzS8WQxw","expanded_url":"http://bit.ly/1qBM9JV","display_url":"bit.ly/1qBM9JV"}],"hashtags":[{"start":42,"end":57,"tag":"antidepressant"},{"start":58,"end":67,"tag":"medicine"},{"start":68,"end":77,"tag":"Valdoxan"},{"start":80,"end":89,"tag":"Thymanax"},{"start":91,"end":103,"tag":"agomelatine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515460606695321600","text":"We've confirmed positive benefit-risk for #antidepressant #medicine #Valdoxan / #Thymanax (#agomelatine): http://t.co/ZadzS8WQxw","id":"515460606695321600","lang":"en","created_at":"2014-09-26T11:19:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/dqydHodOPT","expanded_url":"http://bit.ly/1pfQLG2","display_url":"bit.ly/1pfQLG2"}],"hashtags":[{"start":10,"end":19,"tag":"medicine"},{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515458190579073024","text":"Our human #medicine committee (#CHMP) has recommended 15 new medicines and 3 extensions of indication for approval: http://t.co/dqydHodOPT","id":"515458190579073024","lang":"en","created_at":"2014-09-26T11:09:44.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/C1m8B534hx","expanded_url":"http://bit.ly/1n86H1R","display_url":"bit.ly/1n86H1R"}],"hashtags":[{"start":24,"end":33,"tag":"patients"},{"start":68,"end":78,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"515457074516754432","text":"We've started involving #patients in the benefit-risk evaluation of #medicines as part of a pilot project: http://t.co/C1m8B534hx","id":"515457074516754432","lang":"en","created_at":"2014-09-26T11:05:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/I0wAXgNYAX","expanded_url":"http://bit.ly/1rxtrbE","display_url":"bit.ly/1rxtrbE"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"515456916437602304","text":"Our Management Board is meeting next Thursday, 2 October. We'll publish the outcomes after the meeting: http://t.co/I0wAXgNYAX","id":"515456916437602304","lang":"en","created_at":"2014-09-26T11:04:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/KYU22bFVXg","expanded_url":"http://bit.ly/1n7wxDn","display_url":"bit.ly/1n7wxDn"}],"hashtags":[{"start":56,"end":67,"tag":"veterinary"},{"start":68,"end":78,"tag":"medicines"},{"start":90,"end":101,"tag":"diclofenac"},{"start":127,"end":140,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"515456771050446848","text":"Two more weeks to comment on the risks to vultures from #veterinary #medicines containing #diclofenac: http://t.co/KYU22bFVXg  #consultation","id":"515456771050446848","lang":"en","created_at":"2014-09-26T11:04:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/C1m8B534hx","expanded_url":"http://bit.ly/1n86H1R","display_url":"bit.ly/1n86H1R"}],"hashtags":[{"start":41,"end":50,"tag":"patients"},{"start":81,"end":91,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515441983503237120","text":"We've started a pilot project to involve #patients in benefit-risk evaluation of #medicines: http://t.co/C1m8B534hx","id":"515441983503237120","lang":"en","created_at":"2014-09-26T10:05:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/KC2Bmtz7dB","expanded_url":"http://bit.ly/1rjriRJ","display_url":"bit.ly/1rjriRJ"}],"hashtags":[{"start":53,"end":59,"tag":"hcscm"},{"start":60,"end":66,"tag":"China"},{"start":67,"end":74,"tag":"Pharma"},{"start":75,"end":82,"tag":"events"},{"start":83,"end":93,"tag":"HealthyEU"},{"start":94,"end":108,"tag":"pharmafigures"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515435834213142528","text":"RT @EFPIA: Happy Friday! Efpia's Newsletter is here! #hcscm #China #Pharma #events #HealthyEU #pharmafigures http://t.co/KC2Bmtz7dB","id":"515435834213142528","lang":"en","created_at":"2014-09-26T09:40:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515428343320440832"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/I0wAXgNYAX","expanded_url":"http://bit.ly/1rxtrbE","display_url":"bit.ly/1rxtrbE"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515422988901318656","text":"Our Management Board is meeting next week. We'll publish the outcomes after the meeting: http://t.co/I0wAXgNYAX","id":"515422988901318656","lang":"en","created_at":"2014-09-26T08:49:51.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/bZUMHcBaKa","expanded_url":"http://bit.ly/Yc7NOh","display_url":"bit.ly/Yc7NOh"}],"hashtags":[{"start":12,"end":22,"tag":"guideline"},{"start":40,"end":50,"tag":"medicines"},{"start":98,"end":102,"tag":"IBS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"515421586728681472","text":"Our updated #guideline on evaluation of #medicines for the treatment of irritable bowel syndrome (#IBS) is available: http://t.co/bZUMHcBaKa","id":"515421586728681472","lang":"en","created_at":"2014-09-26T08:44:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/KYU22bFVXg","expanded_url":"http://bit.ly/1n7wxDn","display_url":"bit.ly/1n7wxDn"}],"hashtags":[{"start":56,"end":67,"tag":"veterinary"},{"start":68,"end":78,"tag":"medicines"},{"start":90,"end":101,"tag":"diclofenac"},{"start":126,"end":139,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515419338267197440","text":"Two weeks left to comment on the risks to vultures from #veterinary #medicines containing #diclofenac: http://t.co/KYU22bFVXg #consultation","id":"515419338267197440","lang":"en","created_at":"2014-09-26T08:35:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":90,"end":99,"tag":"dementia"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"annotations":[{"start":21,"end":41,"probability":0.3685,"type":"Organization","normalized_text":"UN Independent Expert"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515168434314035201","text":"RT @AlzheimerEurope: UN Independent Expert calls for member states to protect people with #dementia from stigma, discrimination, neglect ht…","id":"515168434314035201","lang":"en","created_at":"2014-09-25T15:58:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515071718696964096"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/ctwkM5JnGq","expanded_url":"http://ow.ly/BUa2R","display_url":"ow.ly/BUa2R"}],"hashtags":[{"start":66,"end":78,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515168360322322432","text":"RT @eurordis: Take our eNEWS survey and help us better serve your #raredisease information needs http://t.co/ctwkM5JnGq","id":"515168360322322432","lang":"en","created_at":"2014-09-25T15:58:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515077036436881410"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/uqAdoROmYx","expanded_url":"https://www.evidence.nhs.uk/about-evidence-services/bulletins-and-alerts/evidence-updates","display_url":"evidence.nhs.uk/about-evidence…"}],"hashtags":[{"start":56,"end":63,"tag":"Crohns"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515168301493006336","text":"RT @NICEcomms: We’ve published a new Evidence Update on #Crohns disease https://t.co/uqAdoROmYx","id":"515168301493006336","lang":"en","created_at":"2014-09-25T15:57:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515082447894376448"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515168261382864896","text":"RT @MHRAgovuk: New simplified guidance for healthcare professionals reporting suspected ADRs in children to MHRA Yellow Card Scheme http://…","id":"515168261382864896","lang":"en","created_at":"2014-09-25T15:57:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515088366871007232"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":76,"end":88,"tag":"primarycare"}],"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":131,"end":140,"username":"Parlimag","id":"21223877"}],"annotations":[{"start":20,"end":33,"probability":0.3196,"type":"Person","normalized_text":"EU Commisioner"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515168067488579584","text":"RT @PrimaryCare4um: EU Commisioner calls for concrete reforms to strengthen #primarycare &amp; rationalize pharmaceutical spending @Parlimag ht…","id":"515168067488579584","lang":"en","created_at":"2014-09-25T15:56:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515104410809032704"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":92,"end":97,"probability":0.9661,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515167746146197504","text":"RT @EFSA_EU: Celebrate European Researchers’ Night tomorrow! Over 200 science events across Europe - find one in a city near you  http://t.…","id":"515167746146197504","lang":"en","created_at":"2014-09-25T15:55:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515129795408314368"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":12,"end":23,"probability":0.4059,"type":"Organization","normalized_text":"EU Ministers"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515167696527585280","text":"RT @EMCDDA: EU Ministers adopt the European Commission's proposal on 4 substances linked to more than 100 deaths across EU: http://t.co/DG5…","id":"515167696527585280","lang":"en","created_at":"2014-09-25T15:55:24.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515131201792004096"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":40,"end":53,"tag":"healthpolicy"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":57,"end":62,"probability":0.9887,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515167620816179200","text":"RT @cancereu: Successes and failures of #healthpolicy in Europe. Four decades of divergent trends and converging challenges http://t.co/8E9…","id":"515167620816179200","lang":"en","created_at":"2014-09-25T15:55:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515134785837338624"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/xTEqOEKJg4","expanded_url":"http://goo.gl/2WJGdm","display_url":"goo.gl/2WJGdm"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":20,"end":24,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515167527618748418","text":"RT @IAPOtweets: New @WHO Patient’s Communication Tool for Surgical Safety http://t.co/xTEqOEKJg4","id":"515167527618748418","lang":"en","created_at":"2014-09-25T15:54:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515138227330510850"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/E3X7SWuqZF","expanded_url":"http://www.ece2015.org/registration.aspx","display_url":"ece2015.org/registration.a…"}],"hashtags":[{"start":38,"end":46,"tag":"ECE2015"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515167503308554240","text":"RT @ESEndocrinology: Registration for #ECE2015 opens on October 1. Go to http://t.co/E3X7SWuqZF to for more information.","id":"515167503308554240","lang":"en","created_at":"2014-09-25T15:54:38.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515138656260993025"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eXxHQxt7Fd","expanded_url":"http://bit.ly/1oj5gZF","display_url":"bit.ly/1oj5gZF"}],"hashtags":[{"start":88,"end":98,"tag":"medicines"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515167253659394050","text":"RT @ansm: ANSM has published a round-up of the last meeting of our committee for orphan #medicines (COMP): http://t.co/eXxHQxt7Fd","id":"515167253659394050","lang":"en","created_at":"2014-09-25T15:53:39.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":108,"end":123,"tag":"KnowYourSource"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515166729262354432","text":"RT @FDA_Drug_Info: HCPs: Drugs from rogue wholesale distributors may expose your patients to unknown risks. #KnowYourSource http://t.co/C5w…","id":"515166729262354432","lang":"en","created_at":"2014-09-25T15:51:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"515160369372069890"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/bZUMHcBaKa","expanded_url":"http://bit.ly/Yc7NOh","display_url":"bit.ly/Yc7NOh"}],"hashtags":[{"start":55,"end":65,"tag":"medicines"},{"start":132,"end":136,"tag":"IBS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"515118384540045312","text":"We've published the updated guideline on evaluation of #medicines for treatment of irritable bowel syndrome: http://t.co/bZUMHcBaKa #IBS","id":"515118384540045312","lang":"en","created_at":"2014-09-25T12:39:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/jM4h9L6qd9","expanded_url":"http://bit.ly/1sXtp9e","display_url":"bit.ly/1sXtp9e"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"}],"mentions":[{"start":19,"end":28,"username":"ICH_news","id":"305434870"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515065580056219648","text":"We've published an @ICH_news #guideline on assessment and control of DNA reactive impurities in medicines: http://t.co/jM4h9L6qd9","id":"515065580056219648","lang":"en","created_at":"2014-09-25T09:09:38.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/VR9cvPsomI","expanded_url":"http://bit.ly/1uYOzs0","display_url":"bit.ly/1uYOzs0"}],"hashtags":[{"start":113,"end":125,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":62,"end":87,"probability":0.7605,"type":"Organization","normalized_text":"Veterinary Novel Therapies"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515065371284762625","text":"We're recruiting a Scientific Officer to work in the field of Veterinary Novel Therapies: http://t.co/VR9cvPsomI #recruitment","id":"515065371284762625","lang":"en","created_at":"2014-09-25T09:08:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/dT7ZBZMOQe","expanded_url":"http://bit.ly/ZKOuNf","display_url":"bit.ly/ZKOuNf"}],"hashtags":[{"start":124,"end":136,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515065085224841216","text":"We're recruiting a Scientific Officer to work in our Small and Medium-sized Enterprise (SME) Office: http://t.co/dT7ZBZMOQe #recruitment","id":"515065085224841216","lang":"en","created_at":"2014-09-25T09:07:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515064940605231104","text":"We've re-advertised a vacancy for a Continuous Improvement Lead in our Procedure Management Department: http://t.co/yKVx9VvGlF #recruitment","id":"515064940605231104","lang":"en","created_at":"2014-09-25T09:07:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"hashtags":[{"start":112,"end":124,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"515064732127342592","text":"We're recruiting an Enterprise Architect to work in our Information Technology Division: http://t.co/2QhJUJk89X #recruitment","id":"515064732127342592","lang":"en","created_at":"2014-09-25T09:06:16.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":19,"end":21,"probability":0.7034,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514811878154199040","text":"RT @FDA_Drug_Info: FDA Drug Shortage Assistance Award. Recognizing manufacturers who help prevent or alleviate drug shortages. http://t.co/…","id":"514811878154199040","lang":"en","created_at":"2014-09-24T16:21:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514810248503517184"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":92,"end":107,"tag":"prostatecancer"},{"start":108,"end":119,"tag":"drugsafety"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514794593272201217","text":"RT @FDA_Drug_Info: A decade of progress: prostate cancer drugs. Don’t fall for the gimmicks #prostatecancer #drugsafety http://t.co/nRM8aVW…","id":"514794593272201217","lang":"en","created_at":"2014-09-24T15:12:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514793393197940736"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":37,"end":59,"url":"http://t.co/9M5bE3oK3U","expanded_url":"http://bit.ly/1sXMFDR","display_url":"bit.ly/1sXMFDR"}],"hashtags":[{"start":60,"end":67,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514794436518477824","text":"RT @LV_MPA: Preclinical investigator http://t.co/9M5bE3oK3U #newjob","id":"514794436518477824","lang":"pt","created_at":"2014-09-24T15:12:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/972z5PIxYK","expanded_url":"http://ow.ly/BRHeE","display_url":"ow.ly/BRHeE"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514794158385807360","text":"RT @MHRAgovuk: Your essential guide to applying for a marketing authorisation for your medicine: http://t.co/972z5PIxYK","id":"514794158385807360","lang":"en","created_at":"2014-09-24T15:11:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514786696903536640"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/zKZ93oDV5w","expanded_url":"http://go.usa.gov/dWAQ","display_url":"go.usa.gov/dWAQ"}],"hashtags":[{"start":51,"end":57,"tag":"Ebola"}],"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514793875144470528","text":"RT @FDAMedia: There are no approved treatments for #Ebola available for purchase on the Internet http://t.co/zKZ93oDV5w","id":"514793875144470528","lang":"en","created_at":"2014-09-24T15:09:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514783055408820224"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/zKZ93oDV5w","expanded_url":"http://go.usa.gov/dWAQ","display_url":"go.usa.gov/dWAQ"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":[{"start":14,"end":16,"probability":0.8431,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514793855724843008","text":"RT @FDAMedia: FDA issues Warning Letters to three companies marketing fraudulent treatments for Ebola http://t.co/zKZ93oDV5w","id":"514793855724843008","lang":"en","created_at":"2014-09-24T15:09:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514782931651678208"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":25,"end":27,"probability":0.4429,"type":"Organization","normalized_text":"JRC"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514793716763340801","text":"RT @innovationunion: The JRC writes: Review of available methods for assessing chemical safety promotes alternatives to animal testing -… h…","id":"514793716763340801","lang":"en","created_at":"2014-09-24T15:09:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514780851763019776"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/ZvX6zS0UAn","expanded_url":"http://go.usa.gov/dWXh","display_url":"go.usa.gov/dWXh"}],"hashtags":[{"start":85,"end":100,"tag":"prostatecancer"},{"start":101,"end":112,"tag":"drugsafety"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514793464438198273","text":"RT @US_FDA: A decade of progress: prostate cancer drugs. Don’t fall for the gimmicks #prostatecancer #drugsafety http://t.co/ZvX6zS0UAn","id":"514793464438198273","lang":"en","created_at":"2014-09-24T15:08:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514778326112931840"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":18,"end":20,"probability":0.9588,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514767644093071362","text":"RT @DrugInfoAssn: FDA unveils campaign to raise awareness among doctors about fake medicines through the \"Know Your Source\" program. http:/…","id":"514767644093071362","lang":"en","created_at":"2014-09-24T13:25:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514766532963213312"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/UfyJt7Idhz","expanded_url":"http://ht.ly/BLFPH","display_url":"ht.ly/BLFPH"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514754248299794432","text":"RT @FDA_MCMi: Next-Generation Sequencing Standards workshop starts today. Webcast available: http://t.co/UfyJt7Idhz","id":"514754248299794432","lang":"en","created_at":"2014-09-24T12:32:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514753843847262208"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/C2MXvr9LJk","expanded_url":"http://ow.ly/BRkL4","display_url":"ow.ly/BRkL4"}],"hashtags":[{"start":48,"end":55,"tag":"Cancer"},{"start":118,"end":125,"tag":"ESMO14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514754088119328768","text":"RT @myESMO: New Handbook on Rehab.Issues During #Cancer Treatment &amp; Follow-Up now online!  http://t.co/C2MXvr9LJk #ESMO14 http://t.co/BHgeB…","id":"514754088119328768","lang":"en","created_at":"2014-09-24T12:31:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514752860438142976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/RuRvfGITKx","expanded_url":"http://bit.ly/1ruqWa6","display_url":"bit.ly/1ruqWa6"},{"start":108,"end":130,"url":"http://t.co/wX9NAyRKgs","expanded_url":"https://twitter.com/EFSA_EU/status/514751419879280642/photo/1","display_url":"pic.twitter.com/wX9NAyRKgs"}],"hashtags":[{"start":55,"end":61,"tag":"sheep"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514751861468180480","text":"RT @EFSA_EU: Open consultation on the draft opinion on #sheep welfare. Have your say http://t.co/RuRvfGITKx http://t.co/wX9NAyRKgs","id":"514751861468180480","lang":"en","created_at":"2014-09-24T12:23:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514751419879280642"}],"attachments":{"media_keys":["3_514751417660088321"]}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":15,"end":25,"username":"NIAIDNews","id":"59769395"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514751832946917376","text":"RT @FDA_MCMi: .@NIAIDnews antimicrobial resistance workshops conclude today w/ Coordinated Development of Diagnostics, Therapeutics http://…","id":"514751832946917376","lang":"en","created_at":"2014-09-24T12:22:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514751273481281536"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514751743679148034","text":"RT @FDACBER: #FDA study identifies occurrence &amp; potential risk factors for postransfusion purpura (PTP) in elderly patients  http://t.co/OB…","id":"514751743679148034","lang":"en","created_at":"2014-09-24T12:22:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514750675465818112"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/a6RrcZGUpc","expanded_url":"http://bit.ly/13hCFOH","display_url":"bit.ly/13hCFOH"}],"hashtags":[{"start":76,"end":88,"tag":"BiocidesDay"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":89,"end":97,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514742830800334848","text":"RT @EU_ECHA: Join us through the live web-stream at: http://t.co/a6RrcZGUpc #BiocidesDay @EU_ECHA","id":"514742830800334848","lang":"en","created_at":"2014-09-24T11:47:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514742351676592128"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/VR9cvPsomI","expanded_url":"http://bit.ly/1uYOzs0","display_url":"bit.ly/1uYOzs0"}],"hashtags":[{"start":117,"end":129,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":66,"end":91,"probability":0.4249,"type":"Organization","normalized_text":"Veterinary Novel Therapies"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514742488960348160","text":"We've published a vacancy for a short-term Scientific Officer for Veterinary Novel Therapies: http://t.co/VR9cvPsomI #recruitment","id":"514742488960348160","lang":"en","created_at":"2014-09-24T11:45:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/dT7ZBZMOQe","expanded_url":"http://bit.ly/ZKOuNf","display_url":"bit.ly/ZKOuNf"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514741654075764736","text":"We've published a vacancy for a Scientific Officer in our Small and Medium-sized Enterprise Office: http://t.co/dT7ZBZMOQe #recruitment","id":"514741654075764736","lang":"en","created_at":"2014-09-24T11:42:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"hashtags":[{"start":128,"end":140,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514740958228123649","text":"We're re-advertising a vacancy for a Continuous Improvement Lead in our Procedure Management Department: http://t.co/yKVx9VvGlF #recruitment","id":"514740958228123649","lang":"en","created_at":"2014-09-24T11:39:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"hashtags":[{"start":117,"end":129,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514740434774814720","text":"We've published a vacancy for an Enterprise Architect in our Information Technology Division: http://t.co/2QhJUJk89X #recruitment","id":"514740434774814720","lang":"en","created_at":"2014-09-24T11:37:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/jM4h9L6qd9","expanded_url":"http://bit.ly/1sXtp9e","display_url":"bit.ly/1sXtp9e"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"}],"mentions":[{"start":19,"end":28,"username":"ICH_news","id":"305434870"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"514739200936386560","text":"We've published an @ICH_news #guideline on assessment &amp; control of DNA reactive impurities in medicines: http://t.co/jM4h9L6qd9","id":"514739200936386560","lang":"en","created_at":"2014-09-24T11:32:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eKsuew9Rb4","expanded_url":"http://bit.ly/1pbMAed","display_url":"bit.ly/1pbMAed"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":46,"end":57,"tag":"diphtheria"},{"start":59,"end":67,"tag":"tetanus"},{"start":72,"end":82,"tag":"pertussis"},{"start":83,"end":92,"tag":"vaccines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"514736108576710656","text":"#Consultation open on guidance for developing #diphtheria, #tetanus and #pertussis #vaccines for children: http://t.co/eKsuew9Rb4","id":"514736108576710656","lang":"en","created_at":"2014-09-24T11:20:26.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":22,"end":31,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514735102111526912","text":"RT @Eurovaccine: From @EMA_News Proposed single dev't plan for tetanus-diphteria-pertusis vaccines is released for public consultation http…","id":"514735102111526912","lang":"en","created_at":"2014-09-24T11:16:26.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514732632681488384"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/tLHUI10R0Y","expanded_url":"http://bit.ly/1B6mq2n","display_url":"bit.ly/1B6mq2n"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514734828156387328","text":"RT @Legemiddelinfo: 900,000 Norwegians use medicines that may cause addiction. Updated guidelines: http://t.co/tLHUI10R0Y","id":"514734828156387328","lang":"en","created_at":"2014-09-24T11:15:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/81b53HIz4G","expanded_url":"http://bit.ly/1B6bBNz","display_url":"bit.ly/1B6bBNz"}],"hashtags":[{"start":71,"end":78,"tag":"cancer"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514733320660590592","text":"RT @EFPIA: Stanford researchers create 'evolved' protein that may stop #cancer from spreading http://t.co/81b53HIz4G","id":"514733320660590592","lang":"en","created_at":"2014-09-24T11:09:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514719373215690753"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/gP6DHYSGFy","expanded_url":"http://bit.ly/1yqyW0t","display_url":"bit.ly/1yqyW0t"}],"hashtags":[{"start":57,"end":62,"tag":"COPD"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":67,"end":78,"username":"bmj_latest","id":"16949344"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514715642457772032","text":"RT @EFPIA: Management and prevention of exacerbations of #COPD via @bmj_latest http://t.co/gP6DHYSGFy","id":"514715642457772032","lang":"en","created_at":"2014-09-24T09:59:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514711198366195712"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/ATjfI2AkI1","expanded_url":"http://bit.ly/1B64TY3","display_url":"bit.ly/1B64TY3"}],"hashtags":[{"start":32,"end":45,"tag":"applications"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514715494855999488","text":"RT @EFSA_EU: Regulated products #applications to EFSA now via electronic submission http://t.co/ATjfI2AkI1","id":"514715494855999488","lang":"en","created_at":"2014-09-24T09:58:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514709758436450304"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/lbRKi3mwHO","expanded_url":"http://www.nice.org.uk/guidance/date/2014/September","display_url":"nice.org.uk/guidance/date/…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514715304006782976","text":"RT @NICEcomms: Here's a full list of all our guidance and quality standards published so far this month: http://t.co/lbRKi3mwHO","id":"514715304006782976","lang":"en","created_at":"2014-09-24T09:57:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514705984309460992"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/tvHvK1W2Bh","expanded_url":"http://ow.ly/BR05M","display_url":"ow.ly/BR05M"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514715274931867648","text":"RT @egagenerics: EGA White Paper Summary- Factors Supporting a Sustainable European Biosimilars Market http://t.co/tvHvK1W2Bh @redaccionmed…","id":"514715274931867648","lang":"en","created_at":"2014-09-24T09:57:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514705695212855296"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514714938745847808","text":"RT @EFPIA: pharmafigures.eu  is EFPIA's New interactive digital platform - find out more about pharma in your country now! http://t.co/qbz7…","id":"514714938745847808","lang":"en","created_at":"2014-09-24T09:56:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514699829529022464"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/aTZ3Z2eyO0","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:C:2014:332A:TOC","display_url":"eur-lex.europa.eu/legal-content/…"}],"hashtags":[{"start":12,"end":24,"tag":"recruitment"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":[{"start":57,"end":81,"probability":0.7671,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514714828477595648","text":"RT @EURLex: #recruitment Interested in a career with the European Medicines Agency? 3 vacancies were posted today http://t.co/aTZ3Z2eyO0 @E…","id":"514714828477595648","lang":"en","created_at":"2014-09-24T09:55:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514699477123612673"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/QRdjxFUIke","expanded_url":"http://bit.ly/1uhQBEU","display_url":"bit.ly/1uhQBEU"}],"hashtags":[{"start":106,"end":118,"tag":"BiocidesDay"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":54,"end":81,"probability":0.31,"type":"Product","normalized_text":"Biocidal Products Regulation"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514714577461059584","text":"RT @EU_ECHA: Check out our new practical guide on the Biocidal Products Regulation http://t.co/QRdjxFUIke #BiocidesDay http://t.co/egVrQCg8…","id":"514714577461059584","lang":"en","created_at":"2014-09-24T09:54:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514695797381013504"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/tTFdL9U6Ki","expanded_url":"https://twitter.com/EU_ECHA/status/514695010806398976/photo/1","display_url":"pic.twitter.com/tTFdL9U6Ki"}],"hashtags":[{"start":92,"end":104,"tag":"BiocidesDay"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":30,"end":38,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":13,"end":28,"probability":0.9937,"type":"Person","normalized_text":"Camilla Buchanan"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514714490014031872","text":"RT @EU_ECHA: Camilla Buchanan @EU_ECHA Biocidal Products Regulation – legislative framework #BiocidesDay http://t.co/tTFdL9U6Ki","id":"514714490014031872","lang":"en","created_at":"2014-09-24T09:54:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514695010806398976"}],"attachments":{"media_keys":["3_514695009770024960"]}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/5M1V0S9Hiz","expanded_url":"http://bit.ly/1ppYzEj","display_url":"bit.ly/1ppYzEj"}],"hashtags":[{"start":17,"end":23,"tag":"Ebola"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"annotations":[{"start":62,"end":65,"probability":0.6324,"type":"Place","normalized_text":"MEPs"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514714013062938624","text":"RT @Europarl_EN: #Ebola is global security issue according to MEPs but what can be done to tackle lethal virus? http://t.co/5M1V0S9Hiz http…","id":"514714013062938624","lang":"en","created_at":"2014-09-24T09:52:38.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514688201060286465"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/fVbeGK7WbP","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/09/news_detail_002171.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514713801468690432","text":"RT @GCessak: EMA: Avoiding duplication of clinical trials in children http://t.co/fVbeGK7WbP","id":"514713801468690432","lang":"en","created_at":"2014-09-24T09:51:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514685384719364096"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/aF7IYFJwqG","expanded_url":"http://bit.ly/1uY5b3l","display_url":"bit.ly/1uY5b3l"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":90,"end":95,"probability":0.9737,"type":"Place","normalized_text":"Venice"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514685376976678912","text":"RT @EFSA_EU: EFSA meets with Member States representatives in the Advisory Forum today in Venice. Check the agenda http://t.co/aF7IYFJwqG","id":"514685376976678912","lang":"en","created_at":"2014-09-24T07:58:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514678231065432064"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/s0J20oWcxG","expanded_url":"http://bit.ly/1ui027v","display_url":"bit.ly/1ui027v"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514469137650049024","text":"RT @EFSA_EU: Check out our step-by-step guide to EFSA’s scientific process – new interactive tool online http://t.co/s0J20oWcxG http://t.co…","id":"514469137650049024","lang":"en","created_at":"2014-09-23T17:39:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514445851239133185"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/eKsuew9Rb4","expanded_url":"http://bit.ly/1pbMAed","display_url":"bit.ly/1pbMAed"}],"hashtags":[{"start":29,"end":40,"tag":"diphtheria"},{"start":42,"end":50,"tag":"tetanus"},{"start":57,"end":67,"tag":"pertussis"},{"start":68,"end":77,"tag":"vaccines"},{"start":102,"end":113,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514464084394524674","text":"Draft guidance on developing #diphtheria, #tetanus &amp; #pertussis #vaccines to avoid duplication of #paediatric trials: http://t.co/eKsuew9Rb4","id":"514464084394524674","lang":"en","created_at":"2014-09-23T17:19:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/7S63Qaa24i","expanded_url":"http://bit.ly/1s4AP08","display_url":"bit.ly/1s4AP08"}],"hashtags":[{"start":53,"end":65,"tag":"antibiotics"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514440556207165440","text":"A week to comment on draft advice on impact of using #antibiotics in animals on public health and animal health: http://t.co/7S63Qaa24i","id":"514440556207165440","lang":"en","created_at":"2014-09-23T15:46:01.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Qvex1NjUML","expanded_url":"http://bit.ly/1iMbeou","display_url":"bit.ly/1iMbeou"}],"hashtags":[{"start":32,"end":45,"tag":"benzalkonium"},{"start":70,"end":80,"tag":"guideline"},{"start":84,"end":95,"tag":"excipients"},{"start":105,"end":115,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514440289835311104","text":"A week to comment on Q&amp;A on #benzalkonium chloride in revision of #guideline on #excipients in human #medicines: http://t.co/Qvex1NjUML","id":"514440289835311104","lang":"en","created_at":"2014-09-23T15:44:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/xvUug3uu9v","expanded_url":"http://bit.ly/1lV0UcN","display_url":"bit.ly/1lV0UcN"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514440180808548354","text":"A week to comment on concept paper on qualification &amp; reporting of physiologically based pharmacokinetic modelling: http://t.co/xvUug3uu9v","id":"514440180808548354","lang":"en","created_at":"2014-09-23T15:44:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"},{"start":25,"end":29,"username":"WHO","id":"14499829"},{"start":36,"end":41,"username":"NEJM","id":"25950355"}],"annotations":[{"start":40,"end":58,"probability":0.3409,"type":"Other","normalized_text":"Ebola Virus Disease"},{"start":63,"end":73,"probability":0.9536,"type":"Place","normalized_text":"West Africa"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439781141741568","text":"RT @ECDC_Outbreaks: From @WHO &amp; @NEJM : Ebola Virus Disease in West Africa —  The First 9 Months of the Epidemic &amp; Forward Projections http…","id":"514439781141741568","lang":"en","created_at":"2014-09-23T15:42:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514390121618366464"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/EDmOAPrUPO","expanded_url":"http://bit.ly/1mgMbKX","display_url":"bit.ly/1mgMbKX"}],"hashtags":[{"start":93,"end":99,"tag":"Pheur"},{"start":100,"end":109,"tag":"european"},{"start":110,"end":124,"tag":"pharmacopoeia"},{"start":125,"end":137,"tag":"pharmeuropa"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439753471918080","text":"RT @edqm_news: One week left to comment on draft pharmacopoeial texts http://t.co/EDmOAPrUPO #Pheur #european #pharmacopoeia #pharmeuropa","id":"514439753471918080","lang":"en","created_at":"2014-09-23T15:42:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514391941325553664"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EITeu","id":"330860720"}],"annotations":[{"start":29,"end":59,"probability":0.4794,"type":"Other","normalized_text":"The Future of Europe is Science"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439709209411586","text":"RT @EITeu: Registration for \"The Future of Europe is Science\" high-level conference shuts a week today. Don't miss out! http://t.co/GLt5AZb…","id":"514439709209411586","lang":"en","created_at":"2014-09-23T15:42:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514393647333515265"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/kf0YRgCi6L","expanded_url":"http://bit.ly/1yvAmU5","display_url":"bit.ly/1yvAmU5"}],"hashtags":[{"start":118,"end":127,"tag":"OpenEFSA"},{"start":128,"end":140,"tag":"OpenScience"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439643237187584","text":"RT @EFSA_EU: How can EFSA be more open to scientific contributions from society? Have your say http://t.co/kf0YRgCi6L #OpenEFSA #OpenScience","id":"514439643237187584","lang":"en","created_at":"2014-09-23T15:42:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514397889607778304"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":84,"end":94,"tag":"metabolic"},{"start":110,"end":118,"tag":"insulin"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439555341373440","text":"RT @ESEndocrinology: Subclinical hypothyroidism &amp; fatty liver increases odds of #metabolic syndrome &amp; #insulin resistance http://t.co/sVpO7…","id":"514439555341373440","lang":"en","created_at":"2014-09-23T15:42:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514406393139326977"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":118,"end":132,"tag":"urologyweek14"}],"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439245323595776","text":"RT @Uroweb: Use new EAU Patient Information translations in Bulgarian, Croatian, Polish, Spanish &amp; Turkish during #urologyweek14: http://t.…","id":"514439245323595776","lang":"en","created_at":"2014-09-23T15:40:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514422273521254400"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/97cPDp3JOm","expanded_url":"http://bit.ly/1qzVxjm","display_url":"bit.ly/1qzVxjm"}],"hashtags":[{"start":13,"end":25,"tag":"BiocidesDay"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514439193742036993","text":"RT @EU_ECHA: #BiocidesDay programme in detail: http://t.co/97cPDp3JOm","id":"514439193742036993","lang":"en","created_at":"2014-09-23T15:40:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514423642349129729"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/zbxpXTYmYm","expanded_url":"http://www.emsp.org/tmp/EMSP_ConfRepDublin2014_BATv3.pdf","display_url":"emsp.org/tmp/EMSP_ConfR…"}],"hashtags":[{"start":81,"end":88,"tag":"EMSP25"}],"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"},{"start":128,"end":138,"username":"MSIRELAND","id":"19762567"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514385378120577024","text":"RT @eumsplatform: Very pleased to share our Anniversary Spring Conference Report #EMSP25 http://t.co/zbxpXTYmYm! Enjoy de read! @MSIRELAND …","id":"514385378120577024","lang":"en","created_at":"2014-09-23T12:06:45.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514341443721510912"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/pfsGa8Za4v","expanded_url":"http://www.healthcanal.com/ear-nose-throat/55426-lack-of-thyroid-hormone-blocks-hearing-development.html","display_url":"healthcanal.com/ear-nose-throa…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514385275276242945","text":"RT @ESEndocrinology: In the news: Lack of thyroid hormone blocks hearing development http://t.co/pfsGa8Za4v","id":"514385275276242945","lang":"en","created_at":"2014-09-23T12:06:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514342855704600576"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":55,"end":62,"tag":"Cancer"},{"start":98,"end":104,"tag":"Milan"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":74,"end":82,"username":"borgton","id":"1605512862"},{"start":105,"end":117,"username":"BeaLorenzin","id":"515229378"},{"start":118,"end":127,"username":"it2014eu","id":"789311676982042628"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514385030567976961","text":"RT @EU_Health: Progress report European Partnership on #Cancer published; @borgton attends mtg in #Milan @bealorenzin @IT2014EU http://t.co…","id":"514385030567976961","lang":"en","created_at":"2014-09-23T12:05:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514352584258519040"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":29,"end":36,"tag":"ESMO14"},{"start":110,"end":123,"tag":"breastcancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514384609585684481","text":"RT @myESMO: Just in time for #ESMO14: 1st Int. ESO/ESMO consensus guidelines on locally adv. &amp; metastatic #breastcancer http://t.co/xWVuxUB…","id":"514384609585684481","lang":"en","created_at":"2014-09-23T12:03:42.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514382014146166785"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"medicinesmalta","id":"357784930"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514384562856931328","text":"RT @medicinesmalta: Promoting the Choice of medicines! The Medicines Authority working with the Malta Competition and Consumer... http://t.…","id":"514384562856931328","lang":"en","created_at":"2014-09-23T12:03:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514383943035277313"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/xvUug3uu9v","expanded_url":"http://bit.ly/1lV0UcN","display_url":"bit.ly/1lV0UcN"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514384241476763648","text":"One week to comment on concept paper on qualification &amp; reporting of physiologically based pharmacokinetic modelling: http://t.co/xvUug3uu9v","id":"514384241476763648","lang":"en","created_at":"2014-09-23T12:02:14.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/Qvex1NjUML","expanded_url":"http://bit.ly/1iMbeou","display_url":"bit.ly/1iMbeou"}],"hashtags":[{"start":36,"end":49,"tag":"benzalkonium"},{"start":74,"end":84,"tag":"guideline"},{"start":88,"end":99,"tag":"excipients"},{"start":109,"end":119,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514383464729436160","text":"One week to comment on a Q&amp;A on #benzalkonium chloride in revision of #guideline on #excipients in human #medicines: http://t.co/Qvex1NjUML","id":"514383464729436160","lang":"en","created_at":"2014-09-23T11:59:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/7S63Qaa24i","expanded_url":"http://bit.ly/1s4AP08","display_url":"bit.ly/1s4AP08"}],"hashtags":[{"start":93,"end":105,"tag":"antibiotics"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514382337313079296","text":"One more week to comment on advice on the impact on public health and animal health of using #antibiotics in animals: http://t.co/7S63Qaa24i","id":"514382337313079296","lang":"en","created_at":"2014-09-23T11:54:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/S4cttDWYyG","expanded_url":"http://bit.ly/1mp9Sl5","display_url":"bit.ly/1mp9Sl5"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":63,"end":73,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514356363867459584","text":"We've published the #agenda of this week's committee for human #medicines (CHMP): http://t.co/S4cttDWYyG","id":"514356363867459584","lang":"en","created_at":"2014-09-23T10:11:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/I2NxVt3SAV","expanded_url":"http://bit.ly/1uZ0RQg","display_url":"bit.ly/1uZ0RQg"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514054813089550336","text":"RT @AEMPSGOB: Questions &amp; answers: RD 477/2014, authorisation of advanced-therapy medicines produced non-industrially http://t.co/I2NxVt3SAV","id":"514054813089550336","lang":"en","created_at":"2014-09-22T14:13:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":83,"end":93,"tag":"chemicals"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":32,"end":57,"probability":0.677,"type":"Organization","normalized_text":"EFSA Scientific Colloquium"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514045307236401152","text":"RT @EFSA_EU: Presentations from EFSA Scientific Colloquium on exposure to multiple #chemicals are now available on EFSA’s website http://t.…","id":"514045307236401152","lang":"en","created_at":"2014-09-22T13:35:26.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514044964465307649"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/uqAdoROmYx","expanded_url":"https://www.evidence.nhs.uk/about-evidence-services/bulletins-and-alerts/evidence-updates","display_url":"evidence.nhs.uk/about-evidence…"}],"hashtags":[{"start":56,"end":66,"tag":"infection"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514045230002479104","text":"RT @NICEcomms: We’ve published a new Evidence Update on #infection https://t.co/uqAdoROmYx","id":"514045230002479104","lang":"en","created_at":"2014-09-22T13:35:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514044223692505088"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/H8U1U8l5fP","expanded_url":"http://bit.ly/countryproj","display_url":"bit.ly/countryproj"}],"hashtags":[{"start":72,"end":78,"tag":"H2020"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514042851387539456","text":"RT @innovationunion: Check out the new projects that have been added to #H2020 country profiles here: http://t.co/H8U1U8l5fP","id":"514042851387539456","lang":"en","created_at":"2014-09-22T13:25:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514040363624169472"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/S4cttDWYyG","expanded_url":"http://bit.ly/1mp9Sl5","display_url":"bit.ly/1mp9Sl5"}],"hashtags":[{"start":25,"end":32,"tag":"agenda"},{"start":54,"end":63,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514038512866590720","text":"We've just published the #agenda of this week's human #medicine committee (CHMP) meeting: http://t.co/S4cttDWYyG","id":"514038512866590720","lang":"en","created_at":"2014-09-22T13:08:26.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/aXiT5b2SNR","expanded_url":"http://bit.ly/1ucZL5E","display_url":"bit.ly/1ucZL5E"}],"hashtags":{},"mentions":{},"annotations":[{"start":35,"end":40,"probability":0.9439,"type":"Place","normalized_text":"Madrid"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"514038275330547712","text":"We're running a training course in Madrid on the Extended EudraVigilance Medicinal Product Dictionary; 9-10 October: http://t.co/aXiT5b2SNR","id":"514038275330547712","lang":"en","created_at":"2014-09-22T13:07:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/IZ7ogdwtfU","expanded_url":"http://ht.ly/BLCAB","display_url":"ht.ly/BLCAB"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":20,"end":30,"username":"NIAIDNews","id":"59769395"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514037688849403904","text":"RT @FDA_MCMi: First @NIAIDnews workshop live now: Overcoming Bottlenecks in Antibacterial Product Development: http://t.co/IZ7ogdwtfU","id":"514037688849403904","lang":"en","created_at":"2014-09-22T13:05:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514035597166788609"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":15,"end":25,"username":"NIAIDNews","id":"59769395"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514037617718202368","text":"RT @FDA_MCMi: .@NIAIDnews workshops on addressing challenges in antimicrobial resistance this week - avail. via webinar. http://t.co/pTcLrq…","id":"514037617718202368","lang":"en","created_at":"2014-09-22T13:04:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514034998576697344"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/FibjYi5apC","expanded_url":"http://ow.ly/BLpi0","display_url":"ow.ly/BLpi0"}],"hashtags":[{"start":48,"end":56,"tag":"Sarcoma"},{"start":63,"end":68,"tag":"GIST"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514036876811182082","text":"RT @myESMO: Did you know that we've updated all #Sarcoma &amp; #GIST Clinical Practice Guidelines? Download  here http://t.co/FibjYi5apC","id":"514036876811182082","lang":"en","created_at":"2014-09-22T13:01:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514013192889335808"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/rD2YHNES8K","expanded_url":"http://bit.ly/HGeneTherapy","display_url":"bit.ly/HGeneTherapy"}],"hashtags":[{"start":21,"end":33,"tag":"GeneTherapy"},{"start":111,"end":124,"tag":"HorizonMagEU"},{"start":125,"end":129,"tag":"DNA"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"514004208463646720","text":"RT @innovationunion: #GeneTherapy: scientists used a modified virus to fix faulty genes http://t.co/rD2YHNES8K #HorizonMagEU #DNA","id":"514004208463646720","lang":"en","created_at":"2014-09-22T10:52:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"514003282457821184"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/aXiT5b2SNR","expanded_url":"http://bit.ly/1ucZL5E","display_url":"bit.ly/1ucZL5E"}],"hashtags":{},"mentions":{},"annotations":[{"start":40,"end":91,"probability":0.2497,"type":"Other","normalized_text":"Extended EudraVigilance Medicinal Product Dictionary"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"514003758557450240","text":"We've prepared a training course on the Extended EudraVigilance Medicinal Product Dictionary; Madrid, 9-10 October: http://t.co/aXiT5b2SNR","id":"514003758557450240","lang":"en","created_at":"2014-09-22T10:50:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/YbPYza4Utf","expanded_url":"http://bit.ly/OID2014","display_url":"bit.ly/OID2014"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"513998120842457088","text":"RT @IMI_JU: Want to learn about IMI’s new rules &amp; Call topics? Sign up for our info day, 30/9 http://t.co/YbPYza4Utf online registration cl…","id":"513998120842457088","lang":"en","created_at":"2014-09-22T10:27:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"513996153609023488"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/K7aD8DznFK","expanded_url":"http://bit.ly/1C3qouS","display_url":"bit.ly/1C3qouS"}],"hashtags":[{"start":25,"end":33,"tag":"minutes"},{"start":63,"end":81,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"513978632789061632","text":"We've just published the #minutes from the July meeting of our #pharmacovigilance committee (PRAC): http://t.co/K7aD8DznFK","id":"513978632789061632","lang":"en","created_at":"2014-09-22T09:10:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/pu9eVQQ14r","expanded_url":"http://bit.ly/XQvJ9T","display_url":"bit.ly/XQvJ9T"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":54,"end":65,"tag":"veterinary"},{"start":66,"end":76,"tag":"medicines"},{"start":78,"end":83,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"513968559928930304","text":"The #minutes of the July meeting of our committee for #veterinary #medicines (#CVMP) are available: http://t.co/pu9eVQQ14r","id":"513968559928930304","lang":"en","created_at":"2014-09-22T08:30:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":46,"end":60,"tag":"organdonation"},{"start":61,"end":74,"tag":"waitinglists"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"},{"start":121,"end":130,"username":"EODD2014","id":"2483359789"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512977964880117760","text":"RT @edqm_news: The vast majority of people on #organdonation #waitinglists are patients in need of a kidney. 81% in 2012 @EODD2014 http://t…","id":"512977964880117760","lang":"en","created_at":"2014-09-19T14:54:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512892499874959361"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":40,"end":43,"tag":"EU"},{"start":44,"end":51,"tag":"Health"},{"start":115,"end":126,"tag":"healthcare"},{"start":127,"end":131,"tag":"HTA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512977859179454464","text":"RT @EU_Health: Have you seen our latest #EU #Health newsletter? Focus on Health Technology Assessement cooperation #healthcare #HTA http://…","id":"512977859179454464","lang":"en","created_at":"2014-09-19T14:53:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512907247597654016"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/pu9eVQQ14r","expanded_url":"http://bit.ly/XQvJ9T","display_url":"bit.ly/XQvJ9T"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":70,"end":81,"tag":"veterinary"},{"start":82,"end":92,"tag":"medicines"},{"start":117,"end":122,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"512977103659487233","text":"We've published the #minutes of the July meeting of our committee for #veterinary #medicines: http://t.co/pu9eVQQ14r #CVMP","id":"512977103659487233","lang":"en","created_at":"2014-09-19T14:50:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":55,"end":62,"tag":"cancer"},{"start":115,"end":122,"tag":"ESMO14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512976640276955136","text":"RT @myESMO: Press release: Gaps in palliative care for #cancer patients revealed in new research to be presented @ #ESMO14 http://t.co/kGwX…","id":"512976640276955136","lang":"en","created_at":"2014-09-19T14:48:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512958710600437760"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":28,"tag":"Health"},{"start":74,"end":85,"tag":"innovation"},{"start":107,"end":114,"tag":"cancer"}],"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"},{"start":126,"end":135,"username":"it2014eu","id":"789311676982042628"}],"annotations":[{"start":57,"end":61,"probability":0.9812,"type":"Place","normalized_text":"Milan"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512976415688388610","text":"RT @IDFEuropeBxl: EU #Health ministers meet next week in Milan to discuss #innovation for patients, ebola, #cancer prevention @IT2014EU htt…","id":"512976415688388610","lang":"en","created_at":"2014-09-19T14:48:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512974255831515137"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":98,"end":112,"tag":"globalisation"},{"start":117,"end":127,"tag":"pathogens"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":39,"end":53,"probability":0.8782,"type":"Person","normalized_text":"Dr Ilaria Capua"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512976389990285313","text":"RT @ECDC_EU: #ESCAIDE 2014 highlights: Dr Ilaria Capua to open conference with keynote address on #globalisation and #pathogens http://t.co…","id":"512976389990285313","lang":"en","created_at":"2014-09-19T14:47:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512974881873739776"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/ADyX1tLkId","expanded_url":"http://bit.ly/1uLEUoP","display_url":"bit.ly/1uLEUoP"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"},{"start":109,"end":114,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512976344712761345","text":"Our committee for human #medicines meets next week. Highlights published next Friday: http://t.co/ADyX1tLkId #CHMP","id":"512976344712761345","lang":"en","created_at":"2014-09-19T14:47:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/ADyX1tLkId","expanded_url":"http://bit.ly/1uLEUoP","display_url":"bit.ly/1uLEUoP"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"},{"start":36,"end":41,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"512882735732781056","text":"Our committee for human #medicines (#CHMP) meets next week. Highlights out next Friday: http://t.co/ADyX1tLkId","id":"512882735732781056","lang":"en","created_at":"2014-09-19T08:35:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":11,"username":"DrBeadyWeb","id":"2148565617"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511451331165712384","text":"@DrBeadyWeb They will be published within the next few working days, we will tweet the link.","id":"512882099159060480","lang":"en","created_at":"2014-09-19T08:33:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"512873730335600640"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"2148565617"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/LuCKhJUciP","expanded_url":"http://bit.ly/1miqsTR","display_url":"bit.ly/1miqsTR"}],"hashtags":{},"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512625462213115904","text":"RT @ansm: French medicines agency meeting - Technological progress and mastering risk: http://t.co/LuCKhJUciP","id":"512625462213115904","lang":"en","created_at":"2014-09-18T15:33:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/IFs1bLwcBY","expanded_url":"http://ow.ly/BE1ya","display_url":"ow.ly/BE1ya"}],"hashtags":[{"start":68,"end":81,"tag":"EbolaVaccine"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":[{"start":85,"end":86,"probability":0.9759,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512613069491798016","text":"RT @MHRAmedicines: MHRA praised as the first volunteer receives new #EbolaVaccine in UK clinical trial http://t.co/IFs1bLwcBY","id":"512613069491798016","lang":"en","created_at":"2014-09-18T14:44:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512609824631422976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/vGdZVJVjBn","expanded_url":"http://go.usa.gov/pnYJ","display_url":"go.usa.gov/pnYJ"},{"start":98,"end":120,"url":"http://t.co/r6ztKbMQ5Q","expanded_url":"https://twitter.com/FDA_Drug_Info/status/512598728755412992/photo/1","display_url":"pic.twitter.com/r6ztKbMQ5Q"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512608586544209920","text":"RT @FDA_Drug_Info: #FDA approves new drug for opioid-induced constipation: http://t.co/vGdZVJVjBn http://t.co/r6ztKbMQ5Q","id":"512608586544209920","lang":"en","created_at":"2014-09-18T14:26:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512598728755412992"}],"attachments":{"media_keys":["3_512598728163602433"]}},{"entities":{"urls":{},"hashtags":[{"start":22,"end":34,"tag":"counterfeit"},{"start":39,"end":47,"tag":"illegal"},{"start":107,"end":112,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":90,"end":95,"probability":0.9809,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512608427332632576","text":"RT @edqm_news: Use of #counterfeit and #illegal medicines is still a major problem within Europe. Read the #EDQM press release http://t.co/…","id":"512608427332632576","lang":"en","created_at":"2014-09-18T14:25:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512595516371525633"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":16,"end":23,"tag":"Norway"},{"start":54,"end":58,"tag":"AMR"},{"start":77,"end":89,"tag":"antibiotics"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512564882781536256","text":"RT @WHO_Europe: #Norway to host int'l consultation on #AMR, including use of #antibiotics in health care, to provide input to global work o…","id":"512564882781536256","lang":"en","created_at":"2014-09-18T11:32:45.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512543642326929408"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":16,"end":19,"tag":"NL"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512562778838925312","text":"RT @WHO_Europe: #NL: \"We can beat the bugs\". We must prevent transmission; use antibiotics with prudence both in med. &amp; ag.; and develop ne…","id":"512562778838925312","lang":"en","created_at":"2014-09-18T11:24:24.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512542238094925824"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/mFfJoySbzz","expanded_url":"http://bit.ly/1wsctvn","display_url":"bit.ly/1wsctvn"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512562699205885952","text":"RT @URPLWMiPB: How generic medicines differ from innovative - brochure for patients. http://t.co/mFfJoySbzz","id":"512562699205885952","lang":"en","created_at":"2014-09-18T11:24:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":40,"end":44,"tag":"AMR"},{"start":114,"end":119,"tag":"RC64"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":92,"end":111,"probability":0.5872,"type":"Other","normalized_text":"European Action Plan"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512561911649812481","text":"RT @WHO_Europe: Regional perspective on #AMR discussed this afternoon with an update on the European Action Plan. #RC64","id":"512561911649812481","lang":"en","created_at":"2014-09-18T11:20:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512540213554737152"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":33,"end":37,"tag":"AMR"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512561858365382656","text":"RT @WHO_Europe: Some progress on #AMR in terms of use of medicines and agriculture practices, but major knowledge gaps &amp; overall fragmented…","id":"512561858365382656","lang":"en","created_at":"2014-09-18T11:20:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512538445752061952"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":42,"end":46,"tag":"AMR"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512538274066608128","text":"RT @WHO_Europe: Antimicrobial Resistance (#AMR) an increasingly serious public health threat - \"we're winning battle in some areas, but los…","id":"512538274066608128","lang":"en","created_at":"2014-09-18T09:47:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512538110732025856"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/NM6xfBKMhm","expanded_url":"http://bit.ly/1meRBqw","display_url":"bit.ly/1meRBqw"}],"hashtags":[{"start":13,"end":21,"tag":"Vizamyl"},{"start":23,"end":36,"tag":"flutemetamol"},{"start":47,"end":67,"tag":"radiopharmaceutical"},{"start":130,"end":139,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"512526380282966016","text":"The EPAR for #Vizamyl (#flutemetamol (18F)), a #radiopharmaceutical used in brain scans, is now available: http://t.co/NM6xfBKMhm #medicine","id":"512526380282966016","lang":"en","created_at":"2014-09-18T08:59:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/F16Cjl2UTY","expanded_url":"http://www.alz.co.uk/","display_url":"alz.co.uk"}],"hashtags":[{"start":131,"end":139,"tag":"WAM2014"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":40,"end":50,"username":"AlzDisInt","id":"198970635"}],"annotations":[{"start":54,"end":73,"probability":0.4324,"type":"Other","normalized_text":"Dementia Report 2014"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512289862217912320","text":"RT @IAPOtweets: Great work IAPO members @AlzDisInt on Dementia Report 2014! Download report here http://t.co/F16Cjl2UTY and follow #WAM2014…","id":"512289862217912320","lang":"en","created_at":"2014-09-17T17:19:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512226850824024064"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/nqtvwA7aRa","expanded_url":"http://bit.ly/1r9aagw","display_url":"bit.ly/1r9aagw"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":13,"end":27,"probability":0.7178,"type":"Organization","normalized_text":"ECHA Committees"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512289793494253568","text":"RT @EU_ECHA: ECHA Committees issued positive opinions on authorising 16 uses of substances of very high concern http://t.co/nqtvwA7aRa","id":"512289793494253568","lang":"en","created_at":"2014-09-17T17:19:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512227395860848640"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":44,"end":50,"tag":"Ebola"},{"start":63,"end":74,"tag":"WestAfrica"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":112,"end":125,"username":"EP_ThinkTank","id":"400053935"}],"annotations":[{"start":29,"end":30,"probability":0.6345,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512289739081547776","text":"RT @Europarl_EN: MEPs debate EU response to #Ebola epidemic in #WestAfrica. More details about the situation in @EP_ThinkTank briefing http…","id":"512289739081547776","lang":"en","created_at":"2014-09-17T17:19:26.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512228233400840192"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/K5sYIFHfRA","expanded_url":"http://ow.ly/BBJfj","display_url":"ow.ly/BBJfj"}],"hashtags":[{"start":106,"end":118,"tag":"OncologyPRO"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512288721912471553","text":"RT @myESMO: New from ESMO E-Learning: Smoking Cessation in the Oncology Population http://t.co/K5sYIFHfRA #OncologyPRO","id":"512288721912471553","lang":"en","created_at":"2014-09-17T17:15:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512275358037848065"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/NM6xfBKMhm","expanded_url":"http://bit.ly/1meRBqw","display_url":"bit.ly/1meRBqw"}],"hashtags":[{"start":53,"end":73,"tag":"radiopharmaceutical"}],"mentions":{},"annotations":[{"start":42,"end":48,"probability":0.412,"type":"Person","normalized_text":"Vizamyl"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"512288245456310272","text":"We've published the assessment report for Vizamyl, a #radiopharmaceutical used in brain scans: http://t.co/NM6xfBKMhm","id":"512288245456310272","lang":"en","created_at":"2014-09-17T17:13:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":42,"end":45,"tag":"BA"},{"start":102,"end":105,"tag":"MS"}],"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"512168411179548672","text":"RT @eumsplatform: Our Believe and Achieve #BA project is offering 14 internships to young people with #MS across 8 European countries! http…","id":"512168411179548672","lang":"en","created_at":"2014-09-17T09:17:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"512165069124542465"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/umzKpfUCUo","expanded_url":"http://bit.ly/1sroodG","display_url":"bit.ly/1sroodG"}],"hashtags":[{"start":56,"end":61,"tag":"EDQM"},{"start":82,"end":102,"tag":"Radiopharmaceutical"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511898917924253696","text":"RT @edqm_news: Just published! Final programme for next #EDQM training session on #Radiopharmaceutical preparations: http://t.co/umzKpfUCUo…","id":"511898917924253696","lang":"en","created_at":"2014-09-16T15:26:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511898756330307584"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/pBxYJEFw5p","expanded_url":"http://www.medicalnewstoday.com/articles/282559.php","display_url":"medicalnewstoday.com/articles/28255…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511886465706782721","text":"RT @GCessak: Ebola virus protein offers potential drug target: http://t.co/pBxYJEFw5p","id":"511886465706782721","lang":"en","created_at":"2014-09-16T14:36:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511882137705144320"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/ZYEtHvgdQW","expanded_url":"http://go.usa.gov/p2Uh","display_url":"go.usa.gov/p2Uh"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":[{"start":14,"end":16,"probability":0.9433,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511886371561431040","text":"RT @FDAMedia: FDA approves new treatment for opioid-induced constipation: http://t.co/ZYEtHvgdQW","id":"511886371561431040","lang":"en","created_at":"2014-09-16T14:36:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511881842153492480"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/4uV4sshGO0","expanded_url":"http://goo.gl/anpC9o","display_url":"goo.gl/anpC9o"},{"start":94,"end":116,"url":"http://t.co/uRQb5Ze2fN","expanded_url":"https://twitter.com/ArturOlesch/status/511793017737707520/photo/1","display_url":"pic.twitter.com/uRQb5Ze2fN"}],"hashtags":[{"start":16,"end":30,"tag":"PatientSafety"},{"start":38,"end":41,"tag":"EU"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":83,"end":93,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511884556585431040","text":"RT @EU_eHealth: #PatientSafety in the #EU, Infographic: http://t.co/4uV4sshGO0 via @EU_Health http://t.co/uRQb5Ze2fN","id":"511884556585431040","lang":"en","created_at":"2014-09-16T14:29:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511870884785971200"}],"attachments":{"media_keys":["3_511793016525189120"]}},{"entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/enFZXuIKMg","expanded_url":"http://bit.ly/1o03lsz","display_url":"bit.ly/1o03lsz"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511860598305726464","text":"RT @LV_MPA: News from the PRAC (September 2014) http://t.co/enFZXuIKMg","id":"511860598305726464","lang":"en","created_at":"2014-09-16T12:54:11.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/QuTkl3nO45","expanded_url":"http://bit.ly/1t5f7XW","display_url":"bit.ly/1t5f7XW"},{"start":83,"end":105,"url":"http://t.co/osnTjCXPoz","expanded_url":"https://twitter.com/EFPIA/status/511847109570879488/photo/1","display_url":"pic.twitter.com/osnTjCXPoz"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511847557866467328","text":"RT @EFPIA: Ebola virus protein offers potential drug target http://t.co/QuTkl3nO45 http://t.co/osnTjCXPoz","id":"511847557866467328","lang":"en","created_at":"2014-09-16T12:02:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511847109570879488"}],"attachments":{"media_keys":["3_511847108345733120"]}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/Jr5Cn31g2i","expanded_url":"http://bit.ly/1uQChjx","display_url":"bit.ly/1uQChjx"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":44,"end":55,"tag":"Paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511834578043273216","text":"The #minutes from the August meeting of our #Paediatric Committee (PDCO) are now available: http://t.co/Jr5Cn31g2i","id":"511834578043273216","lang":"en","created_at":"2014-09-16T11:10:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/ge25m4hb4z","expanded_url":"http://goo.gl/wpv5Mu","display_url":"goo.gl/wpv5Mu"}],"hashtags":[{"start":109,"end":114,"tag":"RC64"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":79,"end":84,"probability":0.9354,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511834415040069632","text":"RT @WHO: Highlights of day 1 of 64th session of the WHO Regional Committee for Europe http://t.co/ge25m4hb4z #RC64","id":"511834415040069632","lang":"en","created_at":"2014-09-16T11:10:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511834186756681728"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/qg8jgSLxOY","expanded_url":"http://bit.ly/1t41FDW","display_url":"bit.ly/1t41FDW"}],"hashtags":[{"start":31,"end":42,"tag":"veterinary"},{"start":123,"end":136,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511832857892126720","text":"Comment now: revised policy on #veterinary medicines for minor use, minor species / limited market: http://t.co/qg8jgSLxOY #consultation","id":"511832857892126720","lang":"en","created_at":"2014-09-16T11:03:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":125,"end":147,"url":"http://t.co/xvUug3uu9v","expanded_url":"http://bit.ly/1lV0UcN","display_url":"bit.ly/1lV0UcN"}],"hashtags":[{"start":82,"end":98,"tag":"pharmacokinetic"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511832409663619072","text":"Two more weeks to comment: qualification &amp; reporting of physiologically based #pharmacokinetic modelling &amp; analyses: http://t.co/xvUug3uu9v","id":"511832409663619072","lang":"en","created_at":"2014-09-16T11:02:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/7S63Qaa24i","expanded_url":"http://bit.ly/1s4AP08","display_url":"bit.ly/1s4AP08"}],"hashtags":[{"start":90,"end":102,"tag":"antibiotics"}],"mentions":[{"start":47,"end":61,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511832186614734848","text":"Two more weeks to comment on our answer to the @EU_Commission on the impact of the use of #antibiotics in animals: http://t.co/7S63Qaa24i","id":"511832186614734848","lang":"en","created_at":"2014-09-16T11:01:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/Qvex1NjUML","expanded_url":"http://bit.ly/1iMbeou","display_url":"bit.ly/1iMbeou"}],"hashtags":[{"start":44,"end":57,"tag":"benzalkonium"},{"start":73,"end":83,"tag":"excipient"},{"start":87,"end":96,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511832000437952512","text":"Two more weeks to comment on our Q&amp;A on #benzalkonium chloride as an #excipient in #medicine labelling: http://t.co/Qvex1NjUML","id":"511832000437952512","lang":"en","created_at":"2014-09-16T11:00:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/44tLzzzE1W","expanded_url":"http://goo.gl/vvJuop","display_url":"goo.gl/vvJuop"}],"hashtags":[{"start":106,"end":111,"tag":"RC64"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":76,"end":81,"probability":0.9438,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511831237863153664","text":"RT @WHO: Live webcast of the 64th session of the WHO Regional Committee for Europe http://t.co/44tLzzzE1W #RC64","id":"511831237863153664","lang":"en","created_at":"2014-09-16T10:57:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511831063975710720"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/Jr5Cn31g2i","expanded_url":"http://bit.ly/1uQChjx","display_url":"bit.ly/1uQChjx"}],"hashtags":[{"start":25,"end":33,"tag":"minutes"},{"start":65,"end":76,"tag":"Paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511831011798548480","text":"We've just published the #minutes from the August meeting of our #Paediatric Committee (PDCO): http://t.co/Jr5Cn31g2i","id":"511831011798548480","lang":"en","created_at":"2014-09-16T10:56:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/dGdew8PMey","expanded_url":"http://bit.ly/1m7Et6T","display_url":"bit.ly/1m7Et6T"}],"hashtags":[{"start":101,"end":114,"tag":"rarediseases"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511827781064593408","text":"RT @Aifa_ufficiale: Italian medicines agency publishes a list of 'orphan' medicines for treatment of #rarediseases http://t.co/dGdew8PMey","id":"511827781064593408","lang":"en","created_at":"2014-09-16T10:43:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/GB6HI8WqYk","expanded_url":"http://bit.ly/1qQjoxK","display_url":"bit.ly/1qQjoxK"}],"hashtags":[{"start":8,"end":18,"tag":"guideline"},{"start":116,"end":134,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511799950557319168","text":"Revised #guideline on reporting adverse reactions is now available; comes into effect today: http://t.co/GB6HI8WqYk #pharmacovigilance","id":"511799950557319168","lang":"en","created_at":"2014-09-16T08:53:11.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/FwkiPIwUSn","expanded_url":"http://bit.ly/1y5J3Yo","display_url":"bit.ly/1y5J3Yo"}],"hashtags":[{"start":8,"end":18,"tag":"guideline"},{"start":22,"end":40,"tag":"pharmacovigilance"},{"start":41,"end":53,"tag":"inspections"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511799537435148288","text":"Revised #guideline on #pharmacovigilance #inspections is now available; comes into effect today: http://t.co/FwkiPIwUSn","id":"511799537435148288","lang":"en","created_at":"2014-09-16T08:51:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/SFAOYatLkJ","expanded_url":"http://bit.ly/1qWomI3","display_url":"bit.ly/1qWomI3"}],"hashtags":[{"start":13,"end":22,"tag":"Daklinza"},{"start":24,"end":36,"tag":"daclatasvir"},{"start":45,"end":54,"tag":"medicine"},{"start":59,"end":70,"tag":"hepatitisC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"511799083930222592","text":"The EPAR for #Daklinza (#daclatasvir), a new #medicine for #hepatitisC infection is now available: http://t.co/SFAOYatLkJ","id":"511799083930222592","lang":"en","created_at":"2014-09-16T08:49:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/qg8jgSLxOY","expanded_url":"http://bit.ly/1t41FDW","display_url":"bit.ly/1t41FDW"}],"hashtags":[{"start":28,"end":39,"tag":"veterinary"},{"start":120,"end":133,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511798451689254912","text":"We've revised our policy on #veterinary medicines for minor use, minor species / limited market: http://t.co/qg8jgSLxOY #consultation","id":"511798451689254912","lang":"en","created_at":"2014-09-16T08:47:14.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/kf0YRgCi6L","expanded_url":"http://bit.ly/1yvAmU5","display_url":"bit.ly/1yvAmU5"}],"hashtags":[{"start":30,"end":35,"tag":"EFSA"},{"start":44,"end":56,"tag":"OpenScience"},{"start":107,"end":116,"tag":"OpenEFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511797319621435392","text":"RT @EFSA_EU: How to transform #EFSA into an #OpenScience organisation? Still one month to have your say on #OpenEFSA http://t.co/kf0YRgCi6L","id":"511797319621435392","lang":"en","created_at":"2014-09-16T08:42:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511797095515561984"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":125,"end":147,"url":"http://t.co/xvUug3uu9v","expanded_url":"http://bit.ly/1lV0UcN","display_url":"bit.ly/1lV0UcN"}],"hashtags":[{"start":82,"end":98,"tag":"pharmacokinetic"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511796891215200256","text":"Two weeks left to comment: qualification &amp; reporting of physiologically based #pharmacokinetic modelling &amp; analyses: http://t.co/xvUug3uu9v","id":"511796891215200256","lang":"en","created_at":"2014-09-16T08:41:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/WETFrCE4kp","expanded_url":"http://bit.ly/1nZyUCO","display_url":"bit.ly/1nZyUCO"}],"hashtags":[{"start":92,"end":97,"tag":"AIFA"},{"start":98,"end":114,"tag":"pilloledalmondo"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511796199641604097","text":"RT @Aifa_ufficiale: Conclusion of the review of Valdoxan/Thymanax (agomelatine) by the PRAC #AIFA #pilloledalmondo http://t.co/WETFrCE4kp","id":"511796199641604097","lang":"en","created_at":"2014-09-16T08:38:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/7S63Qaa24i","expanded_url":"http://bit.ly/1s4AP08","display_url":"bit.ly/1s4AP08"}],"hashtags":[{"start":90,"end":102,"tag":"antibiotics"}],"mentions":[{"start":47,"end":61,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511795897802698752","text":"Two weeks left to comment on our answer to the @EU_Commission on the impact of the use of #antibiotics in animals: http://t.co/7S63Qaa24i","id":"511795897802698752","lang":"en","created_at":"2014-09-16T08:37:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/Qvex1NjUML","expanded_url":"http://bit.ly/1iMbeou","display_url":"bit.ly/1iMbeou"}],"hashtags":[{"start":44,"end":57,"tag":"benzalkonium"},{"start":73,"end":83,"tag":"excipient"},{"start":87,"end":96,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511795113019072512","text":"Two weeks left to comment on our Q&amp;A on #benzalkonium chloride as an #excipient in #medicine labelling: http://t.co/Qvex1NjUML","id":"511795113019072512","lang":"en","created_at":"2014-09-16T08:33:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":25,"end":43,"tag":"infectiousdisease"},{"start":44,"end":53,"tag":"outbreak"},{"start":111,"end":119,"tag":"ESCAIDE"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511793447532240896","text":"RT @ECDC_EU: Involved in #infectiousdisease #outbreak control / new public health research? Submit abstract to #ESCAIDE by 21 Sept http://t…","id":"511793447532240896","lang":"en","created_at":"2014-09-16T08:27:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511789091516870657"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/JUIIZevW7C","expanded_url":"http://bit.ly/1qWtZWC","display_url":"bit.ly/1qWtZWC"}],"hashtags":[{"start":37,"end":50,"tag":"contaminants"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511573974489497600","text":"RT @EFSA_EU: EFSA data collection on #contaminants in food and feed: Member States to submit data by 1 Oct http://t.co/JUIIZevW7C http://t.…","id":"511573974489497600","lang":"en","created_at":"2014-09-15T17:55:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511498920846180352"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/mrmP75WkAo","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}],"hashtags":[{"start":62,"end":71,"tag":"diabetes"},{"start":72,"end":88,"tag":"neuropsychiatry"},{"start":89,"end":106,"tag":"remoteassessment"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511573924975751169","text":"RT @IMI_JU: Info on IMI 2 – Call 2 indicative topics released #diabetes #neuropsychiatry #remoteassessment http://t.co/mrmP75WkAo","id":"511573924975751169","lang":"en","created_at":"2014-09-15T17:55:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511504122043203584"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/F0JBQXkT8I","expanded_url":"http://go.usa.gov/yKud","display_url":"go.usa.gov/yKud"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":[{"start":36,"end":54,"probability":0.3398,"type":"Other","normalized_text":"FDA Media Tip Sheet"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511573624269336576","text":"RT @FDAMedia: Check out this week's FDA Media Tip Sheet http://t.co/F0JBQXkT8I","id":"511573624269336576","lang":"en","created_at":"2014-09-15T17:53:51.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511539890002350080"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/TwWWkRlaMu","expanded_url":"http://bit.ly/1q8ag2k","display_url":"bit.ly/1q8ag2k"}],"hashtags":[{"start":10,"end":15,"tag":"ANSM"},{"start":70,"end":75,"tag":"PRAC"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":[{"start":64,"end":66,"probability":0.3778,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511573342248509441","text":"RT @ansm: #ANSM has published a round-up of issues discussed at EMA's #PRAC committee last week: http://t.co/TwWWkRlaMu","id":"511573342248509441","lang":"en","created_at":"2014-09-15T17:52:44.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/SFAOYatLkJ","expanded_url":"http://bit.ly/1qWomI3","display_url":"bit.ly/1qWomI3"}],"hashtags":[{"start":42,"end":51,"tag":"Daklinza"},{"start":55,"end":64,"tag":"medicine"},{"start":69,"end":79,"tag":"hepatitis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511483974787796992","text":"We've published the assessment report for #Daklinza, a #medicine for #hepatitis C infection: http://t.co/SFAOYatLkJ","id":"511483974787796992","lang":"en","created_at":"2014-09-15T11:57:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/GB6HI8WqYk","expanded_url":"http://bit.ly/1qQjoxK","display_url":"bit.ly/1qQjoxK"}],"hashtags":[{"start":51,"end":61,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511456908415598592","text":"Revised guidance on reporting adverse reactions in #guideline on good pharmacovigilance practices module VI: http://t.co/GB6HI8WqYk","id":"511456908415598592","lang":"en","created_at":"2014-09-15T10:10:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/FwkiPIwUSn","expanded_url":"http://bit.ly/1y5J3Yo","display_url":"bit.ly/1y5J3Yo"}],"hashtags":[{"start":12,"end":30,"tag":"pharmacovigilance"},{"start":31,"end":43,"tag":"inspections"},{"start":69,"end":79,"tag":"guideline"},{"start":88,"end":106,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"511453379626020864","text":"Guidance on #pharmacovigilance #inspections now out in module III of #guideline on good #pharmacovigilance practices: http://t.co/FwkiPIwUSn","id":"511453379626020864","lang":"en","created_at":"2014-09-15T09:56:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/j1bYeDvzto","expanded_url":"http://bit.ly/1wv9K72","display_url":"bit.ly/1wv9K72"}],"hashtags":[{"start":26,"end":40,"tag":"organdonation"},{"start":59,"end":72,"tag":"becomeadonor"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"},{"start":73,"end":82,"username":"EODD2014","id":"2483359789"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511451556697612288","text":"RT @edqm_news: One single #organdonation can save 8 lives! #becomeadonor @EODD2014 read more here http://t.co/j1bYeDvzto http://t.co/achZ7S…","id":"511451556697612288","lang":"en","created_at":"2014-09-15T09:48:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"511430482249396224"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/EplhwYRuK8","expanded_url":"http://bit.ly/1uraiIV","display_url":"bit.ly/1uraiIV"}],"hashtags":[{"start":28,"end":46,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511451331165712384","text":"Highlights from last week's #pharmacovigilance committee (PRAC) are now available: http://t.co/EplhwYRuK8","id":"511451331165712384","lang":"en","created_at":"2014-09-15T09:47:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/fUZ1huxItG","expanded_url":"http://bit.ly/1tHFrp1","display_url":"bit.ly/1tHFrp1"}],"hashtags":[{"start":20,"end":27,"tag":"herbal"},{"start":42,"end":51,"tag":"Capsicum"},{"start":81,"end":94,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511450895218118656","text":"We've published the #herbal monograph for #Capsicum annuum and C. frutescens for #consultation: http://t.co/fUZ1huxItG","id":"511450895218118656","lang":"en","created_at":"2014-09-15T09:46:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/muIF6bJ8y4","expanded_url":"http://bit.ly/1urXdPz","display_url":"bit.ly/1urXdPz"}],"hashtags":[{"start":41,"end":52,"tag":"diclofenac"},{"start":56,"end":67,"tag":"veterinary"},{"start":68,"end":78,"tag":"medicines"},{"start":123,"end":136,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511450619652341760","text":"We're assessing the risks to vultures of #diclofenac in #veterinary #medicines. Give us your input: http://t.co/muIF6bJ8y4 #consultation","id":"511450619652341760","lang":"en","created_at":"2014-09-15T09:45:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/dOzcBDivfk","expanded_url":"http://bit.ly/1Byj5Lu","display_url":"bit.ly/1Byj5Lu"}],"hashtags":[{"start":50,"end":61,"tag":"veterinary"},{"start":62,"end":72,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"511449827486748672","text":"See the highlights from last week's committee for #veterinary #medicines (CVMP): http://t.co/dOzcBDivfk","id":"511449827486748672","lang":"en","created_at":"2014-09-15T09:41:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/muIF6bJ8y4","expanded_url":"http://bit.ly/1urXdPz","display_url":"bit.ly/1urXdPz"}],"hashtags":[{"start":44,"end":55,"tag":"veterinary"},{"start":77,"end":88,"tag":"diclofenac"},{"start":126,"end":139,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"510467852995137536","text":"We've started assessing risks of the use of #veterinary medicines containing #diclofenac to vultures:  http://t.co/muIF6bJ8y4 #consultation","id":"510467852995137536","lang":"en","created_at":"2014-09-12T16:39:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Y6m7QXiHuA","expanded_url":"http://bit.ly/hN7hpR","display_url":"bit.ly/hN7hpR"}],"hashtags":[{"start":47,"end":54,"tag":"Animal"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510464294048501761","text":"RT @FDAanimalhealth: Have you seen this week's #Animal Federal Register Notices?  http://t.co/Y6m7QXiHuA","id":"510464294048501761","lang":"en","created_at":"2014-09-12T16:25:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510464050665631744"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/6QPGSSDlxU","expanded_url":"http://bit.ly/1sWE7lF","display_url":"bit.ly/1sWE7lF"}],"hashtags":[{"start":82,"end":95,"tag":"contaminants"},{"start":100,"end":111,"tag":"pesticides"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510455096594165760","text":"RT @EFSA_EU: Few days left to register as an observer for EFSA expert meetings on #contaminants and #pesticides http://t.co/6QPGSSDlxU","id":"510455096594165760","lang":"en","created_at":"2014-09-12T15:49:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510454941006442496"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/dOzcBDivfk","expanded_url":"http://bit.ly/1Byj5Lu","display_url":"bit.ly/1Byj5Lu"}],"hashtags":[{"start":40,"end":51,"tag":"veterinary"},{"start":94,"end":99,"tag":"pigs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"510454170424725504","text":"We've published the highlights from our #veterinary committee (CVMP) meeting. New vaccine for #pigs recommended: http://t.co/dOzcBDivfk","id":"510454170424725504","lang":"en","created_at":"2014-09-12T15:45:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/fUZ1huxItG","expanded_url":"http://bit.ly/1tHFrp1","display_url":"bit.ly/1tHFrp1"}],"hashtags":[{"start":27,"end":34,"tag":"herbal"},{"start":48,"end":57,"tag":"Capsicum"},{"start":87,"end":100,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"510452432208691200","text":"We've released a Community #herbal monograph on #Capsicum annuum and C. frutescens for #consultation: http://t.co/fUZ1huxItG","id":"510452432208691200","lang":"en","created_at":"2014-09-12T15:38:38.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/PZ6UxtIFsW","expanded_url":"http://bit.ly/1qPrxBn","display_url":"bit.ly/1qPrxBn"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510422136780238848","text":"RT @EFPIA: EFPIA's Newsletter is here - Happy sunny Friday! http://t.co/PZ6UxtIFsW","id":"510422136780238848","lang":"en","created_at":"2014-09-12T13:38:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510421898602504192"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":56,"end":66,"tag":"Alzheimer"}],"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":43,"end":52,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":129,"end":134,"probability":0.8179,"type":"Person","normalized_text":"Duggan"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510421005735849984","text":"RT @JeanGeorgesAE: Forthcoming workshop of @EMA_News on #Alzheimer's will be key for improving the EU regulatory framework, says Duggan #gl…","id":"510421005735849984","lang":"en","created_at":"2014-09-12T13:33:45.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510416728333885440"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":39,"end":44,"username":"NYAS","id":"12144192"}],"annotations":[{"start":19,"end":32,"probability":0.9956,"type":"Person","normalized_text":"Cynthia Duggan"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510420990145626113","text":"RT @JeanGeorgesAE: Cynthia Duggan from @nyas calling for actionable outcomes: adaptive licensing and global regulatory synchronisation #glo…","id":"510420990145626113","lang":"en","created_at":"2014-09-12T13:33:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510416119320965121"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/CGuZzB63ri","expanded_url":"http://www.medicalnewstoday.com/articles/282409.php","display_url":"medicalnewstoday.com/articles/28240…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510420473877110784","text":"RT @GCessak: 'Significant milestone' in medicine: scientists reset human stem cells: http://t.co/CGuZzB63ri","id":"510420473877110784","lang":"en","created_at":"2014-09-12T13:31:38.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510410209614131200"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/AOPREWU5XU","expanded_url":"https://twitter.com/Eu2P/status/510386258263429120/photo/1","display_url":"pic.twitter.com/AOPREWU5XU"}],"hashtags":{},"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510386524798849025","text":"RT @Eu2P: Master defense: Effectiveness of risk minimisation measures for (es)citalopram. http://t.co/AOPREWU5XU","id":"510386524798849025","lang":"en","created_at":"2014-09-12T11:16:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510386258263429120"}],"attachments":{"media_keys":["3_510386256036249600"]}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/EplhwYRuK8","expanded_url":"http://bit.ly/1uraiIV","display_url":"bit.ly/1uraiIV"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":68,"end":77,"tag":"Valdoxan"},{"start":80,"end":89,"tag":"Thymanax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"510385350095949824","text":"Our #pharmacovigilance committee (PRAC) has finalised its review of #Valdoxan / #Thymanax. Meeting highlights here: http://t.co/EplhwYRuK8","id":"510385350095949824","lang":"en","created_at":"2014-09-12T11:12:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":25,"tag":"OpenScience"},{"start":119,"end":128,"tag":"OpenEFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510374614187667456","text":"RT @EFSA_EU: #OpenScience at EFSA: how can science meet society’s expectations? Have your say on how we transform into #OpenEFSA http://t.c…","id":"510374614187667456","lang":"en","created_at":"2014-09-12T10:29:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510374406963867649"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/cnnW0c4eLl","expanded_url":"http://bit.ly/1pcLgqG","display_url":"bit.ly/1pcLgqG"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510371719434235905","text":"RT @INFARMED_IP: Falsified medicines - Mabthera, 500 mg / 50 ml, concentrate for solution for perfusion http://t.co/cnnW0c4eLl","id":"510371719434235905","lang":"en","created_at":"2014-09-12T10:17:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/Z1bZEeY2A3","expanded_url":"http://bit.ly/1qJbAha","display_url":"bit.ly/1qJbAha"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":46,"end":53,"probability":0.516,"type":"Product","normalized_text":"Facebook"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510370706446897152","text":"RT @INFARMED_IP: Sale of illegal medicines on Facebook - Reductil http://t.co/Z1bZEeY2A3","id":"510370706446897152","lang":"en","created_at":"2014-09-12T10:13:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/f8FKfGZYmJ","expanded_url":"http://bit.ly/1lZgJSb","display_url":"bit.ly/1lZgJSb"},{"start":105,"end":127,"url":"http://t.co/TTV17d3HT7","expanded_url":"https://twitter.com/EFPIA/status/510361035015208960/photo/1","display_url":"pic.twitter.com/TTV17d3HT7"}],"hashtags":[{"start":71,"end":81,"tag":"stemcells"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510364076342792192","text":"RT @EFPIA: 'Significant milestone' in medicine: scientists reset human #stemcells http://t.co/f8FKfGZYmJ http://t.co/TTV17d3HT7","id":"510364076342792192","lang":"en","created_at":"2014-09-12T09:47:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510361035015208960"}],"attachments":{"media_keys":["3_510361033915899904"]}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":34,"tag":"PublicConsultation"},{"start":51,"end":63,"tag":"Horizon2020"},{"start":75,"end":82,"tag":"Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510363983187308544","text":"RT @EU_Health: #PublicConsultation  Your input on  #Horizon2020 programme ‘#Health, demographic change and wellbeing’ 2016-17 http://t.co/4…","id":"510363983187308544","lang":"en","created_at":"2014-09-12T09:47:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510360985132347392"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":50,"end":56,"tag":"H2020"},{"start":57,"end":71,"tag":"SMEinstrument"}],"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510363801431318528","text":"RT @H2020SME: Names of the first beneficiaries of #H2020 #SMEinstrument will be published Thursday next week. Stay tuned!","id":"510363801431318528","lang":"en","created_at":"2014-09-12T09:46:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510358676700672000"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/cgYwtz5AQW","expanded_url":"http://bit.ly/1Bv2XKA","display_url":"bit.ly/1Bv2XKA"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"510343244367286272","text":"We're still welcoming new applications for our adaptive-licensing pilot project. New guidance available: http://t.co/cgYwtz5AQW","id":"510343244367286272","lang":"en","created_at":"2014-09-12T08:24:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/cgYwtz5AQW","expanded_url":"http://bit.ly/1Bv2XKA","display_url":"bit.ly/1Bv2XKA"}],"hashtags":[{"start":24,"end":33,"tag":"guidance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"510112771057676288","text":"We've published further #guidance on our adaptive licensing pilot project: http://t.co/cgYwtz5AQW","id":"510112771057676288","lang":"en","created_at":"2014-09-11T17:08:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":29,"end":37,"tag":"Vaccine"},{"start":69,"end":74,"tag":"RC64"},{"start":114,"end":126,"tag":"vaccination"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":[{"start":130,"end":135,"probability":0.9594,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510072332929761280","text":"RT @WHO_Europe_VPI: European #Vaccine Action Plan to be presented at #RC64 represents a crucial turning point for #vaccination in Europe ht…","id":"510072332929761280","lang":"en","created_at":"2014-09-11T14:28:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510010715386957824"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/2h4OJpSLKV","expanded_url":"http://evidence.nhs.uk/eyes-on-evidence-september-2014.pdf","display_url":"evidence.nhs.uk/eyes-on-eviden…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510072248292868097","text":"RT @NICEcomms: For expert commentary on important new evidence, read Eyes on Evidence. September edition out now http://t.co/2h4OJpSLKV","id":"510072248292868097","lang":"en","created_at":"2014-09-11T14:27:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510017181384732672"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":114,"end":126,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510072008554840064","text":"RT @eurordis: Nominate the person, patient organisation or company that merits a EURORDIS Award for excellence in #raredisease work http://…","id":"510072008554840064","lang":"en","created_at":"2014-09-11T14:26:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510034388957274112"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/jGfqgJTLLC","expanded_url":"http://bit.ly/1BnnYHk","display_url":"bit.ly/1BnnYHk"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":13,"end":38,"probability":0.4635,"type":"Organization","normalized_text":"EFSA Scientific Colloquium"},{"start":43,"end":51,"probability":0.9932,"type":"Place","normalized_text":"Edinburgh"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510071953181667328","text":"RT @EFSA_EU: EFSA Scientific Colloquium in Edinburgh: discussion groups get down to business http://t.co/jGfqgJTLLC","id":"510071953181667328","lang":"en","created_at":"2014-09-11T14:26:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510035034611654656"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/Y6Ggab78fG","expanded_url":"http://bit.ly/1tBb2Zq","display_url":"bit.ly/1tBb2Zq"}],"hashtags":[{"start":68,"end":78,"tag":"polyvinyl"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510071922470944768","text":"RT @EFSAJournal: Modification of the specification on solubility of #polyvinyl alcohol (E1203) http://t.co/Y6Ggab78fG","id":"510071922470944768","lang":"en","created_at":"2014-09-11T14:26:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510038712068370432"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/4sRv213cu8","expanded_url":"http://ow.ly/BndLs","display_url":"ow.ly/BndLs"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":27,"end":59,"probability":0.3676,"type":"Other","normalized_text":"ESMO Metastatic Colorectal Cancer"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510071895707090944","text":"RT @myESMO: New version of ESMO Metastatic Colorectal Cancer guidelines now online. Get yr copy here: http://t.co/4sRv213cu8 #colorectalcan…","id":"510071895707090944","lang":"en","created_at":"2014-09-11T14:26:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"510041130655043585"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/BKBNIoIbIK","expanded_url":"http://bit.ly/1rW8oBi","display_url":"bit.ly/1rW8oBi"}],"hashtags":[{"start":23,"end":34,"tag":"veterinary"},{"start":35,"end":45,"tag":"medicines"}],"mentions":[{"start":67,"end":81,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"510027287736369154","text":"We welcome the revised #veterinary #medicines legislation from the @EU_Commission to support animal health: http://t.co/BKBNIoIbIK","id":"510027287736369154","lang":"en","created_at":"2014-09-11T11:29:15.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/tFvOpM5Nqt","expanded_url":"http://www.ilae.org/Commission/class/diagnostic.cfm","display_url":"ilae.org/Commission/cla…"}],"hashtags":[{"start":77,"end":86,"tag":"epilepsy"}],"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509726686154612737","text":"RT @IlaeWeb: New ILAE Diagnostics Manual: Latest concepts for seizures &amp; #epilepsy. For clinicians http://t.co/tFvOpM5Nqt","id":"509726686154612737","lang":"en","created_at":"2014-09-10T15:34:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509725930412322816"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/ExN4YBwwAp","expanded_url":"http://bit.ly/ZfxmPo","display_url":"bit.ly/ZfxmPo"},{"start":115,"end":137,"url":"http://t.co/7UQasyCSyz","expanded_url":"https://twitter.com/EFSA_EU/status/509720734022000640/photo/1","display_url":"pic.twitter.com/7UQasyCSyz"}],"hashtags":[{"start":23,"end":36,"tag":"contaminants"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509720873390333952","text":"RT @EFSA_EU: Chemical  #contaminants are substances unintentionally present in food or feed http://t.co/ExN4YBwwAp http://t.co/7UQasyCSyz","id":"509720873390333952","lang":"en","created_at":"2014-09-10T15:11:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509720734022000640"}],"attachments":{"media_keys":["3_509720732708794368"]}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":25,"end":31,"probability":0.502,"type":"Place","normalized_text":"Hamburg"},{"start":75,"end":77,"probability":0.8693,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509720338142593024","text":"RT @US_FDA: Commissioner Hamburg speaking @ 21st Century Cures roundtable -FDA is committed to innovation &amp; personalized medicine http://t.…","id":"509720338142593024","lang":"en","created_at":"2014-09-10T15:09:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509719496580665344"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/XHyS3DhYqI","expanded_url":"http://bit.ly/1ulvpwk","display_url":"bit.ly/1ulvpwk"}],"hashtags":[{"start":47,"end":53,"tag":"Ebola"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509718746085490688","text":"RT @ECDC_EU: ECDC releases case definition for #Ebola virus disease to classify cases for epidemiological reporting http://t.co/XHyS3DhYqI","id":"509718746085490688","lang":"en","created_at":"2014-09-10T15:03:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509718528942145536"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/DzXKOsaYNI","expanded_url":"http://ec.europa.eu/food/food/animalnutrition/labelling/medicated_feed_en.htm","display_url":"ec.europa.eu/food/food/anim…"}],"hashtags":[{"start":64,"end":74,"tag":"medicated"},{"start":75,"end":80,"tag":"feed"},{"start":85,"end":93,"tag":"animals"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":15,"end":29,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509718178331918336","text":"RT @EU_Health: @EU_Commission tables modernised rules on use of #medicated #feed for #animals http://t.co/DzXKOsaYNI","id":"509718178331918336","lang":"en","created_at":"2014-09-10T15:00:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509718105279725568"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/QWVKsihXl4","expanded_url":"http://ow.ly/Bkwod","display_url":"ow.ly/Bkwod"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":[{"start":14,"end":16,"probability":0.9179,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509714772863229953","text":"RT @FDAWomen: FDA hosts public meeting on female sexual dysfunction. Register here: http://t.co/QWVKsihXl4","id":"509714772863229953","lang":"en","created_at":"2014-09-10T14:47:26.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509702065606905856"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/JJh3ngsBXD","expanded_url":"http://bit.ly/1lTaBuJ","display_url":"bit.ly/1lTaBuJ"},{"start":112,"end":134,"url":"http://t.co/nhAAWbIHsF","expanded_url":"https://twitter.com/EU_ECHA/status/509690867376865280/photo/1","display_url":"pic.twitter.com/nhAAWbIHsF"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509714425776209920","text":"RT @EU_ECHA: Our terminology database ECHA-term has new features. We hope you like them! http://t.co/JJh3ngsBXD http://t.co/nhAAWbIHsF","id":"509714425776209920","lang":"en","created_at":"2014-09-10T14:46:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509690867376865280"}],"attachments":{"media_keys":["3_509690865900457984"]}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/bpArFfzqpW","expanded_url":"http://bit.ly/WIQ8g0","display_url":"bit.ly/WIQ8g0"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":[{"start":108,"end":113,"probability":0.983,"type":"Place","normalized_text":"Norway"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509714263603445760","text":"RT @Legemiddelinfo: For the third time in a short while, a fake cancer drug (Ipstyl) has been imported into Norway. http://t.co/bpArFfzqpW","id":"509714263603445760","lang":"en","created_at":"2014-09-10T14:45:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/whvIzGJh7O","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/09/news_detail_002165.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509713828490543105","text":"RT @GCessak: Revision of the legal framework for veterinary medicinal products: http://t.co/whvIzGJh7O","id":"509713828490543105","lang":"en","created_at":"2014-09-10T14:43:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509681769982226432"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":87,"end":95,"tag":"vetmeds"}],"mentions":[{"start":17,"end":31,"username":"EU_Commission","id":"157981564"},{"start":32,"end":42,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509671771243819009","text":"RT @IFAHEurope: .@EU_Commission @EU_Health just published prop 4 revised legislation 4 #vetmeds &amp; medicated feed. Our press release: http:/…","id":"509671771243819009","lang":"en","created_at":"2014-09-10T11:56:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509670898996363264"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/BKBNIoIbIK","expanded_url":"http://bit.ly/1rW8oBi","display_url":"bit.ly/1rW8oBi"}],"hashtags":[{"start":68,"end":79,"tag":"veterinary"}],"mentions":[{"start":15,"end":29,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"509671655816560640","text":"We welcome the @EU_Commission's proposal for revised legislation on #veterinary medicines to improve animal health: http://t.co/BKBNIoIbIK","id":"509671655816560640","lang":"en","created_at":"2014-09-10T11:56:06.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/TC0ucLNGOn","expanded_url":"http://bit.ly/WI7MR4","display_url":"bit.ly/WI7MR4"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509665324267208704","text":"RT @GCessak: The Polish medicines agency has published its August 2014 newsletter on medicines on its website. http://t.co/TC0ucLNGOn","id":"509665324267208704","lang":"en","created_at":"2014-09-10T11:30:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":19,"tag":"AMR"},{"start":31,"end":34,"tag":"EU"},{"start":59,"end":69,"tag":"medicated"},{"start":70,"end":75,"tag":"feed"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509643594412871680","text":"RT @EU_Health: #AMR tackled as #EU sets residue limits for #medicated #feed","id":"509643594412871680","lang":"en","created_at":"2014-09-10T10:04:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509643321011367936"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/ximT8ECDmz","expanded_url":"http://europa.eu/!XB36jv","display_url":"europa.eu/!XB36jv"}],"hashtags":[{"start":49,"end":61,"tag":"raredisease"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":76,"end":81,"probability":0.9802,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509630582117376000","text":"RT @EU_Health: Report on the state of the art of #raredisease activities in Europe – 2014 edition http://t.co/ximT8ECDmz","id":"509630582117376000","lang":"en","created_at":"2014-09-10T09:12:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509628687093096448"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/txHlshoGb4","expanded_url":"http://bit.ly/1xHslyl","display_url":"bit.ly/1xHslyl"}],"hashtags":[{"start":44,"end":53,"tag":"OpenEFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509626567807733760","text":"RT @EFSA_EU: EFSA welcomes your comments on #OpenEFSA discussion paper. Public consultation extended 15 Oct http://t.co/txHlshoGb4 http://t…","id":"509626567807733760","lang":"en","created_at":"2014-09-10T08:56:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509626474203467776"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/EWZkHK9JRP","expanded_url":"http://bit.ly/1qAnmuA","display_url":"bit.ly/1qAnmuA"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":39,"tag":"Paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"509621182619209728","text":"The #agenda for this week's #Paediatric Committee (PDCO) meeting is available: http://t.co/EWZkHK9JRP","id":"509621182619209728","lang":"en","created_at":"2014-09-10T08:35:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":22,"end":26,"tag":"AMR"},{"start":28,"end":32,"tag":"Vet"},{"start":93,"end":105,"tag":"antibiotics"},{"start":110,"end":116,"tag":"human"},{"start":117,"end":128,"tag":"infections"}],"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509620380571430912","text":"RT @borgton: Fighting #AMR, #Vet medicines proposal will make it possible to reserve certain #antibiotics for #human #infections only","id":"509620380571430912","lang":"en","created_at":"2014-09-10T08:32:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509617781898481665"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":70,"end":74,"tag":"AMR"},{"start":87,"end":94,"tag":"animal"},{"start":99,"end":105,"tag":"human"},{"start":106,"end":113,"tag":"health"}],"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"},{"start":36,"end":50,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509620348816343040","text":"RT @borgton: College just adopted 2 @EU_Commission proposals tackling #AMR. Protecting #animal and #human #health","id":"509620348816343040","lang":"en","created_at":"2014-09-10T08:32:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509617664357310464"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/onijyx39DX","expanded_url":"http://tinyurl.com/m97hxd6","display_url":"tinyurl.com/m97hxd6"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter for iPhone","conversation_id":"509422601681510400","text":"RT @MHRAmedicines: Information sent to healthcare professionals in August about the safety of medicines http://t.co/onijyx39DX","id":"509422601681510400","lang":"en","created_at":"2014-09-09T19:26:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509382608090697728"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/EUPLCGdavK","expanded_url":"http://reut.rs/WDRZmi","display_url":"reut.rs/WDRZmi"}],"hashtags":[{"start":75,"end":81,"tag":"Ebola"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter for iPhone","conversation_id":"509368634867605505","text":"RT @DrugInfoAssn: Drug and vaccine makers race to discover safe, effective #Ebola meds http://t.co/EUPLCGdavK","id":"509368634867605505","lang":"en","created_at":"2014-09-09T15:52:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509359619983310848"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/JF4BwgtSxJ","expanded_url":"http://ht.ly/Bfjvk","display_url":"ht.ly/Bfjvk"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":14,"end":48,"probability":0.7607,"type":"Organization","normalized_text":"National Vaccine Advisory Committee"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509323733581180928","text":"RT @FDA_MCMi: National Vaccine Advisory Committee meets Sept. 9-10. http://t.co/JF4BwgtSxJ  Webcast starts 9 a.m. EDT - Day 1: http://t.co/…","id":"509323733581180928","lang":"en","created_at":"2014-09-09T12:53:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509321715013652480"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/ky4kQI5hiD","expanded_url":"http://bit.ly/1CMLi2H","display_url":"bit.ly/1CMLi2H"}],"hashtags":[{"start":44,"end":54,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509317192035610625","text":"RT @euparkinsons: The future of research in #Parkinson disease: http://t.co/ky4kQI5hiD","id":"509317192035610625","lang":"en","created_at":"2014-09-09T12:27:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509317107901665280"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509316185889210368","text":"RT @TOPRANEWS: Human medicines highlights - Issue 66 - August 2014: The August 2014 issue of the European Medicines Agency's ... http://t.c…","id":"509316185889210368","lang":"en","created_at":"2014-09-09T12:23:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509315884360294401"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/ywJmcAOmwb","expanded_url":"http://bit.ly/1xCQeqS","display_url":"bit.ly/1xCQeqS"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509310019360555008","text":"RT @TOPRANEWS: Human medicines highlights - Issue 66 - August 2014 http://t.co/ywJmcAOmwb","id":"509310019360555008","lang":"en","created_at":"2014-09-09T11:59:05.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509308474283405312"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509304992843702273","text":"RT @ZVALatvija: Amendments to the State Agency of Medicines price list of public services. The text of the amendments available here:http:/…","id":"509304992843702273","lang":"en","created_at":"2014-09-09T11:39:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509303564808634368"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/EWZkHK9JRP","expanded_url":"http://bit.ly/1qAnmuA","display_url":"bit.ly/1qAnmuA"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":44,"end":55,"tag":"Paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"509299546741288960","text":"We've published the #agenda for this week's #Paediatric Committee (PDCO) meeting: http://t.co/EWZkHK9JRP","id":"509299546741288960","lang":"en","created_at":"2014-09-09T11:17:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/cNPgCGpRqw","expanded_url":"http://bit.ly/1mihksM","display_url":"bit.ly/1mihksM"}],"hashtags":[{"start":76,"end":87,"tag":"Veterinary"},{"start":128,"end":140,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"509298619909165056","text":"One more week to apply to our vacancy for a scientific administrator in our #Veterinary Medicines Dept: http://t.co/cNPgCGpRqw  #recruitment","id":"509298619909165056","lang":"en","created_at":"2014-09-09T11:13:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/JCYikaYC2q","expanded_url":"http://ow.ly/BgXA3","display_url":"ow.ly/BgXA3"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509298273157652481","text":"RT @MHRAgovuk: You can report side effects to a medicine, vaccine or herbal remedy using the Yellow Card Scheme: http://t.co/JCYikaYC2q","id":"509298273157652481","lang":"en","created_at":"2014-09-09T11:12:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509293992715251712"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/gl9giaXxb5","expanded_url":"http://bit.ly/1weOxvm","display_url":"bit.ly/1weOxvm"}],"hashtags":[{"start":92,"end":101,"tag":"ptsafety"},{"start":102,"end":107,"tag":"hcsm"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":78,"end":91,"username":"FiercePharma","id":"18294275"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509297841463123968","text":"RT @HAIEurope: Can social media improve drug safety? http://t.co/gl9giaXxb5 | @FiercePharma #ptsafety #hcsm","id":"509297841463123968","lang":"en","created_at":"2014-09-09T11:10:42.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509285955770253312"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/fOvYjq38j7","expanded_url":"http://www.nice.org.uk/News/Article/nice-to-seek-greater-access-to-clinical-trial-data-when-appraising-drugs","display_url":"nice.org.uk/News/Article/n…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509297538743410688","text":"RT @NICEcomms: NICE to seek greater access to clinical trial data when appraising drugs:\nhttp://t.co/fOvYjq38j7","id":"509297538743410688","lang":"en","created_at":"2014-09-09T11:09:30.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509281635553267712"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/rqGJoewDjw","expanded_url":"http://bit.ly/WCVrxC","display_url":"bit.ly/WCVrxC"},{"start":111,"end":133,"url":"http://t.co/AUljIrLduH","expanded_url":"http://bit.ly/1qbNYD0","display_url":"bit.ly/1qbNYD0"}],"hashtags":{},"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509297201978568704","text":"RT @ansm: Meetings - Health products: the new challenges of innovation and surveillance http://t.co/rqGJoewDjw http://t.co/AUljIrLduH","id":"509297201978568704","lang":"en","created_at":"2014-09-09T11:08:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/r4ngMQ7lzG","expanded_url":"http://bit.ly/WCUWnn","display_url":"bit.ly/WCUWnn"}],"hashtags":[{"start":20,"end":30,"tag":"Medicines"},{"start":35,"end":45,"tag":"pregnancy"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":56,"end":59,"probability":0.3413,"type":"Other","normalized_text":"NEJM"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509296703577817088","text":"RT @Aifa_ufficiale: #Medicines and #pregnancy: study in NEJM confirms safety and efficacy of anti-influenza vaccine http://t.co/r4ngMQ7lzG","id":"509296703577817088","lang":"en","created_at":"2014-09-09T11:06:11.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/cNPgCGpRqw","expanded_url":"http://bit.ly/1mihksM","display_url":"bit.ly/1mihksM"}],"hashtags":[{"start":76,"end":87,"tag":"Veterinary"},{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"509261312246181888","text":"One week left to apply to our vacancy for a scientific administrator in our #Veterinary Medicines Dept: http://t.co/cNPgCGpRqw #recruitment","id":"509261312246181888","lang":"en","created_at":"2014-09-09T08:45:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/9E1S0v1446","expanded_url":"http://bit.ly/1nGcqXz","display_url":"bit.ly/1nGcqXz"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":45,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"509260938013581312","text":"The #agenda of this week's #pharmacovigilance committee (PRAC) meeting is available: http://t.co/9E1S0v1446","id":"509260938013581312","lang":"en","created_at":"2014-09-09T08:44:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/u1YHQaZIxn","expanded_url":"http://bit.ly/1weaBWY","display_url":"bit.ly/1weaBWY"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":38,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"509260833395056640","text":"The #agenda of this week's #veterinary committee (CVMP) meeting is available: http://t.co/u1YHQaZIxn","id":"509260833395056640","lang":"en","created_at":"2014-09-09T08:43:38.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/BnAfYpwjSn","expanded_url":"http://who.int/tb/publications/elimination_framework/en/","display_url":"who.int/tb/publication…"}],"hashtags":[{"start":37,"end":50,"tag":"tuberculosis"},{"start":92,"end":99,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509260049345421312","text":"RT @WHO_Europe_TB: Framework towards #tuberculosis elimination in low-incidence countries | #TBChat http://t.co/BnAfYpwjSn","id":"509260049345421312","lang":"en","created_at":"2014-09-09T08:40:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509248615840104448"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":19,"end":31,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509258048314290176","text":"RT @eurordis: What #raredisease events are taking place this autumn? EURORDIS has a list of international conferences and events. http://t.…","id":"509258048314290176","lang":"en","created_at":"2014-09-09T08:32:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509243900968828928"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/9E1S0v1446","expanded_url":"http://bit.ly/1nGcqXz","display_url":"bit.ly/1nGcqXz"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"509017346451988480","text":"We've published the #agenda of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/9E1S0v1446","id":"509017346451988480","lang":"en","created_at":"2014-09-08T16:36:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/u1YHQaZIxn","expanded_url":"http://bit.ly/1weaBWY","display_url":"bit.ly/1weaBWY"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":54,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"509017097062862850","text":"We've published the #agenda of this week's #veterinary committee (CVMP) meeting: http://t.co/u1YHQaZIxn","id":"509017097062862850","lang":"en","created_at":"2014-09-08T16:35:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/I7tCbqB9FP","expanded_url":"http://bit.ly/1sZqgqQ","display_url":"bit.ly/1sZqgqQ"}],"hashtags":[{"start":56,"end":65,"tag":"duchenne"}],"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509007877735202816","text":"RT @BushbyKate: Technology! Webinar exonskipping trials #duchenne NOW http://t.co/I7tCbqB9FP @TargetMD @DuchenneFSG @ActionDuchenne http://…","id":"509007877735202816","lang":"en","created_at":"2014-09-08T15:58:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509007529561837568"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/BsspDNhlEm","expanded_url":"http://go.usa.gov/V3Rh","display_url":"go.usa.gov/V3Rh"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509007476747145216","text":"RT @FDA_Drug_Info: Join us on Sept. 11 for a webinar for industry on developing drugs for uncomplicated gonorrhea: http://t.co/BsspDNhlEm.","id":"509007476747145216","lang":"en","created_at":"2014-09-08T15:56:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509007406895230976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/F0JBQXkT8I","expanded_url":"http://go.usa.gov/yKud","display_url":"go.usa.gov/yKud"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":[{"start":48,"end":50,"probability":0.8724,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"509002904209199105","text":"RT @FDAMedia: Check out the upcoming events for FDA's leadership in this week's Media Tip Sheet: http://t.co/F0JBQXkT8I","id":"509002904209199105","lang":"en","created_at":"2014-09-08T15:38:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"509002809858338816"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":58,"end":62,"username":"WHO","id":"14499829"}],"annotations":[{"start":84,"end":91,"probability":0.9798,"type":"Place","normalized_text":"Brussels"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508996502069714944","text":"RT @EFSA_EU: Threshold of Toxicological Concern: EFSA and @WHO meet stakeholders in Brussels on 2 Dec. Registration is open http://t.co/EZB…","id":"508996502069714944","lang":"en","created_at":"2014-09-08T15:13:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508996339586588674"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/c0BylSKeyd","expanded_url":"http://bit.ly/1lR2YoO","display_url":"bit.ly/1lR2YoO"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508993788715757568","text":"RT @INFARMED_IP: Falsified medicine - Viramune, nevirapine, extended-release tablet, 400 mg http://t.co/c0BylSKeyd","id":"508993788715757568","lang":"en","created_at":"2014-09-08T15:02:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/fMEQ48o088","expanded_url":"http://bit.ly/1lQXqL7","display_url":"bit.ly/1lQXqL7"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":39,"end":54,"probability":0.551,"type":"Person","normalized_text":"Sandostatina LAR"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508979231247052800","text":"RT @INFARMED_IP: Falsified medicines - Sandostatina LAR and Pegasys http://t.co/fMEQ48o088","id":"508979231247052800","lang":"en","created_at":"2014-09-08T14:04:39.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/p82mQCoAHP","expanded_url":"http://bit.ly/1uG7Exg","display_url":"bit.ly/1uG7Exg"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508978826857447424","text":"RT @INFARMED_IP: Falsified medicines - Clexane and Remicade http://t.co/p82mQCoAHP","id":"508978826857447424","lang":"en","created_at":"2014-09-08T14:03:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":80,"end":90,"tag":"outbreaks"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508978706321506304","text":"RT @ECDC_EU: #ESCAIDE 2014 late breaker abstract call opens today. Abstracts on #outbreaks &amp; new public health research welcome http://t.co…","id":"508978706321506304","lang":"en","created_at":"2014-09-08T14:02:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508978298656137216"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/kk9bgWAmKg","expanded_url":"http://on.wsj.com/1oiQOAl","display_url":"on.wsj.com/1oiQOAl"}],"hashtags":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":18,"end":25,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508957775918301184","text":"RT @DrugInfoAssn: @US_FDA Approves 27 New Medicines So Far This Year, Same Number As All Of 2013 http://t.co/kk9bgWAmKg","id":"508957775918301184","lang":"en","created_at":"2014-09-08T12:39:24.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508955039525011456"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/J366JqjpTT","expanded_url":"http://bit.ly/1ueo15M","display_url":"bit.ly/1ueo15M"}],"hashtags":[{"start":11,"end":17,"tag":"Ebola"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508957395201310720","text":"RT @EFPIA: #Ebola vaccine set for human trials after inducing long-term immunity in monkeys http://t.co/J366JqjpTT","id":"508957395201310720","lang":"en","created_at":"2014-09-08T12:37:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508941727278067712"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508957312279912448","text":"RT @myESMO: Delivering precision medicine in oncology today &amp; in future: promise &amp; challenges of personalised cancer medicine http://t.co/T…","id":"508957312279912448","lang":"en","created_at":"2014-09-08T12:37:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508940956104937472"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/1pVMMYAIy7","expanded_url":"http://bit.ly/1CInAVe","display_url":"bit.ly/1CInAVe"}],"hashtags":[{"start":107,"end":118,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"508933126547324928","text":"We're co-hosting a conference on better medicines for children on 30/09 and 01/10: http://t.co/1pVMMYAIy7  #paediatric","id":"508933126547324928","lang":"en","created_at":"2014-09-08T11:01:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/tkOW1OFbTt","expanded_url":"http://bit.ly/1sUlSJA","display_url":"bit.ly/1sUlSJA"}],"hashtags":[{"start":40,"end":55,"tag":"EudraVigilance"},{"start":95,"end":108,"tag":"consultation"},{"start":109,"end":127,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"508932895134597121","text":"One more week to comment on the revised #EudraVigilance access policy: http://t.co/tkOW1OFbTt  #consultation #pharmacovigilance","id":"508932895134597121","lang":"en","created_at":"2014-09-08T11:00:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/a7fYnJjyxy","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000259.jsp&mid=WC0b01ac0580029487","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"karlosponders","id":"17485749"}],"annotations":[{"start":23,"end":25,"probability":0.5962,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508932176407437312","text":"RT @karlosponders: The EMA is donating items to charities / local authorities following our building move. See http://t.co/a7fYnJjyxy #char…","id":"508932176407437312","lang":"en","created_at":"2014-09-08T10:57:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508931843752992768"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/1pVMMYAIy7","expanded_url":"http://bit.ly/1CInAVe","display_url":"bit.ly/1CInAVe"}],"hashtags":{},"mentions":[{"start":107,"end":120,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"508925163409522689","text":"We're hosting a conference on better medicines for children together with the European Forum for GCP &amp; @DrugInfoAssn: http://t.co/1pVMMYAIy7","id":"508925163409522689","lang":"en","created_at":"2014-09-08T10:29:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/k5xnhjo2ds","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2014/09/WC500172265.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":18,"end":27,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508917906043052032","text":"RT @GCessak: EMA (@EMA_News) Human medicines highlights - August 2014 http://t.co/k5xnhjo2ds","id":"508917906043052032","lang":"en","created_at":"2014-09-08T10:00:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508917789529477120"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508907400636952576","text":"RT @NICEcomms: Join the network: Become a NICE ambassador. Applications now open for our Fellows and Scholars programme: \nhttp://t.co/xUt8I…","id":"508907400636952576","lang":"en","created_at":"2014-09-08T09:19:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508905103760584704"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":115,"end":122,"tag":"asthma"},{"start":123,"end":131,"tag":"ERS2014"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"},{"start":19,"end":28,"username":"UBIOPRED","id":"453922574"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508907068322230272","text":"RT @EuropeanLung: .@UBIOPRED is hosting a symposium on working together to develop new personalised treatments for #asthma #ERS2014","id":"508907068322230272","lang":"en","created_at":"2014-09-08T09:17:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"508898874770341888"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/IWN581KcnV","expanded_url":"http://bit.ly/1sUlSJA","display_url":"bit.ly/1sUlSJA"}],"hashtags":[{"start":40,"end":55,"tag":"EudraVigilance"},{"start":94,"end":107,"tag":"consultation"},{"start":108,"end":126,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"508885090211233792","text":"One week left to comment on the revised #EudraVigilance access policy: http://t.co/IWN581KcnV #consultation #pharmacovigilance","id":"508885090211233792","lang":"en","created_at":"2014-09-08T07:50:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/xeSQoTy3fo","expanded_url":"http://bit.ly/1qziDZY","display_url":"bit.ly/1qziDZY"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"508884277854208000","text":"RT @Aifa_ufficiale: EU Commission: public consultation on the future of \"science 2.0\" http://t.co/xeSQoTy3fo","id":"508884277854208000","lang":"en","created_at":"2014-09-08T07:47:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/7fYOS6xyNL","expanded_url":"http://bit.ly/1CmbocO","display_url":"bit.ly/1CmbocO"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507914689867956224","text":"RT @ECDC_EU: ECDC job vacancy: Expert in Instructional Design/ e-learning Specialist; deadline to apply is 6 October http://t.co/7fYOS6xyNL","id":"507914689867956224","lang":"en","created_at":"2014-09-05T15:34:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507893653315276800"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/EMYahJ52rp","expanded_url":"http://bit.ly/1r7QV2x","display_url":"bit.ly/1r7QV2x"}],"hashtags":[{"start":13,"end":27,"tag":"CallForTender"},{"start":44,"end":59,"tag":"toxicokinetics"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507914577934577664","text":"RT @EFSA_EU: #CallForTender  –  Integrating #toxicokinetics in chemical risk assessment  http://t.co/EMYahJ52rp","id":"507914577934577664","lang":"en","created_at":"2014-09-05T15:34:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507906002470313984"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507914541494464512","text":"RT @FDA_MCMi: Medicines regulators worldwide have committed to enhanced cooperation to speed access to investigational Ebola drugs: http://…","id":"507914541494464512","lang":"en","created_at":"2014-09-05T15:33:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507906319228350465"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/ktynxUVr8v","expanded_url":"http://bit.ly/1o6AzXc","display_url":"bit.ly/1o6AzXc"}],"hashtags":[{"start":10,"end":15,"tag":"ANSM"},{"start":45,"end":63,"tag":"pharmacovigilance"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507914415883448320","text":"RT @ansm: #ANSM has published minutes of its #pharmacovigilance committee meeting in April: http://t.co/ktynxUVr8v","id":"507914415883448320","lang":"en","created_at":"2014-09-05T15:33:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/0ALZpR4nyD","expanded_url":"http://bit.ly/WneqMV","display_url":"bit.ly/WneqMV"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507913960981798912","text":"The EMA website will be temporarily unavailable tomorrow: http://t.co/0ALZpR4nyD","id":"507913960981798912","lang":"en","created_at":"2014-09-05T15:31:39.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/0ALZpR4nyD","expanded_url":"http://bit.ly/WneqMV","display_url":"bit.ly/WneqMV"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"507876498372829184","text":"Our website will be temporarily unavailable tomorrow: http://t.co/0ALZpR4nyD","id":"507876498372829184","lang":"en","created_at":"2014-09-05T13:02:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":37,"end":38,"probability":0.5795,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507874728535949312","text":"RT @MHRApress: MHRA leads innovative EU project on the use of smartphones and social media for drug safety information http://t.co/FNJZoBht…","id":"507874728535949312","lang":"en","created_at":"2014-09-05T12:55:45.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507841584193224704"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/HvmemA2rZP","expanded_url":"http://bit.ly/1tyjP2a","display_url":"bit.ly/1tyjP2a"}],"hashtags":[{"start":64,"end":75,"tag":"acrylamide"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507874561669734400","text":"RT @EFSA_EU: 10 days left to comment on EFSA’s draft opinion on #acrylamide in food. Have your say! http://t.co/HvmemA2rZP","id":"507874561669734400","lang":"en","created_at":"2014-09-05T12:55:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507854629661450240"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":28,"tag":"Cancer"},{"start":33,"end":39,"tag":"heart"},{"start":40,"end":48,"tag":"disease"},{"start":112,"end":121,"tag":"Exposome"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":91,"end":95,"username":"WHO","id":"14499829"}],"annotations":[{"start":98,"end":110,"probability":0.5067,"type":"Person","normalized_text":"Dr Chris Wild"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507874388528869376","text":"RT @innovationunion: #Cancer and #heart #disease risk comes from the world around us, says @WHO’s Dr Chris Wild #Exposome http://t.co/qDthv…","id":"507874388528869376","lang":"en","created_at":"2014-09-05T12:54:24.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507868652449038336"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":66,"end":80,"tag":"healthrecords"}],"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507874345654693888","text":"RT @DigitalAgendaEU: Should patients have access to their digital #healthrecords? An interesting debate between 2 experts. http://t.co/VDCe…","id":"507874345654693888","lang":"en","created_at":"2014-09-05T12:54:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507870831318675456"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/zg3kyhTeTh","expanded_url":"http://bit.ly/1unIHaA","display_url":"bit.ly/1unIHaA"}],"hashtags":[{"start":82,"end":92,"tag":"medicines"},{"start":104,"end":110,"tag":"Ebola"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507813077761671168","text":"Regulators to cooperate to facilitate evaluation of &amp; access to potential new #medicines to counter #Ebola outbreaks: http://t.co/zg3kyhTeTh","id":"507813077761671168","lang":"en","created_at":"2014-09-05T08:50:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/sqS3G2Qy8L","expanded_url":"http://bit.ly/YdKLHs","display_url":"bit.ly/YdKLHs"}],"hashtags":[{"start":58,"end":79,"tag":"pharmacoepidemiology"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507580651688960000","text":"We have a secondment opportunity for a national expert in #pharmacoepidemiology: http://t.co/sqS3G2Qy8L","id":"507580651688960000","lang":"en","created_at":"2014-09-04T17:27:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/twXLOe0nUs","expanded_url":"http://bit.ly/1nxVQsK","display_url":"bit.ly/1nxVQsK"}],"hashtags":[{"start":29,"end":40,"tag":"Translarna"},{"start":44,"end":53,"tag":"medicine"},{"start":58,"end":67,"tag":"Duchenne"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507580539940130816","text":"We've published the EPAR for #Translarna, a #medicine for #Duchenne muscular dystrophy: http://t.co/twXLOe0nUs","id":"507580539940130816","lang":"en","created_at":"2014-09-04T17:26:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/twXLOe0nUs","expanded_url":"http://bit.ly/1nxVQsK","display_url":"bit.ly/1nxVQsK"},{"start":73,"end":95,"url":"http://t.co/lwcpeSK7ep","expanded_url":"http://bit.ly/1gWcRPJ","display_url":"bit.ly/1gWcRPJ"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"deanmayers","id":"236935864"}],"annotations":[{"start":23,"end":32,"probability":0.3437,"type":"Person","normalized_text":"Translarna"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507558741429202945","text":"@deanmayers Read about Translarna on our website: http://t.co/twXLOe0nUs http://t.co/lwcpeSK7ep","id":"507580415532879872","lang":"en","created_at":"2014-09-04T17:26:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"507577113046556673"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"236935864"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/GJzHqif13g","expanded_url":"http://bit.ly/1w5Xved","display_url":"bit.ly/1w5Xved"}],"hashtags":[{"start":116,"end":127,"tag":"regaffairs"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507559980170772481","text":"RT @TOPRANEWS: Read September's Regulatory Rapporteur online  - focus on Veterinary Medicine http://t.co/GJzHqif13g #regaffairs","id":"507559980170772481","lang":"en","created_at":"2014-09-04T16:05:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507523793099960321"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":53,"end":59,"tag":"Ebola"}],"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507559375020765184","text":"RT @ECDC_Outbreaks: ECDC risk assessment:Low risk of #Ebola infection for visitors to affected countries if recommended precautions taken h…","id":"507559375020765184","lang":"en","created_at":"2014-09-04T16:02:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507545230397411328"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/OWCv0OhREh","expanded_url":"http://bit.ly/ZJEn5W","display_url":"bit.ly/ZJEn5W"}],"hashtags":[{"start":37,"end":42,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507559237531488257","text":"RT @EFSA_EU: Register now to observe #EFSA open plenary meeting on contaminants 30 Sept-2 Oct http://t.co/OWCv0OhREh","id":"507559237531488257","lang":"en","created_at":"2014-09-04T16:02:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507549943511674880"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":55,"end":72,"probability":0.367,"type":"Other","normalized_text":"Authorisation List"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507559186411290624","text":"RT @EU_ECHA: Our proposal to add new substances to the Authorisation List is now in public consultation. Comment by 30 November http://t.co…","id":"507559186411290624","lang":"en","created_at":"2014-09-04T16:01:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507552674439372800"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/zg3kyhTeTh","expanded_url":"http://bit.ly/1unIHaA","display_url":"bit.ly/1unIHaA"}],"hashtags":[{"start":0,"end":10,"tag":"Medicines"},{"start":98,"end":104,"tag":"Ebola"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"507558741429202945","text":"#Medicines regulators to work together to facilitate access to potential new medicines to counter #Ebola outbreaks: http://t.co/zg3kyhTeTh","id":"507558741429202945","lang":"en","created_at":"2014-09-04T16:00:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":36,"end":40,"tag":"CTC"},{"start":71,"end":82,"tag":"Metastasis"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":105,"end":121,"username":"MGHCancerCenter","id":"61768492"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507466186788200448","text":"RT @myESMO: Circulating Tumour Cell #CTC Clusters more likely to cause #Metastasis than Single Cells via @MGHCancerCenter http://t.co/PxeQi…","id":"507466186788200448","lang":"en","created_at":"2014-09-04T09:52:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507466151530885120"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/twXLOe0nUs","expanded_url":"http://bit.ly/1nxVQsK","display_url":"bit.ly/1nxVQsK"}],"hashtags":[{"start":42,"end":53,"tag":"Translarna"},{"start":57,"end":66,"tag":"medicine"},{"start":71,"end":80,"tag":"Duchenne"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"507466029409533952","text":"We've published the assessment report for #Translarna, a #medicine for #Duchenne muscular dystrophy: http://t.co/twXLOe0nUs","id":"507466029409533952","lang":"en","created_at":"2014-09-04T09:51:44.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/sqS3G2Qy8L","expanded_url":"http://bit.ly/YdKLHs","display_url":"bit.ly/YdKLHs"}],"hashtags":[{"start":71,"end":92,"tag":"pharmacoepidemiology"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"507465583433379840","text":"We have a professional secondment opportunity for a national expert in #pharmacoepidemiology: http://t.co/sqS3G2Qy8L","id":"507465583433379840","lang":"en","created_at":"2014-09-04T09:49:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":48,"end":67,"tag":"Patient_Engagement"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507209467529011200","text":"RT @cancereu: The Challenges of Conceptualizing #Patient_Engagement in Health Care: A Lexicographic Literature Review-JoPM http://t.co/2SRS…","id":"507209467529011200","lang":"en","created_at":"2014-09-03T16:52:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507147871188049921"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":88,"end":94,"tag":"PhEur"},{"start":104,"end":109,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507209408066383872","text":"RT @edqm_news: Celebrate the 50th Anniversary of the Convention on the Elaboration of a #PhEur with the #EDQM! Places are available http://…","id":"507209408066383872","lang":"en","created_at":"2014-09-03T16:52:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507157222456320001"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/ZmwoJKNXHx","expanded_url":"http://ow.ly/B2snw","display_url":"ow.ly/B2snw"}],"hashtags":[{"start":39,"end":48,"tag":"Oncology"},{"start":64,"end":71,"tag":"immuno"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":93,"end":98,"probability":0.5036,"type":"Place","normalized_text":"Geneva"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507208956763455488","text":"RT @myESMO: Online registr. for Immuno-#Oncology Symposium 2014 #immuno now open. Join us in Geneva! http://t.co/ZmwoJKNXHx http://t.co/21z…","id":"507208956763455488","lang":"en","created_at":"2014-09-03T16:50:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507187242780352512"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/UCo3F6fdDV","expanded_url":"http://1.usa.gov/1nwPWYN","display_url":"1.usa.gov/1nwPWYN"}],"hashtags":[{"start":79,"end":93,"tag":"type2diabetes"}],"mentions":[{"start":3,"end":15,"username":"NIHprevents","id":"119486479"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507208927755653120","text":"RT @NIHprevents: New study finds that 2 in 5 Americans are expected to develop #type2diabetes during their lifetime: http://t.co/UCo3F6fdDV","id":"507208927755653120","lang":"en","created_at":"2014-09-03T16:50:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507189545750650880"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/xaKaZbMs4E","expanded_url":"http://www.surveymonkey.com/s/FXJ26HW","display_url":"surveymonkey.com/s/FXJ26HW"},{"start":94,"end":116,"url":"http://t.co/yenDLBCTH6","expanded_url":"https://twitter.com/EFSA_EU/status/507196329517670401/photo/1","display_url":"pic.twitter.com/yenDLBCTH6"}],"hashtags":[{"start":63,"end":70,"tag":"survey"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507208496602181632","text":"RT @EFSA_EU: Help us redesign our website! Complete the online #survey http://t.co/xaKaZbMs4E http://t.co/yenDLBCTH6","id":"507208496602181632","lang":"en","created_at":"2014-09-03T16:48:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507196329517670401"}],"attachments":{"media_keys":["3_507196329366675456"]}},{"entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/upvWm4gVPx","expanded_url":"http://ow.ly/B2Bbw","display_url":"ow.ly/B2Bbw"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507208197342789632","text":"RT @DigitalAgendaEU: Dealing with chronic diseases can be cheaper &amp; more effective with remote monitoring systems. http://t.co/upvWm4gVPx #…","id":"507208197342789632","lang":"en","created_at":"2014-09-03T16:47:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507197485987926017"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":18,"end":23,"tag":"EPDA"},{"start":34,"end":43,"tag":"Toolkits"},{"start":53,"end":63,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507208088978743296","text":"RT @euparkinsons: #EPDA has many '#Toolkits' to help #Parkinson's organisations. 'Working with social media' is free 2 download @ http://t.…","id":"507208088978743296","lang":"en","created_at":"2014-09-03T16:46:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507207397849329664"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/v7lrA2TftC","expanded_url":"http://bit.ly/1mmVqDQ","display_url":"bit.ly/1mmVqDQ"}],"hashtags":[{"start":96,"end":107,"tag":"pesticides"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":36,"end":45,"username":"Anses_fr","id":"1108628533"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507134616768352256","text":"RT @EFSA_EU: Registration now open: @Anses_fr &amp; EFSA conference on occupational exposure to #pesticides  http://t.co/v7lrA2TftC","id":"507134616768352256","lang":"en","created_at":"2014-09-03T11:54:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507100411602677760"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/a3rBEGzT8b","expanded_url":"http://ow.ly/B1DZz","display_url":"ow.ly/B1DZz"}],"hashtags":[{"start":30,"end":38,"tag":"eHealth"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507134454197141504","text":"RT @EU_eHealth: The latest EU #eHealth in Focus newsletter: http://t.co/a3rBEGzT8b","id":"507134454197141504","lang":"en","created_at":"2014-09-03T11:54:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507110057402986496"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/GIBlmZMmAo","expanded_url":"http://www.easdvirtualmeeting.org","display_url":"easdvirtualmeeting.org"}],"hashtags":[{"start":40,"end":49,"tag":"EASD2014"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507134168351137792","text":"RT @EASDnews: Webcasts and posters from #EASD2014 will be available, for free, beginning on September 16 - http://t.co/GIBlmZMmAo","id":"507134168351137792","lang":"en","created_at":"2014-09-03T11:53:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507123892532830208"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/zYeuo1QKlv","expanded_url":"http://www.haematologica.org/content/99/9","display_url":"haematologica.org/content/99/9"},{"start":101,"end":123,"url":"http://t.co/8iSx5SrMYt","expanded_url":"http://fb.me/6RCBMhQfx","display_url":"fb.me/6RCBMhQfx"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"EHA_Hematology","id":"279001852"}],"annotations":[{"start":43,"end":55,"probability":0.3306,"type":"Organization","normalized_text":"Haematologica"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507134117310660608","text":"RT @EHA_Hematology: The September issue of Haematologica is available online:\nhttp://t.co/zYeuo1QKlv http://t.co/8iSx5SrMYt","id":"507134117310660608","lang":"en","created_at":"2014-09-03T11:52:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"507126395336945664"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/cNPgCGpRqw","expanded_url":"http://bit.ly/1mihksM","display_url":"bit.ly/1mihksM"}],"hashtags":{},"mentions":{},"annotations":[{"start":83,"end":113,"probability":0.9368,"type":"Organization","normalized_text":"Veterinary Medicines Department"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"507134041729269760","text":"Just under two weeks to apply to our vacancy for a scientific administrator in our Veterinary Medicines Department: http://t.co/cNPgCGpRqw","id":"507134041729269760","lang":"en","created_at":"2014-09-03T11:52:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506870877976559617","text":"RT @US_FDA: Over last few years, veterinary drug sponsors have brought to market cancer treatments meant specifically for animals http://t.…","id":"506870877976559617","lang":"en","created_at":"2014-09-02T18:26:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506817429734174721"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/JR8Bd3Bs34","expanded_url":"http://ow.ly/AZfSg","display_url":"ow.ly/AZfSg"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"annotations":[{"start":64,"end":70,"probability":0.5184,"type":"Place","normalized_text":"America"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506870821747720193","text":"RT @IAPOtweets: IAPO news for Sept out now! Featuring our Latin America meeting and more. Check your inboxes or http://t.co/JR8Bd3Bs34","id":"506870821747720193","lang":"en","created_at":"2014-09-02T18:26:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506819352919027712"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/UqW1Xal7cX","expanded_url":"https://www.surveymonkey.com/s/H2SM3P9","display_url":"surveymonkey.com/s/H2SM3P9"}],"hashtags":[{"start":54,"end":61,"tag":"access"},{"start":79,"end":88,"tag":"patients"},{"start":103,"end":115,"tag":"raredisease"}],"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"},{"start":34,"end":43,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506870742001397760","text":"RT @eupatientsforum: Take part in @eurordis survey on #access to medicines for #patients living with a #raredisease: https://t.co/UqW1Xal7cX","id":"506870742001397760","lang":"en","created_at":"2014-09-02T18:26:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506828029466001408"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":52,"end":63,"tag":"healthcare"},{"start":84,"end":87,"tag":"EU"},{"start":127,"end":134,"tag":"CHAFEA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506806894607228930","text":"RT @EU_Health: What core competences &amp; skills 4 #healthcare assistants (HCA) in #EU? Call for tender: study. Ddl. 12/09/14 #CHAFEA http://t…","id":"506806894607228930","lang":"en","created_at":"2014-09-02T14:12:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506733332596817920"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/7fYOS6xyNL","expanded_url":"http://bit.ly/1CmbocO","display_url":"bit.ly/1CmbocO"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":21,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506805534041718784","text":"RT @ECDC_EU: @ECDC_EU is looking for Head of Legal Services; deadline to apply is 1 October. See: http://t.co/7fYOS6xyNL","id":"506805534041718784","lang":"en","created_at":"2014-09-02T14:07:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506785460845543424"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/tDFKhwGcR9","expanded_url":"http://bit.ly/1rKyOG4","display_url":"bit.ly/1rKyOG4"}],"hashtags":[{"start":36,"end":46,"tag":"pesticide"},{"start":87,"end":99,"tag":"prosulfuron"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506805465624625153","text":"RT @EFSAJournal: Peer review of the #pesticide risk assessment of the active substance #prosulfuron http://t.co/tDFKhwGcR9","id":"506805465624625153","lang":"en","created_at":"2014-09-02T14:06:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506786475409948672"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/ZAU4Xc7T6y","expanded_url":"http://bit.ly/1tWNaSs","display_url":"bit.ly/1tWNaSs"}],"hashtags":[{"start":24,"end":39,"tag":"HealthLiteracy"},{"start":65,"end":78,"tag":"InfantHealth"},{"start":124,"end":133,"tag":"EPHA2014"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":115,"end":121,"username":"Merck","id":"35961145"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506805394388549632","text":"RT @EPHA_EU: Bolstering #HealthLiteracy to cut down maternal and #InfantHealth inequalities:http://t.co/ZAU4Xc7T6y @Merck | #EPHA2014 series","id":"506805394388549632","lang":"en","created_at":"2014-09-02T14:06:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506792965524946944"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/LMgN5ZgUsq","expanded_url":"http://1.usa.gov/1nu50qf","display_url":"1.usa.gov/1nu50qf"}],"hashtags":[{"start":110,"end":114,"tag":"fda"},{"start":115,"end":129,"tag":"medicaldevice"}],"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506805357239611392","text":"RT @FDADeviceInfo: Circulatory System Devices Panel Committee Meeting Oct 8-9, 2014: t http://t.co/LMgN5ZgUsq #fda #medicaldevice","id":"506805357239611392","lang":"en","created_at":"2014-09-02T14:06:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506793212372353024"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/wQfq3JOAaI","expanded_url":"http://1.usa.gov/1lwk3Ee","display_url":"1.usa.gov/1lwk3Ee"}],"hashtags":[{"start":120,"end":124,"tag":"fda"},{"start":125,"end":139,"tag":"medicaldevice"}],"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506805106856435712","text":"RT @FDADeviceInfo: Transcript - 7/30/14 Gastroenterology &amp; Urology Devices Committee Meeting http://t.co/wQfq3JOAaI #fda #medicaldevice","id":"506805106856435712","lang":"en","created_at":"2014-09-02T14:05:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506805019229044736"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/cNPgCGpRqw","expanded_url":"http://bit.ly/1mihksM","display_url":"bit.ly/1mihksM"}],"hashtags":{},"mentions":{},"annotations":[{"start":77,"end":107,"probability":0.9407,"type":"Organization","normalized_text":"Veterinary Medicines Department"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"506766865797226496","text":"Two weeks left to apply to our vacancy for a scientific administrator in our Veterinary Medicines Department: http://t.co/cNPgCGpRqw","id":"506766865797226496","lang":"en","created_at":"2014-09-02T11:33:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/PM6VHG5LXq","expanded_url":"http://bit.ly/1x1K9E1","display_url":"bit.ly/1x1K9E1"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506727942387691521","text":"We have a new Head of Communication and a new Head of Human Resources: http://t.co/PM6VHG5LXq","id":"506727942387691521","lang":"en","created_at":"2014-09-02T08:58:50.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/PM6VHG5LXq","expanded_url":"http://bit.ly/1x1K9E1","display_url":"bit.ly/1x1K9E1"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"506483446534123521","text":"We've welcomed a new Head of our Communication Department and a new Head of Human Resources: http://t.co/PM6VHG5LXq","id":"506483446534123521","lang":"en","created_at":"2014-09-01T16:47:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/FEgvdmD7tW","expanded_url":"http://bit.ly/1ltkxLf","display_url":"bit.ly/1ltkxLf"}],"hashtags":[{"start":87,"end":99,"tag":"domperidone"},{"start":104,"end":113,"tag":"motilium"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506435936151146496","text":"RT @ansm: Recommendation from the French medicines agency to minimise cardiac risks of #domperidone and #motilium\n http://t.co/FEgvdmD7tW","id":"506435936151146496","lang":"en","created_at":"2014-09-01T13:38:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/GA0szYHU5h","expanded_url":"http://bit.ly/1nP4XVM","display_url":"bit.ly/1nP4XVM"}],"hashtags":[{"start":18,"end":26,"tag":"generic"},{"start":27,"end":37,"tag":"medicines"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506423282552553472","text":"RT @ansm: List of #generic #medicines: new decision from the French medicines agency\nhttp://t.co/GA0szYHU5h","id":"506423282552553472","lang":"en","created_at":"2014-09-01T12:48:14.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":37,"end":38,"probability":0.7246,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506417831811235840","text":"RT @GCessak: EMA updates guidance on EU periodic-safety-update-report single assessment for nationally authorised medicines http://t.co/Bon…","id":"506417831811235840","lang":"en","created_at":"2014-09-01T12:26:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506417769643274241"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":26,"end":31,"tag":"EFSA"},{"start":72,"end":85,"tag":"ScienceVideo"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"506411215414120448","text":"RT @EFSA_EU: Did you miss #EFSA’s virtual summer school? No worries our #ScienceVideo playlist is available all year round http://t.co/Xdow…","id":"506411215414120448","lang":"en","created_at":"2014-09-01T12:00:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"506411155330711552"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/z7AbTPEd1i","expanded_url":"http://bit.ly/1oxxA9t","display_url":"bit.ly/1oxxA9t"}],"hashtags":[{"start":27,"end":32,"tag":"PSUR"},{"start":112,"end":130,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"506399436562767872","text":"Companies: new guidance on #PSUR single assessment for nationally authorised medicines: http://t.co/z7AbTPEd1i  #pharmacovigilance","id":"506399436562767872","lang":"en","created_at":"2014-09-01T11:13:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/IWN581KcnV","expanded_url":"http://bit.ly/1sUlSJA","display_url":"bit.ly/1sUlSJA"}],"hashtags":[{"start":49,"end":64,"tag":"EudraVigilance"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"506399019187597312","text":"Two weeks left to comment on the revision of the #EudraVigilance access policy for human medicines: http://t.co/IWN581KcnV  #consultation","id":"506399019187597312","lang":"en","created_at":"2014-09-01T11:11:49.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/z7AbTPEd1i","expanded_url":"http://bit.ly/1oxxA9t","display_url":"bit.ly/1oxxA9t"}],"hashtags":[{"start":33,"end":38,"tag":"PSUR"},{"start":117,"end":135,"tag":"pharmacovigilance"}],"mentions":{},"annotations":[{"start":30,"end":31,"probability":0.5034,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"506387658080534528","text":"We've updated our guidance on EU #PSUR single assessment for nationally authorised medicines: http://t.co/z7AbTPEd1i #pharmacovigilance","id":"506387658080534528","lang":"en","created_at":"2014-09-01T10:26:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/IWN581KcnV","expanded_url":"http://bit.ly/1sUlSJA","display_url":"bit.ly/1sUlSJA"}],"hashtags":[{"start":49,"end":64,"tag":"EudraVigilance"},{"start":123,"end":136,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"506384832315015168","text":"Two more weeks to comment on the revision of the #EudraVigilance access policy for human medicines: http://t.co/IWN581KcnV #consultation","id":"506384832315015168","lang":"en","created_at":"2014-09-01T10:15:26.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":25,"tag":"ESCAIDE2014"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505376659714084864","text":"RT @ECDC_EU: #ESCAIDE2014: early bird registration discount until 1 Sept; to date, 160 abstracts selected for poster presentation http://t.…","id":"505376659714084864","lang":"en","created_at":"2014-08-29T15:29:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505373261082148864"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":119,"end":127,"tag":"JoinERN"},{"start":128,"end":135,"tag":"CHAFEA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505305888161554432","text":"RT @EU_Health: Call 4 tender: development of manual &amp; toolbox 2 assess European Reference Networks. Ddl. 12/09/14  #JoinERN #CHAFEA http://…","id":"505305888161554432","lang":"en","created_at":"2014-08-29T10:48:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505251048383340544"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/57k6xNMA4t","expanded_url":"http://bit.ly/1p1wPp1","display_url":"bit.ly/1p1wPp1"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505305821946077184","text":"RT @EU_ECHA: Our media calendar has been updated with upcoming events. Journalists, have a look! http://t.co/57k6xNMA4t http://t.co/5a9hVf4…","id":"505305821946077184","lang":"en","created_at":"2014-08-29T10:47:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505258284429737984"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":69,"end":78,"tag":"EFPC2014"},{"start":94,"end":97,"tag":"EU"},{"start":98,"end":110,"tag":"PrimaryCare"}],"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505305507222282240","text":"RT @PrimaryCare4um: Today's Patient-Centered Medical Home Care Team; #EFPC2014 to discuss the #EU #PrimaryCare variants http://t.co/meg5l49…","id":"505305507222282240","lang":"en","created_at":"2014-08-29T10:46:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505284445755039744"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":39,"end":47,"tag":"Patient"},{"start":120,"end":129,"tag":"Sustains"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":90,"end":103,"username":"benny_eklund","id":"2198059414"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505305479040737280","text":"RT @EU_eHealth: \"Digital Records - The #Patient Must Be Involved!\" (p 33-37): debate with @Benny_Eklund, coordinator of #Sustains. http://t…","id":"505305479040737280","lang":"en","created_at":"2014-08-29T10:46:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505284554069123072"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/S1MaRHw6KW","expanded_url":"http://ow.ly/AJ3sU","display_url":"ow.ly/AJ3sU"}],"hashtags":[{"start":84,"end":89,"tag":"EAMS"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505305420811214848","text":"RT @MHRAgovuk: Applying for Early Access to Medicines - Step 2: Scientific opinion. #EAMS \n http://t.co/S1MaRHw6KW","id":"505305420811214848","lang":"en","created_at":"2014-08-29T10:46:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505286344642670593"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":46,"end":65,"tag":"PublicConsultation"},{"start":95,"end":104,"tag":"OpenEFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505305353035456512","text":"RT @EFSA_EU: Have your say - take part in our #PublicConsultation on the “Transformation to an #OpenEFSA”: deadline 15 Sept  http://t.co/uN…","id":"505305353035456512","lang":"en","created_at":"2014-08-29T10:45:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505293672825761792"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/q3ek8S8C1s","expanded_url":"http://alzheimereurope.newsweaver.com/ConferenceAnnouncement/18v75l2qeje","display_url":"alzheimereurope.newsweaver.com/ConferenceAnno…"}],"hashtags":[{"start":66,"end":72,"tag":"24AEC"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"annotations":[{"start":47,"end":53,"probability":0.7397,"type":"Place","normalized_text":"Glasgow"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"505304969231474688","text":"RT @AlzheimerEurope: The latest updates on our Glasgow conference #24AEC : http://t.co/q3ek8S8C1s","id":"505304969231474688","lang":"en","created_at":"2014-08-29T10:44:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"505300706962571265"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/HOX0Vhbq8T","expanded_url":"http://ow.ly/AMQMa","display_url":"ow.ly/AMQMa"}],"hashtags":[{"start":12,"end":19,"tag":"ESMO14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504971601147092992","text":"RT @myESMO: #ESMO14 progr. is back, this time with late breaking abstract titles included! http://t.co/HOX0Vhbq8T","id":"504971601147092992","lang":"en","created_at":"2014-08-28T12:39:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504682754228105216"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/twnO38LQF2","expanded_url":"http://1.usa.gov/XEsL1X","display_url":"1.usa.gov/XEsL1X"}],"hashtags":[{"start":90,"end":97,"tag":"hiring"},{"start":98,"end":103,"tag":"jobs"},{"start":104,"end":108,"tag":"FDA"},{"start":109,"end":125,"tag":"pharmaceuticals"},{"start":126,"end":137,"tag":"pharmageek"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504971575561846784","text":"RT @FDAanimalhealth: Pharmacologist, We Need You. Apply by Sep 11 http://t.co/twnO38LQF2  #hiring #jobs #FDA #pharmaceuticals #pharmageek","id":"504971575561846784","lang":"en","created_at":"2014-08-28T12:39:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504685143714717698"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/ZFo6VUwLtb","expanded_url":"http://bit.ly/VS1yxI","display_url":"bit.ly/VS1yxI"}],"hashtags":[{"start":15,"end":21,"tag":"PhEur"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504971448763834368","text":"RT @edqm_news: #PhEur Enquiry into AIM and EDA Methodologies – Users requested to send their feedback by 30 November http://t.co/ZFo6VUwLtb","id":"504971448763834368","lang":"en","created_at":"2014-08-28T12:39:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504886776759341056"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/aSiuDfQclx","expanded_url":"http://www.evidence.nhs.uk/about-evidence-services/bulletins-and-alerts/evidence-updates","display_url":"evidence.nhs.uk/about-evidence…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504971026091237376","text":"RT @NICEcomms: We've published a new Evidence Update on acute upper gastrointestinal bleeding http://t.co/aSiuDfQclx","id":"504971026091237376","lang":"en","created_at":"2014-08-28T12:37:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504935580799893504"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":50,"end":57,"tag":"Health"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":96,"end":109,"username":"GasteinForum","id":"370067163"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504970834055036929","text":"RT @EU_eHealth: 6 shortlisted projects for the EU #Health Award 2014, the winner 2 be announced @GasteinForum in Oct. http://t.co/nmZqj3Sw8…","id":"504970834055036929","lang":"en","created_at":"2014-08-28T12:36:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504959465373052928"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/P5uZweIPyy","expanded_url":"http://us8.campaign-archive1.com/?u=7864f766b10b8edd18f19aa56&id=a74977eee1","display_url":"us8.campaign-archive1.com/?u=7864f766b10…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504633727272886274","text":"RT @NICEcomms: Here's a link to this month's NICE News: http://t.co/P5uZweIPyy","id":"504633727272886274","lang":"en","created_at":"2014-08-27T14:17:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504612526609686528"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/BoO3nD0L0x","expanded_url":"http://bit.ly/1sZy4N3","display_url":"bit.ly/1sZy4N3"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":44,"end":47,"probability":0.4434,"type":"Organization","normalized_text":"ECHA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504633538109788160","text":"RT @EU_ECHA: Did you know that you can find ECHA's decisions on REACH and BPR data sharing disputes on our website? http://t.co/BoO3nD0L0x","id":"504633538109788160","lang":"en","created_at":"2014-08-27T14:16:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504621538243391488"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/eIjnQAsYPm","expanded_url":"http://bit.ly/1C2ufJM","display_url":"bit.ly/1C2ufJM"}],"hashtags":[{"start":10,"end":15,"tag":"ANSM"},{"start":120,"end":125,"tag":"COMP"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504633332718915584","text":"RT @ansm: #ANSM has published a French summary of our orphan medicines committee's July meeting: http://t.co/eIjnQAsYPm #COMP","id":"504633332718915584","lang":"en","created_at":"2014-08-27T14:15:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/nrSyo94Ox6","expanded_url":"http://ow.ly/AIZPQ","display_url":"ow.ly/AIZPQ"},{"start":102,"end":124,"url":"http://t.co/S5Ruu3UFLn","expanded_url":"http://ow.ly/i/6FKzQ","display_url":"ow.ly/i/6FKzQ"}],"hashtags":[{"start":96,"end":101,"tag":"EAMS"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504587866547449856","text":"RT @MHRAgovuk: Guidance on how to apply for early access to medicines: \n http://t.co/nrSyo94Ox6 #EAMS http://t.co/S5Ruu3UFLn","id":"504587866547449856","lang":"en","created_at":"2014-08-27T11:14:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504577858140794880"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":16,"end":36,"tag":"VeterinaryMedicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504587759387172864","text":"RT @IFAHEurope: #VeterinaryMedicines are licenced &amp; many safety factors exist to ensure animal products are safe for consumers: http://t.co…","id":"504587759387172864","lang":"en","created_at":"2014-08-27T11:14:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504578613619204096"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/zNf5afo0G3","expanded_url":"http://goo.gl/zAjheH","display_url":"goo.gl/zAjheH"}],"hashtags":[{"start":115,"end":132,"tag":"HealthAndClimate"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":77,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504577718558949378","text":"RT @WHO: Follow WHO global conference on climate change and health via Webex (27-29 August) http://t.co/zNf5afo0G3 #HealthAndClimate","id":"504577718558949378","lang":"en","created_at":"2014-08-27T10:34:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504537210272886784"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/AItBZc39zD","expanded_url":"http://jamia.bmj.com/content/early/2014/07/24/amiajnl-2014-002804.abstract","display_url":"jamia.bmj.com/content/early/…"}],"hashtags":[{"start":48,"end":55,"tag":"health"},{"start":79,"end":87,"tag":"privacy"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":129,"end":139,"username":"JAMIA_BMJ","id":"17584832"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504577663403851776","text":"RT @EU_eHealth: Study: 13% of patients withhold #health information because of #privacy/security concerns http://t.co/AItBZc39zD @JAMIA_BMJ…","id":"504577663403851776","lang":"en","created_at":"2014-08-27T10:34:24.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504537512061452288"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/3acqsfHbt8","expanded_url":"http://ow.ly/ALuTK","display_url":"ow.ly/ALuTK"}],"hashtags":[{"start":39,"end":45,"tag":"H2020"},{"start":59,"end":64,"tag":"SMEs"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":[{"start":46,"end":53,"probability":0.5548,"type":"Other","normalized_text":"Info Day"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504577549482348544","text":"RT @EU_eHealth: Watch the video of the #H2020 Info Day for #SMEs: http://t.co/3acqsfHbt8","id":"504577549482348544","lang":"en","created_at":"2014-08-27T10:33:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504545107564326912"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/X3ZV6iua58","expanded_url":"http://www.nice.org.uk/guidance/date","display_url":"nice.org.uk/guidance/date"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504577234150387712","text":"RT @NICEcomms: Here's a full list of all our guidance, quality standards and support products for August: http://t.co/X3ZV6iua58","id":"504577234150387712","lang":"en","created_at":"2014-08-27T10:32:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504553206874390529"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/Qr0m5G3fjf","expanded_url":"http://ow.ly/ALB90","display_url":"ow.ly/ALB90"}],"hashtags":[{"start":33,"end":44,"tag":"Evaluation"},{"start":48,"end":56,"tag":"eHealth"},{"start":102,"end":108,"tag":"study"},{"start":109,"end":116,"tag":"health"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504577129703800832","text":"RT @EU_eHealth: Call for tender: #Evaluation of #eHealth Action Plan 2012-2020 http://t.co/Qr0m5G3fjf #study #health","id":"504577129703800832","lang":"en","created_at":"2014-08-27T10:32:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504559147422343168"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/6xlRnrblXt","expanded_url":"http://bit.ly/1wBrG0R","display_url":"bit.ly/1wBrG0R"},{"start":113,"end":135,"url":"http://t.co/rtRAGqmWa5","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":17,"end":28,"username":"FDArecalls","id":"18058609"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504297971346051072","text":"@JorgeHernnRamre @FDArecalls See our website for info on Pradaxa http://t.co/6xlRnrblXt or send us your query to http://t.co/rtRAGqmWa5","id":"504576323415994368","lang":"en","created_at":"2014-08-27T10:29:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"504297971346051072"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"513331314"},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/mpUaAMFrhX","expanded_url":"http://bit.ly/1nxtMFx","display_url":"bit.ly/1nxtMFx"}],"hashtags":[{"start":64,"end":74,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":10,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504573930326474753","text":"Check our new booklet on how the European regulatory system for #medicines works: http://t.co/mpUaAMFrhX","id":"504573930326474753","lang":"en","created_at":"2014-08-27T10:19:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":19,"end":21,"probability":0.8639,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504297156665442304","text":"RT @FDA_Drug_Info: FDA posts draft guidance for industry: Controlled Correspondence Related to Generic Drug Development.  http://t.co/BHts3…","id":"504297156665442304","lang":"en","created_at":"2014-08-26T15:59:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504284239941365760"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":113,"end":118,"tag":"bcsm"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504296980345274369","text":"RT @myESMO: ESMOChannel interview w/ E.de Azambuja: Reducing ovarian failure during chemo in early breast cancer #bcsm http://t.co/kX9IlXlm…","id":"504296980345274369","lang":"en","created_at":"2014-08-26T15:59:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504294826008145921"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":28,"end":36,"tag":"Twitter"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":45,"end":60,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504245122557808641","text":"RT @ECDC_EU: Follow our new #Twitter account @ECDC_Outbreaks for the latest disease outbreaks &amp; potential health threats to the EU incl #Eb…","id":"504245122557808641","lang":"en","created_at":"2014-08-26T12:33:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504188783030697984"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":89,"end":97,"tag":"vacancy"},{"start":106,"end":121,"tag":"Communications"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504244669019336704","text":"RT @EFSA_EU: Do you have strong experience in communications and people management? EFSA #vacancy Head of #Communications Dept http://t.co/…","id":"504244669019336704","lang":"en","created_at":"2014-08-26T12:31:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504191528949260289"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/BjqFYsflP3","expanded_url":"http://bit.ly/1tz9RvH","display_url":"bit.ly/1tz9RvH"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":39,"end":43,"probability":0.3636,"type":"Other","normalized_text":"IMI 2"},{"start":52,"end":57,"probability":0.9669,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504244315934445568","text":"RT @IMI_JU: There are info sessions on IMI 2 across Europe in the next few weeks. Find your local event at http://t.co/BjqFYsflP3","id":"504244315934445568","lang":"en","created_at":"2014-08-26T12:29:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504218037231558656"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/vhY5HZBTfY","expanded_url":"http://www.worldhealthsummit.org/the-summit/program/next-generation-of-science-journalists-2014.html","display_url":"worldhealthsummit.org/the-summit/pro…"}],"hashtags":[{"start":42,"end":54,"tag":"Journalists"},{"start":109,"end":115,"tag":"WHS14"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":82,"end":97,"username":"WorldHealthSmt","id":"46646735"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504244249731563521","text":"RT @EU_Health: Next Generation of Science #Journalists - Call for Applications by @WorldHealthSmt Ddl: 01.09 #WHS14 http://t.co/vhY5HZBTfY","id":"504244249731563521","lang":"en","created_at":"2014-08-26T12:29:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504226859832594432"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/mpUaAMFrhX","expanded_url":"http://bit.ly/1nxtMFx","display_url":"bit.ly/1nxtMFx"}],"hashtags":[{"start":72,"end":82,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"504244042050568192","text":"We've published a new booklet on how the European regulatory system for #medicines works: http://t.co/mpUaAMFrhX","id":"504244042050568192","lang":"en","created_at":"2014-08-26T12:28:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/s7zSarMEac","expanded_url":"http://bit.ly/1ueIxBM","display_url":"bit.ly/1ueIxBM"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504187960435408896","text":"RT @EU_ECHA: Last day to register for our ePIC industry webinar. Check out the agenda and register now http://t.co/s7zSarMEac http://t.co/r…","id":"504187960435408896","lang":"en","created_at":"2014-08-26T08:45:51.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"503912155113340928"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":35,"end":43,"tag":"Patient"},{"start":112,"end":122,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":18,"end":34,"username":"eupatientsforum","id":"545343465"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"504186916225703936","text":"RT @EU_Health: MT @eupatientsforum #Patient or health professional? Please take few minutes on benefit-risk for #medicines survey https://t…","id":"504186916225703936","lang":"en","created_at":"2014-08-26T08:41:42.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"504175621694840832"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/HjNLEfHsic","expanded_url":"http://1.usa.gov/1l17kJt","display_url":"1.usa.gov/1l17kJt"}],"hashtags":[{"start":64,"end":78,"tag":"ClinicalTrial"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":18,"end":25,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter for iPhone","conversation_id":"502882517431906304","text":"RT @DrugInfoAssn: @US_FDA unveils plan to improve collection of #ClinicalTrial Data http://t.co/HjNLEfHsic DIA's Clinical Trials Series htt…","id":"502882517431906304","lang":"en","created_at":"2014-08-22T18:18:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502858482002165761"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/gw3rg36wS7","expanded_url":"http://www.modernhealthcare.com/article/20140821/BLOG/308219995","display_url":"modernhealthcare.com/article/201408…"}],"hashtags":[{"start":32,"end":38,"tag":"drugs"},{"start":58,"end":65,"tag":"Amazon"},{"start":72,"end":76,"tag":"FDA"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":42,"end":49,"username":"amazon","id":"20793816"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502847237282889729","text":"RT @nakosbalamotis: Will we see #drugs on @amazon? --&gt; #Amazon meets #FDA: http://t.co/gw3rg36wS7","id":"502847237282889729","lang":"en","created_at":"2014-08-22T15:58:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502847104293675008"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":28,"end":36,"tag":"Twitter"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":45,"end":60,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502828231041765376","text":"RT @ECDC_EU: Follow our new #Twitter account @ECDC_Outbreaks for the latest disease outbreaks &amp; potential health threats to the EU incl #Eb…","id":"502828231041765376","lang":"en","created_at":"2014-08-22T14:42:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502828133683568640"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":118,"end":119,"probability":0.9585,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502823452223737856","text":"RT @MHRAgovuk: Our Good Clinical Practice Guide gives you guidance in conducting clinical trials for medicines in the UK. http://t.co/JPqmj…","id":"502823452223737856","lang":"en","created_at":"2014-08-22T14:23:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502817859786252288"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":56,"end":62,"tag":"Ebola"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9568,"type":"Organization","normalized_text":"FDA"},{"start":75,"end":85,"probability":0.9609,"type":"Place","normalized_text":"West Africa"},{"start":107,"end":109,"probability":0.6454,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502823367532347392","text":"RT @US_FDA: FDA has a new webpage dedicated to the 2014 #Ebola outbreak in West Africa, where we will post FDA updates http://t.co/dS5sHK7h…","id":"502823367532347392","lang":"en","created_at":"2014-08-22T14:23:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502817472706539520"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":85,"end":91,"tag":"Ebola"},{"start":92,"end":96,"tag":"WNF"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502823327644520448","text":"RT @ECDC_EU: ECDC's communicable disease threat report, Week 34; includes updates on #Ebola #WNF and Salmonella Enteriditis http://t.co/Elm…","id":"502823327644520448","lang":"en","created_at":"2014-08-22T14:23:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502814304601927680"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/mnMG9I9oX2","expanded_url":"http://bit.ly/1s9VBXn","display_url":"bit.ly/1s9VBXn"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":37,"end":45,"probability":0.4985,"type":"Other","normalized_text":"Alzheimer"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502822961091715072","text":"RT @EFPIA: Predicting Progression of Alzheimer’s Disease Using Ordinal Regression http://t.co/mnMG9I9oX2","id":"502822961091715072","lang":"en","created_at":"2014-08-22T14:21:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502805882414309377"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"},{"start":87,"end":100,"tag":"HealthClaims"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502802751316049920","text":"RT @EFSA_EU: #PublicConsultation - Revision of the guidance on gut and immune function #HealthClaims. Open until 10 Sept http://t.co/iC2ScG…","id":"502802751316049920","lang":"en","created_at":"2014-08-22T13:01:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502801391103266816"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/GVoD8NlvuI","expanded_url":"http://bit.ly/VHL6Ad","display_url":"bit.ly/VHL6Ad"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":98,"end":113,"username":"VaccinesEurope","id":"1262320285"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502802590271553536","text":"RT @EFPIA: IPROVE announces joint European vision for vaccination research http://t.co/GVoD8NlvuI @VaccinesEurope","id":"502802590271553536","lang":"en","created_at":"2014-08-22T13:00:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502794710730407936"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/S2FyI1ZRxT","expanded_url":"http://bit.ly/1p1DvmY","display_url":"bit.ly/1p1DvmY"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502802439557623809","text":"RT @GCessak: The characteristics of medicinal products covered by \nNotice of the Minister of Health of 22 August 2014 http://t.co/S2FyI1ZRxT","id":"502802439557623809","lang":"en","created_at":"2014-08-22T13:00:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/oSm9OGrXQ2","expanded_url":"http://bit.ly/1sZzebs","display_url":"bit.ly/1sZzebs"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502802017749057538","text":"RT @LV_MPA: Postponed introduction of communication solution for license applications http://t.co/oSm9OGrXQ2","id":"502802017749057538","lang":"en","created_at":"2014-08-22T12:58:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/hDJogqXAn6","expanded_url":"http://bit.ly/1mDwPxM","display_url":"bit.ly/1mDwPxM"}],"hashtags":[{"start":41,"end":48,"tag":"plasma"},{"start":57,"end":64,"tag":"fibrin"},{"start":75,"end":87,"tag":"haemostatic"},{"start":122,"end":135,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502783418355433472","text":"One week left to comment on our paper on #plasma-derived #fibrin sealant / #haemostatic products: http://t.co/hDJogqXAn6  #consultation","id":"502783418355433472","lang":"en","created_at":"2014-08-22T11:44:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/kgX3KM7BPv","expanded_url":"http://bit.ly/1obj7R5","display_url":"bit.ly/1obj7R5"}],"hashtags":[{"start":85,"end":98,"tag":"constipation"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502783296351510528","text":"One more week to comment on our guideline on the evaluation of medicines for chronic #constipation: http://t.co/kgX3KM7BPv  #consultation","id":"502783296351510528","lang":"en","created_at":"2014-08-22T11:44:13.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/GknGGNY4Gw","expanded_url":"http://bit.ly/1hZfaS0","display_url":"bit.ly/1hZfaS0"}],"hashtags":[{"start":39,"end":56,"tag":"pharmacokinetics"},{"start":83,"end":89,"tag":"renal"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502783198817177600","text":"One more week to comment: guideline on #pharmacokinetics of medicines in decreased #renal function: http://t.co/GknGGNY4Gw  #consultation","id":"502783198817177600","lang":"en","created_at":"2014-08-22T11:43:50.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/NI6UBQKcAF","expanded_url":"http://bit.ly/1hXMcg3","display_url":"bit.ly/1hXMcg3"}],"hashtags":[{"start":42,"end":49,"tag":"herbal"},{"start":63,"end":72,"tag":"Cetraria"},{"start":123,"end":136,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502783104063664128","text":"One week left to comment on our Community #herbal monograph on #Cetraria islandica (Iceland moss): http://t.co/NI6UBQKcAF  #consultation","id":"502783104063664128","lang":"en","created_at":"2014-08-22T11:43:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/8VaVUnPSrO","expanded_url":"http://bit.ly/1mPOLDe","display_url":"bit.ly/1mPOLDe"}],"hashtags":[{"start":42,"end":49,"tag":"herbal"},{"start":63,"end":73,"tag":"Agrimonia"},{"start":85,"end":94,"tag":"agrimony"},{"start":121,"end":134,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502782994965598209","text":"One week left to comment on our Community #herbal monograph on #Agrimonia eupatoria (#agrimony): http://t.co/8VaVUnPSrO  #consultation","id":"502782994965598209","lang":"en","created_at":"2014-08-22T11:43:01.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/MKlIeoi60N","expanded_url":"http://bit.ly/1pl29Ev","display_url":"bit.ly/1pl29Ev"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502763147380662272","text":"RT @URPLWMiPB: Beta interferons: risk of thrombotic microangiopathy and nephrotic syndrome: http://t.co/MKlIeoi60N","id":"502763147380662272","lang":"en","created_at":"2014-08-22T10:24:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"},{"start":36,"end":46,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502750280728211456","text":"RT @NICEcomms: Sign up for the next @TOPRANEWS roundtable event (24 Sept) to hear more about NICE's Scientific Advice programme: http://t.c…","id":"502750280728211456","lang":"en","created_at":"2014-08-22T09:33:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502750009948123136"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/NwirhUZEqg","expanded_url":"http://bit.ly/1wgrWCr","display_url":"bit.ly/1wgrWCr"}],"hashtags":[{"start":19,"end":28,"tag":"European"},{"start":29,"end":43,"tag":"Pharmacopoeia"},{"start":101,"end":107,"tag":"PhEur"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502745517089361922","text":"RT @edqm_news: New #European #Pharmacopoeia Style Guide available to download http://t.co/NwirhUZEqg #PhEur","id":"502745517089361922","lang":"en","created_at":"2014-08-22T09:14:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502745400861011968"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/dfyGzGPBE7","expanded_url":"http://bit.ly/VGFhDe","display_url":"bit.ly/VGFhDe"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502740078415052800","text":"Our office is closed on Monday. An emergency phone number will be available: http://t.co/dfyGzGPBE7","id":"502740078415052800","lang":"en","created_at":"2014-08-22T08:52:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/hDJogqXAn6","expanded_url":"http://bit.ly/1mDwPxM","display_url":"bit.ly/1mDwPxM"}],"hashtags":[{"start":41,"end":48,"tag":"plasma"},{"start":57,"end":64,"tag":"fibrin"},{"start":75,"end":87,"tag":"haemostatic"},{"start":122,"end":135,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502739040383557633","text":"One more week to comment on our paper on #plasma-derived #fibrin sealant / #haemostatic products: http://t.co/hDJogqXAn6  #consultation","id":"502739040383557633","lang":"en","created_at":"2014-08-22T08:48:22.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/kgX3KM7BPv","expanded_url":"http://bit.ly/1obj7R5","display_url":"bit.ly/1obj7R5"}],"hashtags":[{"start":85,"end":98,"tag":"constipation"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502738770501058560","text":"One week left to comment on our guideline on the evaluation of medicines for chronic #constipation: http://t.co/kgX3KM7BPv  #consultation","id":"502738770501058560","lang":"en","created_at":"2014-08-22T08:47:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/GknGGNY4Gw","expanded_url":"http://bit.ly/1hZfaS0","display_url":"bit.ly/1hZfaS0"}],"hashtags":[{"start":39,"end":56,"tag":"pharmacokinetics"},{"start":83,"end":89,"tag":"renal"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502738582986293248","text":"One week left to comment: guideline on #pharmacokinetics of medicines in decreased #renal function: http://t.co/GknGGNY4Gw  #consultation","id":"502738582986293248","lang":"en","created_at":"2014-08-22T08:46:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/NI6UBQKcAF","expanded_url":"http://bit.ly/1hXMcg3","display_url":"bit.ly/1hXMcg3"}],"hashtags":[{"start":42,"end":49,"tag":"herbal"},{"start":63,"end":72,"tag":"Cetraria"},{"start":123,"end":136,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502738374571347968","text":"One more week to comment on our Community #herbal monograph on #Cetraria islandica (Iceland moss): http://t.co/NI6UBQKcAF  #consultation","id":"502738374571347968","lang":"en","created_at":"2014-08-22T08:45:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/8VaVUnPSrO","expanded_url":"http://bit.ly/1mPOLDe","display_url":"bit.ly/1mPOLDe"}],"hashtags":[{"start":42,"end":49,"tag":"herbal"},{"start":63,"end":73,"tag":"Agrimonia"},{"start":85,"end":94,"tag":"agrimony"},{"start":121,"end":134,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"502738197009686528","text":"One more week to comment on our Community #herbal monograph on #Agrimonia eupatoria (#agrimony): http://t.co/8VaVUnPSrO  #consultation","id":"502738197009686528","lang":"en","created_at":"2014-08-22T08:45:01.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/Az3trTGoMQ","expanded_url":"http://bit.ly/1oXJuiC","display_url":"bit.ly/1oXJuiC"}],"hashtags":[{"start":59,"end":69,"tag":"Medicrime"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":15,"end":21,"probability":0.9756,"type":"Place","normalized_text":"Moldova"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502737429909241856","text":"RT @edqm_news: Moldova is the latest country to ratify the #Medicrime Convention http://t.co/Az3trTGoMQ","id":"502737429909241856","lang":"en","created_at":"2014-08-22T08:41:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502734612616187905"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/WJkKvLXIh1","expanded_url":"http://bit.ly/1s8LnGP","display_url":"bit.ly/1s8LnGP"}],"hashtags":[{"start":25,"end":36,"tag":"systematic"},{"start":37,"end":45,"tag":"reviews"},{"start":102,"end":115,"tag":"PlosMedicine"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502737199264448512","text":"RT @Aifa_ufficiale: From #systematic #reviews to interventions in clinical practice: in an article in #PlosMedicine http://t.co/WJkKvLXIh1","id":"502737199264448512","lang":"en","created_at":"2014-08-22T08:41:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":36,"end":46,"tag":"pesticide"},{"start":119,"end":132,"tag":"pyriproxyfen"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502496293080809472","text":"RT @EFSAJournal: Peer Review of the #pesticide risk assessment of confirmatory data submitted for the active\nsubstance #pyriproxyfen http:/…","id":"502496293080809472","lang":"en","created_at":"2014-08-21T16:43:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502461532157272065"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/YTcsj3EAtm","expanded_url":"http://bit.ly/1p0t4Qy","display_url":"bit.ly/1p0t4Qy"}],"hashtags":[{"start":35,"end":41,"tag":"Ebola"},{"start":94,"end":98,"tag":"EVD"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502496230757654528","text":"RT @ECDC_EU: Increased testing for #Ebola virus disease to be expected http://t.co/YTcsj3EAtm #EVD","id":"502496230757654528","lang":"en","created_at":"2014-08-21T16:43:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502464194458169344"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/BZGBwTPegv","expanded_url":"http://bit.ly/VG14eo","display_url":"bit.ly/VG14eo"}],"hashtags":[{"start":27,"end":41,"tag":"bromocriptine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502487057823186944","text":"Restrictions on the use of #bromocriptine for stopping breast milk production have been agreed: http://t.co/BZGBwTPegv","id":"502487057823186944","lang":"en","created_at":"2014-08-21T16:07:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/dfyGzGyyC7","expanded_url":"http://bit.ly/VGFhDe","display_url":"bit.ly/VGFhDe"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"502486661457264640","text":"We are closed on Monday 25 August. An emergency phone number will be available: http://t.co/dfyGzGyyC7","id":"502486661457264640","lang":"en","created_at":"2014-08-21T16:05:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/Sjh2bA0GIS","expanded_url":"http://ow.ly/AruLZ","display_url":"ow.ly/AruLZ"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502447859518947328","text":"RT @MHRAgovuk: How to report suspected unexpected serious adverse reactions during clinical trials: \n http://t.co/Sjh2bA0GIS http://t.co/3r…","id":"502447859518947328","lang":"en","created_at":"2014-08-21T13:31:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502421289605533696"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/i90uEWxEuq","expanded_url":"http://ow.ly/AzcNr","display_url":"ow.ly/AzcNr"}],"hashtags":[{"start":116,"end":121,"tag":"bcsm"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502447634301616128","text":"RT @myESMO: ESMOChannel: Reducing ovarian failure during chemotherapy in early breast cancer http://t.co/i90uEWxEuq #bcsm","id":"502447634301616128","lang":"en","created_at":"2014-08-21T13:30:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502438900045185024"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/bd4bcBRsey","expanded_url":"http://bit.ly/1AAoDEV","display_url":"bit.ly/1AAoDEV"}],"hashtags":[{"start":16,"end":21,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502386428844990464","text":"@EvePierron See #PRAC recommendations on signals adopted at the 3-6 Feb 2014 meeting: http://t.co/bd4bcBRsey","id":"502390854641025024","lang":"en","created_at":"2014-08-21T09:44:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"502386428844990464"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"518554840"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/BZGBwTPegv","expanded_url":"http://bit.ly/VG14eo","display_url":"bit.ly/VG14eo"}],"hashtags":[{"start":44,"end":58,"tag":"bromocriptine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"502381519802224640","text":"Restrictions have been agreed on the use of #bromocriptine for stopping breast milk production: http://t.co/BZGBwTPegv","id":"502381519802224640","lang":"en","created_at":"2014-08-21T09:07:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/bzsA7bKvsA","expanded_url":"http://1.usa.gov/1oZXMtd","display_url":"1.usa.gov/1oZXMtd"}],"hashtags":[{"start":19,"end":34,"tag":"ClinicalTrials"},{"start":135,"end":139,"tag":"fda"}],"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502370091976384512","text":"RT @FDADeviceInfo: #ClinicalTrials: Enhancing Data Qual, Encouraging Participation &amp; Improving Transparency http://t.co/bzsA7bKvsA #fda #me…","id":"502370091976384512","lang":"en","created_at":"2014-08-21T08:22:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502151692583202816"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/Y6b8fyy95e","expanded_url":"http://ow.ly/AwFOC","display_url":"ow.ly/AwFOC"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":46,"end":48,"probability":0.7235,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502369881921421312","text":"RT @FDA_Drug_Info: Is your medicine safe? New FDA action plan seeks to make medicine safer for women and minorities http://t.co/Y6b8fyy95e","id":"502369881921421312","lang":"en","created_at":"2014-08-21T08:21:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502186291778560000"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/nECznCeDWA","expanded_url":"http://bit.ly/1rlWZKZ","display_url":"bit.ly/1rlWZKZ"}],"hashtags":[{"start":29,"end":38,"tag":"Gazyvaro"},{"start":42,"end":51,"tag":"medicine"},{"start":76,"end":86,"tag":"leukaemia"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502129017433382912","text":"We've published the EPAR for #Gazyvaro, a #medicine for chronic lymphocytic #leukaemia: http://t.co/nECznCeDWA","id":"502129017433382912","lang":"en","created_at":"2014-08-20T16:24:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/ike3Qx7kUb","expanded_url":"http://1.usa.gov/MuVu9X","display_url":"1.usa.gov/MuVu9X"}],"hashtags":[{"start":116,"end":120,"tag":"fda"},{"start":121,"end":135,"tag":"medicaldevice"}],"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502090193823105028","text":"RT @FDADeviceInfo: Excellent customer service is important to us. Please take our survey at http://t.co/ike3Qx7kUb  #fda #medicaldevice","id":"502090193823105028","lang":"en","created_at":"2014-08-20T13:50:05.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502089794361778176"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/fZlbqZtfQ0","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":29,"end":32,"probability":0.5064,"type":"Organization","normalized_text":"ECHA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502083552423714817","text":"RT @EU_ECHA: Want to work at ECHA? Apply for our Administrative Assistant position by 1 September http://t.co/fZlbqZtfQ0","id":"502083552423714817","lang":"en","created_at":"2014-08-20T13:23:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502083488040751104"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/vfM9UaFuNH","expanded_url":"http://ow.ly/AweyR","display_url":"ow.ly/AweyR"}],"hashtags":[{"start":68,"end":76,"tag":"OSH2014"}],"mentions":[{"start":3,"end":11,"username":"EU_OSHA","id":"23600999"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502075626464239616","text":"RT @EU_OSHA: EU-OSHA showcases new research, tools and resources at #OSH2014 http://t.co/vfM9UaFuNH @OSH2014","id":"502075626464239616","lang":"en","created_at":"2014-08-20T12:52:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502034821783515137"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502075536622227456","text":"RT @egagenerics: Insights from the EGA annual meeting @IHS #pharmaceutical #industry #medicines\nhttp://t.co/TaQTSHDfQK","id":"502075536622227456","lang":"en","created_at":"2014-08-20T12:51:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502046779488337920"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":14,"end":29,"tag":"Cardiovascular"},{"start":42,"end":49,"tag":"stroke"},{"start":72,"end":76,"tag":"CVD"}],"mentions":[{"start":3,"end":12,"username":"escardio","id":"21572529"}],"annotations":[{"start":61,"end":66,"probability":0.9917,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502075497313218560","text":"RT @escardio: #Cardiovascular disease and #stroke decline in Europe but #CVD remains the single, greatest cause of death: http://t.co/cbzfU…","id":"502075497313218560","lang":"en","created_at":"2014-08-20T12:51:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502047405680758784"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/nECznCeDWA","expanded_url":"http://bit.ly/1rlWZKZ","display_url":"bit.ly/1rlWZKZ"}],"hashtags":[{"start":42,"end":51,"tag":"Gazyvaro"},{"start":55,"end":64,"tag":"medicine"},{"start":89,"end":99,"tag":"leukaemia"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Bitly","conversation_id":"502051741593247744","text":"We've published the assessment report for #Gazyvaro, a #medicine for chronic lymphocytic #leukaemia: http://t.co/nECznCeDWA","id":"502051741593247744","lang":"en","created_at":"2014-08-20T11:17:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/dxYZ2AnA9h","expanded_url":"http://arch.apec.org/about/about-arch","display_url":"arch.apec.org/about/about-ar…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502039984019628032","text":"RT @nice_intl: The use of health technology assessment in tobacco control (http://t.co/dxYZ2AnA9h). Please fill in our survey: https://t.co…","id":"502039984019628032","lang":"en","created_at":"2014-08-20T10:30:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501972108352958464"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502039793250078720","text":"RT @innovationunion: #ResearchHeadlines - The cross-border initiative focused on defence against diabetes: Type 1 diabetes results... http:…","id":"502039793250078720","lang":"en","created_at":"2014-08-20T10:29:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501994705945509888"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":32,"end":39,"tag":"active"},{"start":40,"end":55,"tag":"pharmaceutical"},{"start":56,"end":68,"tag":"ingredients"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502039628552339456","text":"RT @edqm_news: Do you work with #active #pharmaceutical #ingredients? Our webinar will cover a wide variety of related topics http://t.co/C…","id":"502039628552339456","lang":"en","created_at":"2014-08-20T10:29:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502009759709822976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"},{"start":56,"end":66,"tag":"pesticide"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502039460343975936","text":"RT @EFSA_EU: #PublicConsultation on guidance to predict #pesticide concentrations in soil closes in 2 weeks. Submit your comments: http://t…","id":"502039460343975936","lang":"en","created_at":"2014-08-20T10:28:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502021167197474816"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/xmIAqdhgSd","expanded_url":"http://bit.ly/1w8aFLH","display_url":"bit.ly/1w8aFLH"}],"hashtags":[{"start":29,"end":38,"tag":"EPHA2014"},{"start":82,"end":89,"tag":"Health"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"502039229355266048","text":"RT @EPHA_EU: Check agenda of #EPHA2014 conference: http://t.co/xmIAqdhgSd With EU #Health Commissioner. Registration closes today: http://t…","id":"502039229355266048","lang":"en","created_at":"2014-08-20T10:27:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"502033657507635201"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/Qit4jD9gF5","expanded_url":"http://bit.ly/1pafori","display_url":"bit.ly/1pafori"}],"hashtags":[{"start":77,"end":86,"tag":"research"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501752108224614400","text":"RT @EFPIA: Tumors shrink following bacteria injection http://t.co/Qit4jD9gF5 #research","id":"501752108224614400","lang":"en","created_at":"2014-08-19T15:26:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501751056775528448"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":20,"end":28,"tag":"Measles"},{"start":35,"end":43,"tag":"rubella"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":[{"start":68,"end":73,"probability":0.9859,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501750909039542272","text":"RT @WHO_Europe_VPI: #Measles &amp; #rubella will not be eliminated from Europe without stepped up action. Here's the plan: http://t.co/4DbBwYhh…","id":"501750909039542272","lang":"en","created_at":"2014-08-19T15:21:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501740634458169345"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/rGEt3lqELG","expanded_url":"http://ow.ly/AqL60","display_url":"ow.ly/AqL60"},{"start":106,"end":128,"url":"http://t.co/PFMGP34qrm","expanded_url":"http://ow.ly/i/6Av1Z","display_url":"ow.ly/i/6Av1Z"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501733443978657793","text":"RT @MHRAgovuk: Everything you need to know about clinical trials for medicines.  \n http://t.co/rGEt3lqELG http://t.co/PFMGP34qrm","id":"501733443978657793","lang":"en","created_at":"2014-08-19T14:12:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501730873793052672"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":55,"end":67,"tag":"PrimaryCare"},{"start":90,"end":95,"tag":"EFPC"},{"start":112,"end":122,"tag":"Barcelona"},{"start":123,"end":132,"tag":"EFPC2014"}],"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":37,"end":50,"username":"nsiriwardena","id":"235645730"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501733227888123905","text":"RT @PrimaryCare4um: Great video from @nsiriwardena why #PrimaryCare experts should become #EFPC member; come to #Barcelona #EFPC2014 http:/…","id":"501733227888123905","lang":"en","created_at":"2014-08-19T14:11:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501729118598471680"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/ZY4oSciOBA","expanded_url":"http://bit.ly/1oNiFOb","display_url":"bit.ly/1oNiFOb"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":43,"end":59,"username":"WorldPharmaNews","id":"43886423"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501717720665448448","text":"RT @EFPIA: Aspirin has a second effect via @WorldPharmaNews http://t.co/ZY4oSciOBA","id":"501717720665448448","lang":"en","created_at":"2014-08-19T13:10:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501717567271350272"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/cGjafiB5kh","expanded_url":"http://youtu.be/3zNL21gjwuo","display_url":"youtu.be/3zNL21gjwuo"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":42,"end":55,"tag":"ScienceVideo"},{"start":83,"end":96,"tag":"HealthClaims"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501704114192252929","text":"RT @EFSA_EU: #EFSA virtual summer school: #ScienceVideo No.6. How does EFSA assess #HealthClaims? http://t.co/cGjafiB5kh","id":"501704114192252929","lang":"en","created_at":"2014-08-19T12:15:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501700113094672384"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/kexkp18Yay","expanded_url":"http://www.medicalnewstoday.com/articles/281192.php#.U_M4QRWXj2A.twitter","display_url":"medicalnewstoday.com/articles/28119…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":49,"end":57,"probability":0.4718,"type":"Other","normalized_text":"Alzheimer"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501703988824510464","text":"RT @GCessak: DNA methylation in brain 'linked to Alzheimer's disease' | Medical News Today: http://t.co/kexkp18Yay","id":"501703988824510464","lang":"en","created_at":"2014-08-19T12:15:26.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501695946518835201"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/kOzlaWp2Ma","expanded_url":"http://www.consultation-science20.eu/","display_url":"consultation-science20.eu"}],"hashtags":[{"start":66,"end":76,"tag":"science20"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501675174794907648","text":"RT @innovationunion: Don't forget our open public consultation on #science20: science in transition http://t.co/kOzlaWp2Ma","id":"501675174794907648","lang":"en","created_at":"2014-08-19T10:20:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501674852152274944"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/n6ZsHJrltm","expanded_url":"http://bit.ly/1kRbp2K","display_url":"bit.ly/1kRbp2K"}],"hashtags":[{"start":71,"end":76,"tag":"AIFA"},{"start":77,"end":84,"tag":"EUPATI"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501670899545022465","text":"RT @Aifa_ufficiale: The patient at the centre: from theory to practice #AIFA #EUPATI http://t.co/n6ZsHJrltm","id":"501670899545022465","lang":"en","created_at":"2014-08-19T10:03:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/mLmwvqcP62","expanded_url":"http://ow.ly/AtxtW","display_url":"ow.ly/AtxtW"}],"hashtags":[{"start":23,"end":30,"tag":"Cancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501660990464086016","text":"RT @myESMO: Testicular #Cancer - Treatment Strategies &amp; Fertility Preservation. New E-Learning module http://t.co/mLmwvqcP62","id":"501660990464086016","lang":"en","created_at":"2014-08-19T09:24:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501659667224092672"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/NmMi3hesCh","expanded_url":"http://bit.ly/1tcIZ4q","display_url":"bit.ly/1tcIZ4q"}],"hashtags":[{"start":76,"end":80,"tag":"CEP"},{"start":94,"end":99,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501653047760932864","text":"RT @edqm_news: The July Activity Report for the Certification of Substances #CEP is available #EDQM http://t.co/NmMi3hesCh","id":"501653047760932864","lang":"en","created_at":"2014-08-19T08:53:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501652629018394624"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":76,"end":85,"tag":"safefood"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501644668497825793","text":"RT @IFAHEurope: Food-producing animals need to be in good health to provide #safefood. When they are ill they need medicines too: http://t.…","id":"501644668497825793","lang":"en","created_at":"2014-08-19T08:19:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501644542014398464"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/Juz7DPfeua","expanded_url":"http://europa.eu/!py39MP","display_url":"europa.eu/!py39MP"}],"hashtags":[{"start":46,"end":49,"tag":"EU"},{"start":50,"end":57,"tag":"Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501642465624211456","text":"RT @EU_Health: What projects funded under the #EU #Health Programme? Read the 2012 Annual Report http://t.co/Juz7DPfeua","id":"501642465624211456","lang":"en","created_at":"2014-08-19T08:10:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501641937137696771"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/d5STbm2Pv8","expanded_url":"http://bit.ly/1tiXa6o","display_url":"bit.ly/1tiXa6o"},{"start":91,"end":113,"url":"http://t.co/TNmqzz4QKV","expanded_url":"https://twitter.com/EFPIA/status/501641597055172608/photo/1","display_url":"pic.twitter.com/TNmqzz4QKV"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":47,"end":55,"probability":0.5468,"type":"Other","normalized_text":"Alzheimer"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501641969748426752","text":"RT @EFPIA: DNA methylation in brain 'linked to Alzheimer's disease' http://t.co/d5STbm2Pv8 http://t.co/TNmqzz4QKV","id":"501641969748426752","lang":"en","created_at":"2014-08-19T08:09:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501641597055172608"}],"attachments":{"media_keys":["3_501641596124028929"]}},{"entities":{"urls":{},"hashtags":[{"start":39,"end":47,"tag":"quality"},{"start":59,"end":80,"tag":"radiopharmaceuticals"},{"start":99,"end":104,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501641735249100800","text":"RT @edqm_news: Are you involved in the #quality control of #radiopharmaceuticals ? Sign up for the #EDQM September training session http://…","id":"501641735249100800","lang":"en","created_at":"2014-08-19T08:08:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501641080094617600"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/jSOFBAE8Mj","expanded_url":"http://bit.ly/1p8RDQz","display_url":"bit.ly/1p8RDQz"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":66,"end":103,"probability":0.3814,"type":"Organization","normalized_text":"Yuhuan Prosafe International Co., Ltd."}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501641014571188224","text":"RT @INFARMED_IP: Fake EC Certificate of conformity - Manufacturer Yuhuan Prosafe International Co., Ltd. http://t.co/jSOFBAE8Mj","id":"501641014571188224","lang":"en","created_at":"2014-08-19T08:05:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/rurZ9ia0Fm","expanded_url":"http://ow.ly/ArUJX","display_url":"ow.ly/ArUJX"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter for iPhone","conversation_id":"501421098073063425","text":"RT @IAPOtweets: Media alert! Seen but not heard? The patient voice in drug regulation today: http://t.co/rurZ9ia0Fm","id":"501421098073063425","lang":"en","created_at":"2014-08-18T17:31:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501412039257231361"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/SGpnN7Xy8g","expanded_url":"http://www.mhragmdp.co.uk/page/view/about/","display_url":"mhragmdp.co.uk/page/view/abou…"}],"hashtags":[{"start":108,"end":115,"tag":"GMDP14"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":60,"end":61,"probability":0.8161,"type":"Place","normalized_text":"EU"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter for iPhone","conversation_id":"501420722972295168","text":"RT @MHRAgovuk: Keep up to date with changes taking place in EU GMDP, GMP &amp; GDP Symposium 2014: 9-12 Dec #GMDP14 http://t.co/SGpnN7Xy8g","id":"501420722972295168","lang":"en","created_at":"2014-08-18T17:29:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501401613995900928"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":43,"end":57,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501397878460661761","text":"RT @PrimaryCare4um: Public consultation on @EU_Commission EXPH opinion on quality of health care with special emphasis on patient safety ht…","id":"501397878460661761","lang":"en","created_at":"2014-08-18T15:59:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501397769651621889"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":119,"end":130,"tag":"Parkinsons"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":[{"start":70,"end":72,"probability":0.3687,"type":"Product","normalized_text":"GPs"}]},"public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501396501600677888","text":"RT @NICEcomms: We're looking for a range of health professionals from GPs to neurosurgeons to help develop guidance on #Parkinsons \nhttp://…","id":"501396501600677888","lang":"en","created_at":"2014-08-18T15:53:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501395766100103168"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501396416078831616","text":"RT @eurordis: .@CDCN_Cure are trying to solve a deadly #raredisease w/ an innovative approach that will impact many diseases http://t.co/AZ…","id":"501396416078831616","lang":"en","created_at":"2014-08-18T15:53:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501395710760468480"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/f6cENirutG","expanded_url":"http://ow.ly/Arr3M","display_url":"ow.ly/Arr3M"}],"hashtags":{},"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501381462114181121","text":"RT @HealthCanada: Updated label changes enhance the safe and appropriate use of controlled release opioids: http://t.co/f6cENirutG","id":"501381462114181121","lang":"en","created_at":"2014-08-18T14:53:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501380566135357440"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/dhvyRuRLqk","expanded_url":"http://nyti.ms/Vz0U8x","display_url":"nyti.ms/Vz0U8x"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":63,"end":71,"username":"nytimes","id":"807095"}],"annotations":[{"start":24,"end":27,"probability":0.9806,"type":"Place","normalized_text":"U.S."}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501378289580392448","text":"RT @EFPIA: Treatment in U.S. Is Rare Chance to Study Ebola via @nytimes http://t.co/dhvyRuRLqk","id":"501378289580392448","lang":"en","created_at":"2014-08-18T14:41:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501376971486797825"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/KAKyxCxBJl","expanded_url":"http://bit.ly/1o5AtOn","display_url":"bit.ly/1o5AtOn"}],"hashtags":[{"start":82,"end":103,"tag":"medicineinteractions"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501377042303430656","text":"RT @ansm: The French medicines agency has published an update to the thesaurus of #medicineinteractions \nhttp://t.co/KAKyxCxBJl","id":"501377042303430656","lang":"en","created_at":"2014-08-18T14:36:16.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/IXCn6JzuKv","expanded_url":"http://1.usa.gov/1kOkTvu","display_url":"1.usa.gov/1kOkTvu"}],"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501369309076418560","text":"RT @FDACBER: #FDA Updated Communication on Use of Jet Injectors with Inactivated Influenza Vaccines  http://t.co/IXCn6JzuKv","id":"501369309076418560","lang":"en","created_at":"2014-08-18T14:05:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501369125688856576"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/6a1DncY9bx","expanded_url":"http://ow.ly/AqFH6","display_url":"ow.ly/AqFH6"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501362538211442688","text":"RT @MHRAgovuk: Subscribe to our Drug Safety Update to get the latest advice on medicine use: \n http://t.co/6a1DncY9bx","id":"501362538211442688","lang":"en","created_at":"2014-08-18T13:38:38.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501360495556055041"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":32,"end":42,"username":"NIAIDNews","id":"59769395"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501355661935251456","text":"RT @FDA_MCMi: Save the date for @NIAIDNews workshops on addressing challenges in antimicrobial resistance - Sept. 22-24: http://t.co/1Q2VX6…","id":"501355661935251456","lang":"en","created_at":"2014-08-18T13:11:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501355553130831872"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/lTkCcwJM9i","expanded_url":"http://ow.ly/Ar7o6","display_url":"ow.ly/Ar7o6"}],"hashtags":[{"start":107,"end":119,"tag":"OncologyPRO"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501355069208793088","text":"RT @myESMO: New from ESMO Guidelines: Myelodysplastic syndromes (MDS) - free access http://t.co/lTkCcwJM9i #OncologyPRO","id":"501355069208793088","lang":"en","created_at":"2014-08-18T13:08:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501352770059132928"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":[{"start":17,"end":25,"probability":0.9498,"type":"Place","normalized_text":"Australia"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501349928770486272","text":"RT @egagenerics: Australia joining pilot program for international cooperation in approvals of generic medicines approvals http://t.co/w2iI…","id":"501349928770486272","lang":"en","created_at":"2014-08-18T12:48:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501349840354152451"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/oD7Oy0or9C","expanded_url":"http://bit.ly/1nLnXU4","display_url":"bit.ly/1nLnXU4"}],"hashtags":[{"start":38,"end":43,"tag":"EFSA"},{"start":81,"end":94,"tag":"ScienceVideo"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501339217918976001","text":"RT @EFSA_EU: Missed the first week of #EFSA virtual summer school? Check out our #ScienceVideo playlist http://t.co/oD7Oy0or9C","id":"501339217918976001","lang":"en","created_at":"2014-08-18T12:05:58.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501337728168890369"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/HL4FyfHjax","expanded_url":"http://bit.ly/1ri5mqU","display_url":"bit.ly/1ri5mqU"}],"hashtags":[{"start":49,"end":61,"tag":"antibiotics"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501323973934997505","text":"RT @Aifa_ufficiale: Unnecessary prescriptions of #antibiotics: the role of doctors and patients http://t.co/HL4FyfHjax","id":"501323973934997505","lang":"en","created_at":"2014-08-18T11:05:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/yE0vTWpoTP","expanded_url":"http://bit.ly/1BsYnO4","display_url":"bit.ly/1BsYnO4"},{"start":101,"end":123,"url":"http://t.co/pWYUjY8a4Q","expanded_url":"https://twitter.com/EFPIA/status/501316964095393792/photo/1","display_url":"pic.twitter.com/pWYUjY8a4Q"}],"hashtags":[{"start":11,"end":20,"tag":"RESEARCH"},{"start":21,"end":28,"tag":"CANCER"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501319913248931840","text":"RT @EFPIA: #RESEARCH #CANCER - Top four cancer killer rates ‘fall by a third’ http://t.co/yE0vTWpoTP http://t.co/pWYUjY8a4Q","id":"501319913248931840","lang":"en","created_at":"2014-08-18T10:49:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501316964095393792"}],"attachments":{"media_keys":["3_501316963126509568"]}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Al0aHPDvpS","expanded_url":"http://bit.ly/1ri47rw","display_url":"bit.ly/1ri47rw"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501319763394854914","text":"RT @INFARMED_IP: Evaluation of the contribution of medicinal product for human use in the clinic: Ultibro Breezhaler http://t.co/Al0aHPDvpS","id":"501319763394854914","lang":"en","created_at":"2014-08-18T10:48:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Xg1vrjoAZo","expanded_url":"http://bit.ly/1mbks9V","display_url":"bit.ly/1mbks9V"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501319627973345280","text":"RT @INFARMED_IP: Evaluation of the contribution of medicinal product for human use in the clinic: Xoterna Breezhaler http://t.co/Xg1vrjoAZo","id":"501319627973345280","lang":"en","created_at":"2014-08-18T10:48:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/OZXxlIi4j1","expanded_url":"http://bit.ly/VyPelN","display_url":"bit.ly/VyPelN"}],"hashtags":[{"start":57,"end":69,"tag":"Horizon2020"},{"start":99,"end":105,"tag":"H2020"}],"mentions":[{"start":3,"end":16,"username":"eInclusionEU","id":"193623549"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501319384116510720","text":"RT @eInclusionEU: Commission fires starting gun for 2015 #Horizon2020 calls http://t.co/OZXxlIi4j1 #H2020","id":"501319384116510720","lang":"en","created_at":"2014-08-18T10:47:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501310302701756416"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501297432446382080","text":"RT @egagenerics: EGA Vision 2015, the Way forward for more Efficient Regulatory Environment for Generic and Biosimilar Medicines http://t.c…","id":"501297432446382080","lang":"en","created_at":"2014-08-18T09:19:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501296248654028800"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/se727byrQW","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2014/08/WC500170944.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":65,"end":89,"probability":0.7197,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501293964264501248","text":"RT @GCessak: Human medicines highlights published monthly by the European Medicines Agency - July 2014: http://t.co/se727byrQW","id":"501293964264501248","lang":"en","created_at":"2014-08-18T09:06:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501292987989905408"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/G3orSoNfSF","expanded_url":"http://www.medicalnewstoday.com/releases/281101.php?tw","display_url":"medicalnewstoday.com/releases/28110…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501281254495752192","text":"RT @GCessak: Improved understanding of bacteria's sophisticated immune system: http://t.co/G3orSoNfSF","id":"501281254495752192","lang":"en","created_at":"2014-08-18T08:15:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501280800357502976"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501280716542709760","text":"RT @EFPIA: 'No junk science': EFPIA's '3D' approach to data sharing via @ScripMikeWard http://t.co/MDnxBbJUL9","id":"501280716542709760","lang":"en","created_at":"2014-08-18T08:13:30.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"501277235991810048"}],"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/AMUd5azZlD","expanded_url":"http://bit.ly/1yPUtL2","display_url":"bit.ly/1yPUtL2"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501280192196005888","text":"RT @INFARMED_IP: Press release - OncoTICE (BCG) http://t.co/AMUd5azZlD","id":"501280192196005888","lang":"en","created_at":"2014-08-18T08:11:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/f6oTrZPUZ0","expanded_url":"http://bit.ly/YnDAfJ","display_url":"bit.ly/YnDAfJ"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"501279913924919296","text":"RT @INFARMED_IP: National Formulary of Medicines - Module on medicines for the treatment of diabetes mellitus. http://t.co/f6oTrZPUZ0","id":"501279913924919296","lang":"en","created_at":"2014-08-18T08:10:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/XRIOdWuaFE","expanded_url":"http://1.usa.gov/XEsL1X","display_url":"1.usa.gov/XEsL1X"}],"hashtags":[{"start":21,"end":29,"tag":"Vacancy"},{"start":81,"end":87,"tag":"Apply"},{"start":115,"end":120,"tag":"jobs"},{"start":121,"end":125,"tag":"FDA"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"500324406196203521","text":"RT @FDAanimalhealth: #Vacancy Announcement: Program Analyst Positions Available. #Apply Now http://t.co/XRIOdWuaFE #jobs #FDA","id":"500324406196203521","lang":"en","created_at":"2014-08-15T16:53:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"500323568354598912"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":159,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"500311240166866944","text":"RT @WHO: Decades of scientific research have failed to find a curative or preventive agent of proven safety and effectiveness in humans for…","id":"500311240166866944","lang":"en","created_at":"2014-08-15T16:01:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"500311213562396672"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":15,"end":20,"probability":0.9631,"type":"Place","normalized_text":"London"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"500310739660574721","text":"RT @MHRApress: London man sentenced to 16 weeks for repeatedly selling dangerous super-strength ‘herbal’ erection drug http://t.co/AXYXtcyu…","id":"500310739660574721","lang":"en","created_at":"2014-08-15T15:59:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"500310485838102528"}],"attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":23,"end":31,"tag":"Nigeria"},{"start":112,"end":118,"tag":"Ebola"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":274,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"500310612271169537","text":"RT @WHO: Two people in #Nigeria have died after drinking salt water which was rumoured to be protective against #Ebola","id":"500310612271169537","lang":"en","created_at":"2014-08-15T15:58:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"500309889861033984"}],"attachments":{"media_keys":{}}}]
